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As for all mammals, we have to breathe for oxygen uptake and for the release of 
carbon dioxide. Most of the oxygen is consumed in the mitochondria. Thus, oxygen 
has to be transported from the lungs to the mitochondria and carbon dioxide has to be 
transported back to the lungs. It is the purpose of this thesis to evaluate methods that 
measure this transport function i.e. circulation or cardiac output. Furthermore we 
study factors that determine cardiac output. In a normal individual who is breathing 
spontaneously, blood pressure decreases on inspiration and recovers on expiration. 
However, the change in systolic pressure does not exceed 5 mmHg. This change in 
pressure as well as in blood flow with respiration is reversed and increased during 
applied intermittent positive pressure ventilation (IPPV) in mechanically ventilated 
patients, figure 1.1.
Figure 1.1 Fluctuations of blood flow dependent on blood volume. Recordings of flow velocity an the 
aorta (Vao) and volume flow in the pulmonary artery (Q’ap) during the ventilatory cycle (V’ is air flow 
measured in tracheal cannula and PT is airway pressure) at different blood volumes. From Versprille et 
al. 1982 [2].
For instance, Jansen [1] and Versprille [2] conducted in the early-1980s several 
studies describing the influence of mechanical ventilation on cardiac output (cardio-
pulmonary interaction) in animals. From these results it became obvious that 
monitoring cardiac output and cardio-pulmonary interaction provides invaluable 
clinical information about an individual’s hemodynamic status (such as amount of 
effective circulating blood, effects of volume loading on cardiac output and effects of 
different ventilator setting on cardiac output) and the abilities to transport oxygen. 
Today, there are a number of companies that market devices for monitoring cardiac 
output and cardiac-pulmonary interaction. These devices all have a number of 
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characteristics that need to be understood before the devices can be used 
appropriately. Furthermore, these devices need to be extensively evaluated before 
they can be introduced safely and reliably in the Intensive Care Unit (ICU). The aim 
of the introduction is to give some historical, physiological and methodological 
background information. 
This thesis aims to describe the evaluation of the cardiac output methods most often 
used in the ICU. 
Historical and physiological aspects of cardiac output and respirator induced 
changes in blood flow and pressure
In early studies of continuous positive pressure ventilation (CPAP) and intermittent 
positive pressure ventilation (IPPV) in man and animals the measurement of blood 
flow was too time-consuming (Fick and indicator-dilution methods) for studying
cyclic changes in blood flow. The presence of such fluctuations has been reported 
already in 1869 by Hering in a paper entitled: “Ūber den Einfluss der Athmung auf 
den Kreislauf” [3]. From the mid-1960s, after development of the electromagnetic 
flow meter, ventilator related changes in flow during IPPV and continuous positive 
airway pressure (CPAP) ventilation were published [2, 4-6]. Recordings made by 
Jansen [1] and Versprille [2], showed the characteristic phenomenon of flow 
modulation by IPPV, figure 1.1.
Figure 1.2 Fluctuation in right ventricular stroke volume dependent on blood volume. The ratio of 
maximum right ventricular stroke volume (Qs,rv,max) and the minimum value (Qs,rv,min) is plotted against 
changes of blood volume with respect to normovolemia, which is indicated on the abscissa. Note that at 
severe hypovolemia the ratio decreases; this is comparable to shock. A study in piglets. From 
Versprille et al. 1982 [2]. 
During inflation of the lungs, venous return is hindered by an increase in intra-
thoracic pressure which results in a decrease in right ventricular output.
10
Right ventricular stroke volume is lowest at the end of lung inflation (and stays low 
during an end-inspiratory pause). When spontaneous expiration starts right ventricular 
output rapidly increases and stays at a constant level during the last part of expiration. 
Left ventricular output follows with a few heart beats behind right ventricular output 
due to the long (~ 2 seconds) transit time of blood through the pulmonary circulation. 
Left ventricular output is, however, slightly less modulated. In 1980 and 1982, Jansen
[1] and Versprille [2] showed in their animal experiments that the amplitude of 
modulation was reversely related to mean blood flow and to the volemic status of the 
animals, figure 1.2. Here modulation of ventricular output is characterized by 
maximal blood flow divided by minimal blood flow (modulation =Q’max/Q’min). 
According to the Frank-Starling mechanism [7] the decrease in transmural right 
ventricular pressure (Pra,tm) – i.e. the pressure difference over the wall of the right 
ventricle- with lung insufflation results in a decrease in right ventricular output [8, 9].
For a fixed change in transmural pressure the amount of decrease in ventricular output 
depends on the shape of and the work point on the Frank-Starling curve, figure 1.3. 
Figure 1.3 Schematic representation of the Frank-Starling relation between filling status and 
transmural pressure (X-axis) and stroke volume (Y-axis). During low filling status of the ventricle –
with a low transmural pressure, the more likely the ventricle is operating on the steep portion of the 
curve and hence a given change in filling status (Δ Pcv,tm) will induce a significant change in stroke 
volume (ΔSV). From Michard 2005 [29].
During a low filling status of the ventricle -with a low transmural pressure- stroke 
volume diminishes markedly during insufflation whereas it diminishes less strikingly 













stroke volume during mechanical ventilation with a fixed tidal volume and respirator 
frequency is low in hypervolemia and high in hypovolemic filling status of the heart. 
Perel et al. [10] used systolic arterial pressure as a surrogate for ventricular stroke 
volume and defined systolic pressure variation (SPV) during mechanical ventilation 
as the sum of Δup and Δdown, figure 1.4. For this determination a single prolonged 
end expiratory pause is needed.
Figure 1.4 Description of respiratory changes in arterial pressure during mechanical ventilation. The 
systolic pressure variation (SPV) is the difference between SPmax and SPmin a few heart beats later, 
during expiration. Pa is arterial pressure; Paw is airway pressure. From Michard 2005 [29].
Michard et al. [11] proposed to quantify respirator induced variation in arterial pulse 
pressure (PP), as surrogate for stroke volume. Pulse pressure variation (PPV) is found 
by calculation the difference between maximum (PPmax) and minimum pulse 
pressure (PPmin) over a single mechanical breath divided by the mean of both values 
i.e. PPV(%) = 100*(PPmax-PPmin)/[(PPmax+PPmin)/2], figure 1.5. 
Berkenstadt et al. [12] and Reuter et al. [13, 14] used a similar formula to determine 
pulse contour stroke volume variation. Stroke volume variation (SVV) is calculated 
as: SVV(%) = 100*(SVmax-SVmin)/[(SVmax+SVmin)/2]
Stroke volume variation (SVV) and pulse pressure variation (PPV) are an integral part 
of today’s beat-to-beat pulse contour cardiac output monitoring systems (such as 
Pulsion’s PiCCO system, LiDCO’s PulseCO system and Edwards FloTrac-Vigileo 
system, which are evaluated in this thesis).
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Figure 1.5 Description of resiratory changes in arterial pressure during mechanical ventilation. Pa is 
arterial pressure; Paw is airway pressure; PPV is pulse pressure variation; SVV is stroke volume 
variation. From Michard 2005 [29].
Also, Doppler recordings of aortic blood flow at the level of the aortic annulus or in 
the descending aorta have been used to quantify the respiratory variation in aortic 
peak velocity (APVV) or in aortic blood flow (ABFV) [15-17].
However, despite evidence generated in literature, the use of SPV, PPV or SVV 
(APVV and ABFV)  for characterizing the volemic condition is limited to patients 
who are fully dependent on mechanical ventilation (with no spontaneous breathing 
activity), who are ventilated with tidal volumes larger than 8 mL/kg and who have a 
regular heart rate. These conditions are often not fulfilled in ICU patients. 
Thermodilution as reference method for cardiac output
“In assessing any method of measurement it is clearly necessary to know the probable 
error of the standard against which it is compared” [18]. In this thesis pulmonary 
thermodilution is used as reference method for all methods evaluated. However, for a 
reliable application several conditions have to be fulfilled. First, complete mixing of 
cold injectate with blood; Second, no loss or gain of cold between the site of injection 
(entrance right atria) and site detection (pulmonary artery); Third, constant blood 
flow. The condition of constant blood flow is, as explained in the above paragraph, 
violated during mechanical ventilation. As shown in theoretical and physical models 
as well as in animal and patient studies [19-23], the errors in the estimation of mean 
flow –cardiac output- by the bolus injection technique may be very large, especially if 
the frequency content of the dilution curve is similar to that of the flow modulation as 
occurs during mechanical ventilation.
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Among different solutions for this problem Jansen et al. [23] demonstrated a very 
practical one. By averaging the results of 4 estimates initiated at moments equally 
distributed over the ventilatory cycle highly reproducible results were found in 
animals and humans [23, 24] figure 1.6. 
Figure 1.6 Calculation of cardiac output average based on a systematic selection and random selection 
of sinle estimates. Values are given in % of the mean of a series of all 12 estimates. a; 12 single 
estimates of a patient plotted against the moment of injection in the ventilatory cycle. Phase 100% is 
the same as 0% coincide with the start of insufflation. b; 6 two point averaged (2-p-a) values 
consecutively plotted on the horizontal axis, c; 4  three point averaged (3-p-a) values , and d a 3 four 
point averaged (4-p-a) value. From Jansen 1995 [25].
In a patient study [25], the standard deviation decreased from 13.0% for single 
thermodilution estimates to 3.2 % if the averaged value of 3 measurements equally 
distributed over the ventilatory cycle (for instance the first at 0% the second at 33% 
and the third at 66% of ventilatory cycle) was taken. This standard deviation was still 
7.2% for the averaged value of three randomly applied measurements. In this thesis 
the averaged value of three measurements equally spread over the ventilatory cycle 
was taken, unless it was explicitly stated differently.
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Analysis of agreement between methods of measurement
A correct evaluation of cardiac output devices from literature is often hampered by 1) 
incomplete description of the methods, patient characteristics and measurement 
conditions, 2) incomplete description of results, or 3) use of a non validated reference 
method or acceptance of an imprecise method. In this thesis different less invasive 
methods of cardiac output measurement and monitoring are evaluated against a well 
studied reference method with high precision, i.e. the bolus thermodilution method. 
The evaluation of new methods to measure physiological variables is facilitated by 
standardization of reporting results. It has been proposed that assessing repeatability 
should be followed by assessing agreement with an established technique. Bland and 
Altman [26] advocated the use of a graphical method by plotting for each subject the
difference between the method under study and the reference method against their 
mean and argued that if the new method agrees sufficiently with the old, the old may 
be replaced. Here the idea of agreement plays a crucial role. Limits of agreement are 
calculated as mean difference (bias) ± 1.96 * standard deviation (SD). SD is also 
called precision [26, 27]. Strict rules when a new method may replace an older 
reference method are given by Critchley and Critchley [28] and not by Bland-Altman. 
These rules as well as Bland-Altman plots are analysed throughout the thesis.
Outline of the thesis
In this thesis, different recently developed methods to monitor cardiac output and 
ventilator induced stroke volume and pulse pressure variation are evaluated in ICU 
patients. The thesis contains the following items:
 In the second chapter the interchange-ability of femoral artery pressure and 
radial artery pressure as input for the PiCCO pulse contour system is tested.
 In chapter 3 the quality and tracking ability of five different pulse contour 
methods are evaluated by simultaneous comparison of cardiac output values 
with that of the conventional thermodilution technique (COtd). The five 
different pulse contour methods enclosed in this study were: Wesseling’s cZ 
method; the modified Modelflow method; the LiDCO system; the PiCCO 
system and a recently developed Hemac method. 
 In chapter 4 a review of the PiCCO pulse contour cardiac output monitoring 
system is given addressing our clinical experiences with this device.
 In chapter 5 the FloTrac-Vigileo pulse contour cardiac output system is 
evaluated. Its results are compared with that of other pulse contour methods. 
 In chapter 6 the tracking abilities of cardiac output changes by three less 
invasive cardiac output methods requiring no calibration were evaluated. The 
following methods were studied: 1. FloTrac-Vigileo, 2. uncalibrated modified 
Modelflow and 3. HemoSonic100 trans-esophageal ultrasound. In this study 
cardiac output changes were achieved by changing ventilator settings and by 
passive leg raising. 
 In chapter 7 an alternative method for calibration of the modified Modelflow 
is tested. For this purpose aortic diameter is measured by the HemoSonic 100 
transesophageal ultrasound system.
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 In chapter 8 data of stroke volume variation (SVV) obtained with two different 
pulse contour systems were compared in different clinical conditions. 
 The last chapter of this thesis the main results of previous chapters will be 
summarized in English and Dutch.
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Summary
This study was performed to determine the interchangeability of femoral artery 
pressure and radial artery pressure as input of the PiCCO system (Pulsion Medical 
Systems, Munich, Germany). We studied 15 intensive care patients after cardiac 
surgery. Five second averages of the cardiac output derive from the femoral artery 
pressure (COfem) were compared to 5 second averages derived from the radial artery 
pressure (COrad). The equality of the two PiCCO devices used in this study was 
confirmed. 
One patient was excluded from our study because of problems in the pattern 
recognition of the arterial pressure signal. In the remaining fourteen patients, 14734 
comparative cardiac output values were analysed. The mean sample time was 88 min, 
range [30-119 min]. Mean (SD) COfem was 6.24 (1.1) l.min-1 and mean COrad was 
6.23 (1.1) l.min-1. The Bland-Altman analysis showed an excellent agreement with a 
bias of -0.01 l.min–1, and limits of agreement from 0.60 to -0.62 l.min-1. If changes in 
CO were larger than 0.5 l.min-1, in 97% the direction of changes in COfem and COrad 
were equal. We conclude that femoral artery pressure and radial artery pressure are 
interchangeable as input of the PiCCO device allowing to change to the radial artery 
pressure line if the preferred femoral artery pressure line is no longer available for 
use.
Introduction
During cardiac surgery as well as during the first hours of ICU care, fluctuations in 
mean arterial pressure and cardiac index are the primary indicators for intervention 
[1]. When patients are hemodynamic unstable a continuous measurement of cardiac 
output is highly desirable. For this reason, different methods to monitor cardiac output 
continuously have found there way to the operating room (OR) and intensive care unit 
(ICU) [2-8]. Among the available pulse contour methods, the PiCCO system, with 
femoral artery pressure as input and calibrated by transpulmonary thermodilution, 
appears to have a clinical acceptable accuracy and tracking capability [9]. However, 
the femoral artery catheterization might become restrained in certain patients. In these 
patients, in whom the femoral arterial catheter is no longer available, the standard 
radial artery catheter seems a logical alternative, but this approach has not been 
validated yet.
Therefore the goal of the present study is to evaluate the interchangeability of femoral 
artery pressure and radial artery pressure as input of the pulse contour method of the 
PiCCO system in patients after cardiac surgery.
Patients and methods
Patients The study was approved by the hospital ethics committee and was conducted 
according to the principles stated in the Helsinki convention. Written informed 
consent was obtained the day before surgery. Fifteen patients (11 men and 4 women, 
mean age 73 years) scheduled to undergo elective cardiac surgery on cardiopulmonary 
bypass (11 patients with CAGB and 4 patients with mitral valve annuloplasty) were 
included in the study. Patients with significant valvular regurgitation and/or atrial 
fibrillation, aneurismal deformities to the aorta or symptomatic peripheral vascular 
disease were excluded. Patients were pre-medicated with sublingual lorazepam 
(0.05mg/kg). Radial arterial blood pressure was monitored via a 20 Gauge, 3.8 cm 
long radial catheter inserted by Seldinger technique and connected to a pressure 
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transducer (PX600F, Edwards Lifesciences). Central venous pressure was measured 
with a MultiCath 3 venous catheter (Vigon GmbH & Co, Aachen, Germany), 
connected to a pressure transducer (PX600F, Edwards Lifesciences). Anaesthesia 
during surgery was performed according to institutional standards.
After transfer of the patients to the ICU, a second arterial pressure line was inserted 
with a Seldinger technique into the right femoral artery (4F, 16cm long thermistor-
tipped arterial catheter PV2014L16; Pulsion Medical Systems, Munich, Germany) and 
connected to a cardiac output monitor (PiCCO, Pulsion). Pulse contour cardiac output 
was calibrated with 3 transpulmonary thermodilution measurements. For each 
thermodilution measurement, 20ml cold (3-8oC) saline was injected, via the central 
venous catheter. The results and calculated average of the 3 cardiac output 
measurements were documented. 
All patients were mechanically ventilated with an oxygen level of 40%, a respiratory 
frequency of 12-14 min-1, and positive end expiratory pressure of 5 cmH2O. Tidal 
volume (6-8 ml.kg-1) was adapted to maintain the arterial PCO2 between 40 and 45 
mmHg. A hemodynamic stable status was achieved using fluids and catecholamines. 
The observation period started after introduction of the femoral artery catheter and 
stopped at the onset of weaning. During the observation period, up to 6 hours, the 
radial artery pressure, femoral artery pressure and central venous pressure were 
continuously stored on computer disk. The sample frequency was 100Hz and the 
resolution 0.2 mmHg. It should be noted that during this recording sessions great care 
was taken to flush, check, and if necessary, re-zero the pressure transducers when 
necessary. Every patient experienced full recovery from anaesthesia within 8 hours 
and was discharged from ICU the next, first post-operative day. 
Data analysis
Applying the same femoral blood pressure to both devices for 103 minutes, the 
equality of the two PiCCO monitoring devices was tested. The two devices were 
calibrated using the same calibration factor. The pulse contour output data of the 
PiCCO devices was collected with a computer program (PiCCOWin, Pulsion, 
Munich, Germany), with 5-second averages to allow statistical analysis.
Next, from each patient, the radial and femoral arterial pressure was played back from 
the computer disk (for at least a 1-hour period) to the two PiCCO monitoring devices. 
PiCCO1 was used for cardiac output from the femoral pressure (COfem) and PiCCO2 
was used for cardiac output calculations of the simultaneously played back radial 
arterial pressure (COrad). At start the cardiac output values were set equal to the mean 
of the three values documented at the bedside. For both COfem and COrad the same 
calibration factor was used. The pulse contour output data of the PiCCO devices were 
collected with a computer program (PiCCOWin), and the averaged data were stored 
on a computer disk every five seconds. 
Statistics
The mean statistical tool is the Bland-Altman analysis with differences in data pairs 
plotted against their mean [10]. The agreement between COfem and COrad was 
computed as bias [mean (SD)], with limits of agreement computers as bias ± 2SD. Of 
each patient, changes in COfem and changes in COrad were calculated by subtracting 
the measured cardiac output value from the mean cardiac output value of the patient. 
The agreement of changes in cardiac output were computed using a cross tabulation. 




The equality of the two devices was tested with the same femoral artery pressure as 
input for both devices. We obtained two sets of 1243 data points, each data point 
being 5-second average of the pulse contour cardiac output. These two sets were 
marked with PiCCO1 and PiCCO2. Using these sets, no difference was found 
between the two monitoring devices (bias 0.03 l.min-1, 95% CI -0.0015 to 0.0067, p = 
0.215). The upper and lower limits of agreement were 0.151 and -0.145 l.min-1, 
confirming an excellent agreement between both cardiac output devices.
In fifteen patients, radial and femoral artery blood pressure was recorded. An 
illustration of an individual patient is presented in figure 2a.1.
Figure 2a.1 Data of an individual patient. Thin line pulse contour cardiac output (CO) from the 
femoral artery pressure and solid line CO from the radial artery pressure.
One patient was excluded because of problems with the pattern recognition of the 
pressure signal, visualized on the screen of the PiCCO devices. From the remaining 
fourteen patients we analyzed a total of 1053 recording minutes (per patient mean 88
min, range [30-119 min]) resulting in 14734-paired values of COrad and COfem. The 
mean cardiac output measured with the femoral blood pressure was 6.24, SD (1.1) 
l.min-1 and with the radial arterial pressure 6.23, SD (1.1) l.min-1. This irrelevant small 
difference was, however, statistically different from zero (p = 0.05).
The Bland-Altman analysis (Fig. 2a.2) showed in excellent agreement between 
COfem and COrad. The irrelevant small bias of -0.007 l.min-1 was significant 
different from zero (95% CI = -0.012 to -0.002, p = 0.05) with upper and lower limits 
of agreement of 0.60 and -0.62 l.min–1, respectively. 
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Figure 2a.2 Bland-Altman plot with pulse contour cardiac output from the femoral artery pressure 
(COfem) and from the radial artery pressure (COrad). The solid line represents the bias and the dashed 
lines the limits of agreement.
Trending capability of the methods is indicated by plotting the relationship of changes 
of COfem versus changes of COrad, figure 2a.3. It is noticeable that in this 
relationship ideally all data point should be placed in the upper-right and the lower-
left quadrant. The agreement of positive and of negative changes of COfem and 
COrad was calculated by a cross tabulation. We found 84.8% of the changes in 
agreement with each other. When accepting a change in cardiac output smaller then ± 
0.5 l.min-1, as not clinically relevant, then 97.3 % of the changes are in agreement of 
each other.
Discussion
Our study demonstrated that the radial artery pressure is interchangeable with the 
femoral artery pressure as input of the PiCCO device. This result allows continuing 
cardiac output monitoring in case of a problem with the femoral artery pressure line 
by switching over to the more commonly used radial artery pressure line. 
The accuracy of pulse contour cardiac output from the femoral artery pressure 
calibrated by the transpulmonary arterial thermodilution technique using the PiCCO 
system has been studied in a number of different patient populations with clinically 
accepted results [9]. However, in cardiac surgical patients, femoral artery 
catheterization is often avoided to keep unrestricted access to the groin for 
cardiopulmonary bypass cannulation or placement of an intra-aortic balloon pump 
when necessary [12]. Therefore, L’E Orme et al. [11] and Wouters et al. [12]
investigated the feasibility of the brachial arterial approach to compute cardiac output.
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Figure 2a.3 Relationship between changes in femoral artery pulse contour cardiac output (change 
COfem) and changes in pulse contour radial artery cardiac output (change COrad). Ideally all data 
points should be in the upper right and in the lower left quadrant. The line of identical change is 
indicated, dashed line.
In both studies the transpulmonary thermodilution values found via the brachial artery 
agreed with the results obtained from the pulmonary artery catheter, bias 0.38, SD 
(0.77) l.min-1 and 0.91, SD (0.49) l.min-1, respectively. Therefore, both authors 
concluded that transpulmonary thermodilution cardiac output measurement via the 
brachial artery catheter is interchangeable with the cardiac output derived from a 
pulmonary artery catheter. In addition, Wouters et al. [12] showed pulse contour 
analyses using a brachial arterial catheter to agree with pulmonary artery 
thermodilution, bias 1.08, SD (0.75) l.min-1.
The main purpose of our study was to show the possibility to continue cardiac output 
monitoring, by pulse contour, in case of problems with the femoral arterial line and 
was not set up to prevent the placement of the femoral arterial line at start. To our 
opinion, the high agreement between COfem and COrad, bias -0.007, SD (0.31) l.min-
1, allows us to change from femoral to radial artery pressure line for continuation of 
the cardiac output monitoring. Furthermore, the high agreement between COfem and 
COrad indicate a sufficient pressure waveform quality of the radial artery pressure for 
pulse contour analysis. This although, different authors [13-15] reported that the 
systolic radial artery pressure is higher compared to systolic aortic pressure, diastolic 
and mean pressures were found to be equal between both sites. 
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The software in the PiCCO systems used is based on an extension of the original 
Wesseling algorithm [3]. In this algorithm stroke volume is related to the area under 
the systolic portion of the pressure wave with corrections made on basis of individual 
aortic compliance and systemic vascular resistance of the patient. As accounts for all 
pulse contour methods, ideally the aortic pressure waveform should be used as input 
of the pulse contour method. Certainly, the femoral artery pressure waveforms as well 
as the brachial artery waveform come closer to this aortic pressure waveform than the 
radial artery waveform. But, by integration the pressure over the whole systolic 
period, to obtain stroke volume, the pressure waveform purity becomes less relevant. 
Also, Wesseling et al. [3] observed no difference between pulse contour cardiac 
output derived from the aortic pressure and that from the radial artery pressure. 
Therefore, a dominant role of arterial pressure waveform on the computation of 
cardiac output by pulse contour seems not present. Our results confirmed this. 
Conclusion
We conclude that the femoral artery pressure and radial artery pressure are 
interchangeable as input of the PiCCO device to compute cardiac output allowing to 
change to the radial artery pressure line if the preferred femoral artery pressure line is 
no longer available for use. Regular visual inspection of the pressure waveform on the 
monitor screen is strongly advised.
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Letter to the editor
Monitoring cardiac output from the radial artery pressure waveform
R.M. L'E. Orme and D.W. Pigott
R.M. L'E. Orme,Cheltenham General Hospital Cheltenham GL53 7AN, UK
D.W. Pigott, John Radcliffe Hospital Oxford OX3 9DU, UK
We would like to raise a number of points concerning de Wilde and colleagues' paper 
[1] comparing the radial and femoral artery for measurement of cardiac output using 
the PiCCO system (Pulsion Medical Systems, Munich, Germany). Their study 
involved collecting radial and femoral artery pressures traces onto computer and then 
playing back the data through the PiCCO device. The radial artery pressure was 
recorded from a 3.5-cm catheter, whereas a 4 F 16cm PiCCO catheter was used for 
the femoral artery waveform. The calibration factor obtained from the femoral 
catheter by arterial thermodilution was then used to calculate cardiac output from the 
radial artery waveform. Bland-Altman analysis of radial vs femoral artery-derived 
cardiac output yielded acceptable bias and a precision of -0.01 l.min−1 and 0.61 
l.min−1, respectively.
We believe that their conclusion that radial and femoral artery pressure waveforms are 
interchangeable for cardiac output determination using the PiCCO system fails to 
appreciate the fundamental issue of calibration. To determine cardiac output via pulse 
contour analysis, it is first measured by transpulmonary arterial thermodilution using a 
modified Stewart-Hamilton equation to obtain a value for aortic impedance. 
Previously, we have shown that to achieve successful calibration requires the 
thermistor-tipped arterial catheter to be sited centrally [2]. We compared 
thermodilution measurements of cardiac output from a 50 cm radial artery catheter 
using the PiCCO system with a pulmonary artery catheter. Although the catheter tip 
was likely to lie within either the distal subclavian or proximal brachial artery, we did 
not use the brachial route as stated by de Wilde and colleagues. In addition, we were 
unable to measure cardiac output and hence reliably calibrate the device for pulse 
contour analysis when the radial catheter was withdrawn by more than 5cm despite 
using iced injectate to improve the signal to noise ratio. Pulsion Medical Systems also 
recommend that the device is calibrated at least once every 24hrs to maintain 
acceptable accuracy.
We believe, therefore, that the authors' study has limited practical application as it is 
impossible accurately to measure cardiac output by pulse contour analysis using the 
PiCCO system via a short radial catheter without first inserting a centrally sited 
thermistor-tipped catheter. Only in the unlikely situation of the failure of the dedicated 
arterial catheter following successful calibration could a radial catheter be used; and 
then it could only be used for the short-term.
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A reply
We thank Drs Orme and Pigott for their comments. They questioned our conclusion 
that radial and femoral artery pressure waveforms are interchangeable because it fails 
to take into account the fundamental issue of calibration. This is only partially correct. 
Calibration by transpulmonary thermodilution with detection of the dilution curve in 
the radial artery leads to an overestimation of cardiac output [1]. This overestimation 
is not related to a poor signal-to noise ratio, which might otherwise be compensated 
for by using iced injectate.
It is related to loss of indicator during its transport from injection to detection site.
In their letter, Orme and Pigott conclude that after changing from the femoral to the 
radial pressure site, the pulse contour method could be used for a maximum of 24hrs
because Pulsion Medical Systems recommend calibrating the PiCCO device at least 
once every 24hrs. In our opinion, they have concentrated too much on the use of
monitoring absolute cardiac output over longer time periods and therefore the 
weakness in the pulse contour method. They have ignored the ability of this technique 
in monitoring changes in cardiac output due to interventions or treatments over short 
time periods (such as hours) as well as its ability to monitor changes in the patient’s 
filling status by determining stroke volume variation or pulse pressure variation.
A further reason to undertake our study was our curiosity about whether the shape of 
the pressure wave form influences the results of pulse contour analyses. The pulse 
contour method used by Pulsion can be subdivided into two parts. The first part is 
related to the integration of the area under the systolic part of the pressure curve. This 
process filters out the shape of the curve. The second part is related to the shape of the 
pressure wave by multiplication of the arterial compliance with the first derivative of 
the arterial pressure. These two parts must be added to compute cardiac output. 
Although the shapes of the femoral and radial artery differ, the calculated cardiac 
output does not.
We showed that the more frequently available radial artery pressure is interchangeable 
with the femoral artery pressure. Both sites can be used to determine cardiac output 
estimates of equal quality. We hope this finding will result in more widespread use of 
this device and further work on its calibration by methods other than transpulmonary 
femoral thermodilution.
R.B.P. de Wilde, P.C.M. van den Berg, J.R.C. Jansen
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Summary
The bias, precision and tracking ability of five different pulse contour methods were 
evaluated by simultaneous comparison of cardiac output values from the conventional 
thermodilution technique (COtd). The five different pulse contour methods included 
in this study were: Wesseling's method (cZ); the Modelflow method; the LiDCO 
system; the PiCCO system and a recently developed Hemac method. We studied 24 
cardiac surgery patients undergoing uncomplicated coronary artery bypass grafting. In 
each patient, the first series of COtd was used to calibrate the five pulse contour 
methods. In all, 199 series of measurements were accepted by all methods and 
included in the study. COtd ranged from 2.14 to 7.55 l.min−1, with a mean of 4.81 
l.min−1. Bland-Altman analysis showed the following bias and limits of agreement: 
Wesseling's cZ, 0.23 and -0.80 to 1.26 l.min−1; Modelflow, 0.00 and -0.74 to 0.74 
l.min−1; LiDCO, -0.17 and -1.55 to 1.20 l.min−1; PiCCO, 0.14 and -1.60 to 1.89 
l.min−1; and Hemac, 0.06 and -0.81 to 0.93 l.min−1. Changes in cardiac output larger 
than 0.5 l.min−1 (10%) were correctly followed by the Modelflow and the Hemac 
method in 96% of cases. In this group of subjects, without congestive heart failure, 
with normal heart rhythm and reasonable peripheral circulation, the best results in 
absolute values as well as in tracking changes in cardiac output were measured using 
the Modelflow and Hemac pulse contour methods, based on non-linear three-element 
Windkessel models.
Introduction
Monitoring of hemodynamic pressures and cardiac output are the keystones in general 
management of surgical and intensive care patients. A change in fluid management 
and use of catecholamines is often based on these findings. However, in recent years, 
the rationale behind and efficiency of hemodynamic monitoring to affect outcome has 
been questioned [1]. One of the reasons for the limited value of cardiac output 
monitoring is the non-continuous nature of most used methods, whereas in highly 
unstable patients continuous monitoring would be more appropriate. Among the 
methods to monitor cardiac output continuously an increasing amount of attention has 
been focused on pulse contour methods [2–19]. However, in a literature survey, we 
showed large differences between various pulse contour methods and the 
conventional bolus thermodilution method [20]. We evaluated the bias, precision and 
tracking ability of five different pulse contour techniques by simultaneous comparison 
of cardiac output values with that of the standard right heart bolus thermodilution 
technique (COtd). The five methods studied were Wesseling's cZ method (COcz); the 
Modelflow method (COmf); LiDCO's PulseCO method (COli); the PiCCO method 
(COpi); and a recently developed Hemac method integrated in a haemodynamic 
monitoring and blood pressure control unit (COhe).
Methods
Patients In a prospective study the bias, precision, limits of agreement and tracking 
ability of five different pulse contour cardiac output methods were compared with 
standard thermodilution cardiac output (COtd) under conditions of routine use during 
cardiac surgery. The study was conducted according to the principles of the Helsinki 
declaration. After approval from the local ethics committee, written informed consent 
for participation in the study was obtained from all patients. This consent was 
obtained the day before surgery. All patients had symptomatic coronary artery disease 
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without previous myocardial infarction. Patients with congestive heart failure (NYHA 
class IV), aortic aneurysm, extensive peripheral arterial occlusive disease, or 
concomitant heart valve disease, were not considered for this study. Patients with 
postoperative arrhythmia or the necessity for artificial pacing or heart assist devices 
were also not considered. No postoperative complications were monitored.
Following premedication with lorazepam 5 mg two hours before surgery, a peripheral 
venous cannula, a radial artery cannula (20G) and a 7F pulmonary artery catheter 
were sited. Anaesthesia was induced and maintained with continuous infusion of 
propofol and sufentanil. Muscle relaxation was maintained with pancuronium 
bromide. The lungs were ventilated with a PEEP of 2–5 cmH2O, at a rate of 10–15 
breaths.min−1. Minute ventilation was adjusted to maintain arterial pCO2 between 4.2 
and 5.6 kPa. The patients were treated with vasodilators and/or inotropes according to 
local guidelines.
Study protocol
During the study we used the arterial pressure signal, a respiratory signal from a 
ventilator or a capnogram, a COM-2 thermodilution cardiac output computer 
(Edwards, Irvine, CA, USA), and a computer to control a proprietary 
electromechanical pump for bolus injection.
After specific identifiable changes in the patient's circulatory state a series of 
measurements was performed. We aimed to carry out a measurement series, at the 
following times; 3 min after the induction of anaesthesia, immediately after 
sternotomy, after opening of the pericardium, just before and just after cardio-
pulmonary bypass, after sternal fixation, after the completion of surgery, and after 
changes in drug dose. Pulmonary artery thermodilution was carried out with a bolus 
injection of 10 ml iced dextrose 5% solution at 4–7 °C, as measured by the in-line 
injectate sensor. All thermodilution cardiac output measurements and pulse contour 
analyses were performed over the same time periods. The radial artery pressure was 
used as input for the five pulse contour methods. Figure 3.1 shows a schematic 
diagram of the connection of the five pulse contour methods to the radial artery 
pressure. As can be observed, one pressure line and one pressure transducer are used 
to create an electrical radial pressure signal that is used by all five methods. An 
electric signal input for the PiCCO device is created using a pressure transducer 
simulator (PC80200, Pulsion Medical Systems, Munich, Germany).
The PiCCO (Pulsion) device is calibrated by a thermodilution simulator that generates 
thermodilution curves from which cardiac output (COtd) is computed by the PiCCO 
device equal to the values found by the conventional pulmonary artery thermodilution 
method. Furthermore, we used the radial artery pressure instead of the preferred 
femoral artery pressure as input for the PiCCO device because a recent study [21]
showed the interchangeability of both pressure sites.
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Figure 3.1 Schematic diagram of the setup in the five pulse contour methods with a single pressure 
transducer.
To compare the cardiac output found by each of the five different methods with 
thermodilution cardiac output, the beat-to beat values were first averaged over the 
beats recorded during a single thermodilution measurement. Next, the four averaged 
values of pulse contour cardiac output and four thermodilution cardiac output 
measurements were averaged to obtain one single pair of values for further analysis. 
All data were stored on computer disk for off-line analysis.
Arterial pulse contour techniques
The estimation of cardiac output via pulse contour analysis is an indirect method. 
Cardiac output is computed from a pressure pulsation based on a model of the 
circulation. The original concept of the pulse contour method for estimation of beat-
to- beat stroke volume was first described by Otto Frank in 1899 as the classic 
Windkessel model [22]. Most pulse contour methods used today are derived from this 
model.
Wesseling's cZ method (BMEYE, Academic Medical Center, Amsterdam, the 
Netherlands) relates cardiac output to the area under the systolic portion of the arterial 
pressure wave (Asys). Dividing Asys by aortic impedance (Zao) provides a measure 
of stroke volume: Vz = Asys/Zao. In Wesseling's model the mean arterial pressure 
(Pmean) is used to correct the pressure dependent non-linear changes in cross 
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sectional area of the aorta. The heart rate (HR) is used to correct for pressure 
reflections from the periphery. The corrections for arterial pressure and heart rate are 
age (Age) dependent. A detailed description of this method can be found elsewhere 
[2, 6]. Briefly, the computation can be written as: 
where COCZ is Wesseling's pulse contour cardiac output. The calibration factor, cal = 
COCZ/COref, is determined at least once for each patient by comparing pulse contour 
cardiac output with an absolute cardiac output estimate determined by thermodilution 
(COref).
The Modelflow method (BMEYE) simulates the classical three-element Windkessel 
model to estimate cardiac output (COmf). The model includes three principal 
components of opposition: characteristic impedance, which represents the opposition 
of the aorta to pulsatile inflow; Windkessel compliance, which represents the 
resistance of the aorta to volume increases; and peripheral resistance, which 
represents the opposition of the vascular beds to the drainage of blood. Systemic 
peripheral resistance depends on many factors, including circulatory filling, 
metabolism, sympathetic tone and presence of vaso-active drugs. Aortic compliance 
decreases substantially when arterial pressure increases. This non-linear behaviour of 
the aorta would be a major source of error if not taken into account. These non-linear 
relationships were studied in vitro by Langewouters et al. [23] and described as 
mathematical functions whose properties regress closely dependent on patient age and 
gender, and slightly dependent on height and weight. A patient's aortic cross-sectional 
area is, however, not accurately known and true values in individual patients may 
deviate about 30% from Langewouters' study population average. Thus the 
uncertainty in computed cardiac output is also 30%. Therefore, to derive absolute 
cardiac output, calibration against thermodilution is performed once for each patient 
[6, 9].
The Hemac pulse contour method is part of a hemodynamic monitoring and 
automated blood pressure control program, recently developed by two of the authors. 
Its pulse contour method is based on a three-element Windkessel model, similar to the 
Modelflow method. However, instead of relying on in vitro, non-linear relations 
between cross-sectional area of the aorta and arterial pressure described by 
Langewouters [23] we used in vivo measurements of patients to correct the 
Langewouters relations. Via this new pressure/volume relationship we computed for 
each heartbeat the Windkessel compliance and aortic characteristic impedance, based 
on mean arterial pressure of the heartbeat. Total peripheral resistance was used from 
the previous heartbeat. Blood flow is found by solving the differential equation of the 
three-element Windkessel model. Stroke volume is given by integrated the flow over 
the ejection time of the heartbeat. Multiplying the stroke volume by the heart rate 
gives the cardiac output. Next, a new value of peripheral resistance is found by 
dividing the mean pressure by the computed cardiac output. Calibration with 
thermodilution improves the absolute accuracy of the method.
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The PulseCO cardiac output method (LiDCO, London, UK) provides stroke volume 
from the arterial pressure waveform using an autocorrelation algorithm. The algorithm 
is not dependent on waveform morphology, but, it calculates nominal stroke volume 
after a pressure to volume transformation using a curvilinear pressure/volume 
relationship. The nominal stroke volume is converted to actual stroke volume by 
calibration of the algorithm. Usually, the calibration is performed by an independent 
indicator dilution measurement, e.g. lithium dilution cardiac output from the LiDCO 
system [10–12]. To allow comparisons with other measuring methods, in this study, a 
standard bolus thermodilution cardiac output method was used for calibration.
The PiCCO system (Pulsion Medical Systems, Munich, Germany) utilises pulse 
contour analysis according to a modified version of Wesseling's cZ algorithm [13, 
16]. This pulse-contour algorithm analyses the actual shape of the pressure waveform 
in addition to the area under the systolic portion of the pressure wave. The software 
takes into account the individual aortic compliance and systemic vascular resistance 
based on the following considerations. During systole, more blood is ejected from the 
left ventricle into the aorta than actually leaves the aorta. During the subsequent 
diastole, the volume remaining in the aorta flows into the arterial network at a rate 
determined by the aortic compliance (C), systemic vascular resistance (R), and the 
blood pressure (Windkessel effect). The shape of the arterial pressure curve 
(exponential decay time = R × C) after the dicrotic notch is representative for this 
passive emptying of the aorta. The systemic vascular resistance, R, is determined by 
the quotient of mean arterial pressure (MAP) and cardiac output measured by the 
reference method (R = MAP/CO). As the decay time and R are known, the 
compliance, C, can be computed. The PiCCO algorithm is summarised in the 
following equation: 
where COpi = cardiac output; K = calibration factor; HR = heart rate; P = arterial 
blood pressure; ∫P(t)dt, area under the systolic part of the pressure curve; SVR = 
systemic vascular resistance; C(p) = pressure-dependent arterial compliance; and dP/dt 
= describes the shape of the pressure wave.
The calibration and reference method
Thermodilution cardiac output measurements were performed with a computer 
controlled injectate syringe, an iced injectate container (CO-SET, Edwards, Irvine, 
CA, USA), a motor driven injectate syringe, a thermodilution pulmonary artery 
catheter, and a COM-2 cardiac output computer (Edwards). The start of a ventilatory 
cycle was derived from the ventilator. At precisely timed delays, four bolus injections 
(i.e. after 25% or 50% or 75% or 100% of respiratory cycle) were automatically 
started [24–26]. The averaged value of four measurements, equally spread over the 
ventilatory cycle, was assumed to represent the mean cardiac output [24].
Data analysis
We excluded the first series of cardiac output values in each patient from further 
analysis because it was used to calibrate the five pulse contour methods, and thus 
resulted in zero difference between the thermodilution measurements and the method 
to be evaluated.
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To evaluate the tracking capability of the pulse contour methods for each patient, a 
trend score was computed. The trend score in an individual patient is found by 
subtracting the calibration (first cardiac output value) from consecutive cardiac output 
measurements. A positive trend is observed if the changes in cardiac output were in 
the same direction, whereas a negative trend was scored with changes in opposite 
direction. Ideally, only positive scores should be present. Separate scores were 
counted for changes when thermodilution cardiac output values differed by at least a 
clinically relevant 0.5 l.min−1.
Hemodynamic stability was verified by analysis of mean arterial pressure and heart 
rate during a thermodilution series. Stability was considered absent if mean arterial 
pressure and heart rate averaged per injection period deviated more than 5% from 
their series average [9]. A condition of severe, persistent arrhythmias during 
thermodilution passage was additionally considered as absence of stability. If stability 
was not present, the series was excluded from further analysis.
Statistics
We used Bland-Altman analysis with the difference in cardiac output between COtd 
and each of the five pulse contour techniques plotted against their mean [27]. The 
agreement between pulse contour and thermodilution cardiac output is computed as 
the bias (mean (SD)), with limits of agreement computed as bias (2 SD) when 
differences followed normal distributions [27]. Normality was tested with the 
Kolmogorov-Smirnov one-sample test. The coefficient of variation was computed as 
CV = (SD/mean) × 100%. The agreement in changes was computed using cross 
tabulation. Data averages are given as mean (SD). A p-value < 0.05 was considered 
statistically significant.
Results
In five female and nineteen male patients, we performed 248 series of four cardiac 
output measurements. Twenty-four measurements were rejected due to heart rhythm 
irregularities or hemodynamic instability during measurements (defined as a deviation 
in mean arterial pressure of more than 5% within the series). Furthermore, 25 series 
were rejected because one or more of the pulse contour methods included in our study 
detected an abnormal/error condition. In four measurements an error caused 
dysfunction of all methods indicated by damped wave form detected by the 
Modelflow method, in 12 measurements the LiDCO device indicated unstable data, 
the dicrotic notch was not properly detected by the PiCCO and Hemac in twelve
patients and in six patients by the cZ method. Some series were rejected by more than 
one device. Thus, 199 series of measurements fell within the pre-set criteria and were 
accepted by all five pulse contour methods, and these were analysed.
The range of thermodilution cardiac output values was 2.14 to 7.55 l.min−1, mean 
value 4.81 l.min−1. The values of the five different pulse contour methods and of 
thermodilution are presented in Table 3.1. Bland-Altman analysis (Fig. 3.2 and Table 
3.2) showed the agreement between thermodilution cardiac output and each of the five 
different pulse contour methods.
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Table 3.1 Cardiac output by thermodilution and each of the five pulse contour methods.
Method Mean CO Range of CO
min max
l.min-1 l.min-1 l.min-1
COtd 4.81 2.14 7.55
cZ 4.57 2.22 7.21
MF 4.80 2.52 7.13
LiDCO 4.97 2.53 8.90
PiCCO 4.66 2.07 9.67
Hemac 4.74 2.38 7.99
Results of 199 observations. CO, cardiac output; mean, mean value of all series of CO measurements; max, 
min, maximal and minimal value of CO respectively; COtd, cardiac output by thermodilution.
No statistical difference could be detected between the normal distribution and the 
distributions of the differences of thermodilution and each of the five methods (the p 
value ranged from 0.08 to 0.86). The difference between thermodilution and 
Wesseling's cZ, the PiCCO and the LiDCO methods showed a small bias. The Bland-
Altman plot (Fig. 3.2) shows that the spread of values is different among the methods. 
This is confirmed by ANOVA, which showed significant (p < 0.001) unequal 
homogeneity of the variances of the five methods.
The Modelflow and Hemac pulse contour methods have the smallest bias (0.00 and 
0.06 l.min−1) and the smallest range of the limits of agreement (-0.74 to 0.74, and -
0.81 to 0.93 l.min−1). Bias and limits of agreement for LiDCO were -0.17 and -1.55 to 
1.20 l.min−1, respectively, and for PiCCO, 0.14 and -1.60 to 1.89 l.min−1, respectively.
Tracking cardiac output with serial measurements
The changes in cardiac output of each of the five pulse contour methods against 
changes in thermodilution cardiac output are shown in figure 3.3. The changes in 
cardiac output in all five pulse contour methods correlate significantly with the 
changes in cardiac output by thermodilution.
The agreement of positive and negative changes in COtd and CO in each of the five 
pulse contour methods are calculated using cross tabulation. We found the highest 
score for the Modelflow and Hemac methods, and a lower score for the LiDCO and 
PiCCO methods (Table 3.3). These scores improve if clinically irrelevant changes 
smaller than 0.5 l.min−1 (i.e. < 10% change) are not counted. Of the changes 96% 
were in agreement with each other for the Modelflow and Hemac methods.
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Figure 3.2 Bland-Altman plot with cardiac output values in five pulse contour methods and cardiac 
output values by conventional thermodilution method. CO, cardiac output; COtd, CO by 
thermodilution; COcz, CO by Wesselings cZ method; COmf, CO by Modelflow; COli, CO by the 
LiDCO system; COpi, CO by the PiCCO system; COhe, CO by the Hemac system. The solid line 
represents the bias and the dashed line the limits of agreement by 2 SD.
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Figure 3.3 Relationship between changes in cardiac output values in five pulse contour plotted against 
changes and changes in cardiac output values by conventional thermodilution method. For 
abbreviations see figure 3.2. The line of identical change is indicated (dashed line).
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n, number of observations; agreement, sum of percentage of data points in the upper right quadrant and 
in the lower left quadrant of figure 3.3; disagreement, sum of percentage of data points in the upper left 
quadrant and in the lower right quadrant of figure 3.3. 
Discussion
We evaluated the bias, precision and tracking ability of five different pulse contour 
techniques by simultaneous comparison of their cardiac output values with the cardiac 
output values measured by the conventional thermodilution technique. The mean 
difference in cardiac output between thermodilution and each of the five methods is 
low (range -0.17 to 0.33 l.min−1). However, the limits of agreement differ 
considerably, with the best results being found for the Modelflow and Hemac 
methods. Besides this, the Modelflow and Hemac were the most reliable in tracking 
changes in cardiac output, compared with COtd.
Jansen and van den Berg recently published the results of a literature survey on 
continuous cardiac output monitoring [20], which reported the results of Wesseling's 
cZ, Modelflow, LiDCO and the PiCCO method. No published results are available yet 
for the Hemac pulse contour method.
We found in our study better precision and limits of agreement for each of the pulse 
contour methods than those published, except for the LiDCO (Table 3.2). This was 
true for the PiCCO method where we used the radial artery pressure instead of the 
femoral artery pressure.
The data used in this study were filtered out by preset exclusion criteria and needed to 
be accepted by all five pulse contour methods. We could include 199 measurement 
series of outspoken quality in our evaluation. Having data accepted by all five pulse 
contour methods is clinically impractical, but we consider this strategy as the fairest 
for the purpose of our study. As this study was set up to investigate the bias, precision 
and tracking changes in cardiac output, comparison of cardiac output should not be 
impaired by inadequate arterial pressure recordings or by a poor reference method.
We used the averaged result of four thermodilution measurements under stable 
hemodynamic and ventilatory conditions to calibrate each of the five pulse contour 
methods once per patient. Thereafter, we used the same technique as reference 
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method. The injections for thermodilution cardiac output measurement were 
synchronised with the mechanical ventilation, and spread over the ventilatory cycle. 
In this way much closer estimates of real mean cardiac output can be obtained [24–
26] because ventilatory effects on circulation are taken into account. In a previous 
study we showed that our thermodilution errors are probably limited to no more than 
5% SD, whereas in clinical practice an SD of 10–20% is accepted. Application of this 
precise calibration and reference method may have positively influenced our results.
Because aortic pressure is usually not available clinically, radial artery or femoral 
artery pressure is used instead. Although the radial and femoral pressure waves are 
distorted with respect to aortic pressure, the pulse contour methods should accept 
these pressures. Measurement of cardiac output using Wesseling's cZ and Modelflow 
methods is not affected by whether the arterial pressure is measured in the aorta or in 
the radial artery [6]. Our study shows that cardiac output estimates from radial 
pressure can be accurate. In a recently published study [21] we showed the 
interchangeability of femoral artery pressure and radial artery pressure measurements 
as the input for the PiCCO system (Bland-Altman analysis showed a bias of -0.01 
l.min−1, and limits of agreement from -0.62 to 0.60 l.min−1). Therefore, it seemed 
justified to use the radial pressure as input for the PiCCO system as we did in our 
comparison.
Critchley and Critchley [28] stated that if a new method is to replace an older, 
established method, the new method should have errors not greater than the older 
method. Therefore, knowledge and a careful application of the older method as a 
reliable reference method are essential for a good evaluation of a new technique. 
Otherwise, the difference between the evaluated method and the reference method 
could be determined mainly by the reference method.
Clinically, the conventional thermodilution method has been accepted as the 'gold 
standard'. However, single estimates of cardiac output show substantial scatter (with a 
precision of 15%) [24, 26, 29, 30]. To improve the precision, the results of multiple 
measurements have to be averaged. A triplicate, randomly injected series of 
thermodilution measurements has an error of approximately 10% [24, 29, 30]. The 
averaged result of four thermodilution measurements at moments equally spread over 
the ventilatory cycle has an error of less than 5% [24].
The precision of the new method can be computed if the precision of the reference 
(ref) and the precision of the comparison (dif) are known using Pythagoras' law: 
[28]. The averaged precision of each of the five pulse contour 
methods was calculated from the averaged differences between each of the five pulse 
contour methods and the conventional bolus thermodilution method, assuming two 
levels of precision for the thermodilution, i.e. 10% and 5% (Table 3.2).
None of the five pulse contour methods can replace the thermodilution technique with 
four measurements equally spread over the ventilatory cycle, even after calibration by 
a precise thermodilution technique. However, the Modelflow method (5% vs 6%) and 
the Hemac method (5% vs 7%) come close (Table 3.2). Most of the pulse contour 
methods can replace the thermodilution technique with three measurements randomly 
applied.
All pulse contour methods included in our study require calibration for each patient 
using a method such as thermodilution. After calibration, the purpose of the pulse 
contour methods is to track clinical changes in cardiac output accurately. To analyse 
the tracking capabilities of the five pulse contour method by Bland-Altman analysis 
seems insufficient. Therefore, we plotted the changes in cardiac output by the five 
methods against thermodilution cardiac output (Fig. 3.3). Furthermore, in an attempt 
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to quantify the tracking quality of the five methods, we compared the number of 
changes of the same direction in cardiac output found by thermodilution with those 
found by each of the five methods (Table 3.3). If we consider changes smaller than 
10% (i.e. a change of 0.5 l.min−1 on a mean CO of 5.0 l.min−1) as clinical irrelevant, 
then 96% of the changes were correctly followed by the Modelflow and Hemac 
method. Therefore, these two methods are able to follow changes in cardiac output 
accurately.
Conclusion
All pulse contour techniques need a reliable invasive calibration. After calibration, 
most methods may replace the thermodilution method with a precision of 10% (i.e. 
the averaged result of three randomly performed measurements). The Modelflow and 
Hemac techniques could replace the thermodilution estimates based on the averaged 
result of four measurements done equally, spread over the ventilatory cycle. The 
slightly lower precision of the continuous pulse contour cardiac output techniques 
may, in clinical settings, be outweighed by the advantages of being automatic and 
continuous. Under research conditions the use of the conventional thermodilution 
method with four measurements equally spread over the ventilatory cycle remains the 
method of choice. Due to the character of the examined study population, it must be 
emphasised that the findings of this study are still restricted to patients without 
congestive heart failure, with normal heart rhythm and reasonable peripheral 
circulation.
Potential conflict of interest
None of the authors has any commercial interest either in the devices or in the 
manufacture of the devices named in this study.
45
References
1. Pinsky MR. Rationale for cardiovascular monitoring. Current Opinion in 
Critical Care 2003; 9:222–4. 
2. Jansen JR, Wesseling KH, Settels JJ, Schreuder JJ. Continuous cardiac output 
monitoring by pulse contour during cardiac surgery. European Heart Journal
1990; 11 (Suppl. I):26–32. 
3. Gratz I, Kraidin J, Jacobi AG, deCastro NG, Spagna P, Larijani GE. 
Continuous noninvasive cardiac output as estimated from the pulse contour 
curve. Journal of Clinical Monitoring 1992; 8:20–7. 
4. Weissman C, Ornstein EJ, Young WL. Arterial pulse contour analysis trending 
of cardiac output: hemodynamic manipulations during cerebral arteriovenous 
malformation resection. Journal of Clinical Monitoring 1993; 9:347–53. 
5. Irlbeck M, Forst H, Briegel J, Haller M, Peter K. Continuous measurement of 
cardiac output with pulse contour analysis. Anaesthesist 1995; 44:493–500. 
6. Wesseling KH, Jansen JR, Settels JJ, Schreuder JJ. Computation of aortic flow 
from pressure in humans using a nonlinear, three-element model. Journal of 
Applied Physiology 1993; 74:2566–73. 
7. Jellema WT, Wesseling KH, Groeneveld AB, Stoutenbeek CP, Thijs LG, van 
Lieshout JJ. Continuous cardiac output in septic shock by simulating a model 
of the aortic input impedance: a comparison with bolus injection 
thermodilution. Anesthesiology 1999; 90:1317–28. 
8. Harms MP, Wesseling KH, Pott F, et al. Continuous stroke volume monitoring 
by modelling flow from non-invasive measurement of arterial pressure in 
humans under orthostatic stress. Clinical Science (London) 1999; 97:291–301. 
9. Jansen JR, Schreuder JJ, Mulier JP, Smith NT, Settels JJ, Wesseling KH. A 
comparison of cardiac output derived from the arterial pressure wave against 
thermodilution in cardiac surgery patients. British Journal of Anaesthesia
2001; 87:212–22. 
10. Hamilton TT, Huber LM, Jessen ME. PulseCO: a less-invasive method to 
monitor cardiac output from arterial pressure after cardiac surgery. Annuals of 
Thoracic Surgery 2002; 74:S1408–12. 
11. Jonas MM, Tanser SJ. Lithium dilution measurement of cardiac output and 
arterial pulse waveform analysis: an indicator dilution calibrated beat-by-beat 
system for continuous estimation of cardiac output. Current Opinion in 
Critical Care 2002; 8:257–61. 
12. Linton NW, Linton RA. Estimation of changes in cardiac output from the 
arterial blood pressure waveform in the upper limb. British Journal of 
Anaesthesia 2001; 86:486–96. 
46
13. Godje O, Hoke K, Lamm P, et al. Continuous, less invasive, hemodynamic 
monitoring in intensive care after cardiac surgery. Thoracic and 
Cardiovascular Surgery 1998; 46:242–9. 
14. Garcia-Rodriguez C, Pittman J, Cassell CH, et al. Lithium dilution cardiac 
output measurement: a clinical assessment of central venous and peripheral 
venous indicator injection. Critical Care Medicine 2002; 30:2199–204. 
15. Godje O, Friedl R, Hannekum A. Accuracy of beat-to-beat cardiac output 
monitoring by pulse contour analysis in hemodynamical unstable patients.
Medical Science Monitor 2001; 7:1344–50. 
16. Godje O, Hoke K, Goetz AE, et al. Reliability of a new algorithm for 
continuous cardiac output determination by pulse-contour analysis during 
hemodynamic instability. Critical Care Medicine 2002; 30:52–8. 
17. Della Rocca G, Costa MG, Pompei L, Coccia C, Pietropaoli P. Continuous and 
intermittent cardiac output measurement: pulmonary artery catheter versus 
aortic transpulmonary technique. British Journal of Anaesthesia 2002; 
88:350–6. 
18. Della Rocca G, Costa MG, Coccia C, et al. Cardiac output monitoring: aortic 
transpulmonary thermodilution and pulse contour analysis agree with standard 
thermodilution methods in patients undergoing lung transplantation. Canadian 
Journal of Anaesthesia 2003; 50:707–11. 
19. Linton R, Band D, O'Brien T, Jonas M, Leach R. Lithium dilution cardiac 
output measurement: a comparison with thermodilution. Critical Care 
Medicine 1997; 25:1796–800. 
20. Jansen JR, van den Berg PC. Cardiac output by thermodilution and arterial 
pulse contour techniques. In: Pinsky, MR, Payen, D, . Functional 
Hemodynamic Monitoring. Berlin: Springer-Verlag, 2005:135–52.
21. de Wilde RB, Breukers RB, van den Berg PC, Jansen JR. Monitoring cardiac 
output using the femoral and radial arterial pressure waveform. Anaesthesia
2006; 61:743–6. 
22. Sagawa K, Lie RK, Schaefer J. Translation of Otto Frank's Paper 'die 
Grundform des Arteriellen Pulses'. Zeitschrift für Biologie 37: 483–526 
(1899). Journal of Molecular and Cellular Cardiology 1990; 22:253–77. 
23. Langewouters GJ, Wesseling KH, Goedhard WJ. The pressure dependent 
dynamic elasticity of 35 thoracic and 16 abdominal human aortas in vitro 
described by a five component model. Journal of Biomechanics 1985; 18:613–
20. 
47
24. Jansen JR, Schreuder JJ, Settels JJ, Kloek JJ, Versprille A. An adequate 
strategy for the thermodilution technique in patients during mechanical 
ventilation. Intensive Care Medicine 1990; 16:422–5. 
25. Jansen JR, Schreuder JJ, Bogaard JM, van Rooyen W, Versprille A. 
Thermodilution technique for measurement of cardiac output during artificial 
ventilation. Journal of Applied Physiology 1981; 51:584–91. 
26. Jansen JR, Versprille A. Improvement of cardiac output estimation by the 
thermodilution method during mechanical ventilation. Intensive Care 
Medicine 1986; 12:71–9. 
27. Bland JM, Altman DG. Statistical methods for assessing agreement between 
two methods of clinical measurement. Lancet 1986; 1:307–10. 
28. Critchley LA, Critchley JA. A meta-analysis of studies using bias and 
precision statistics to compare cardiac output measurement techniques. 
Journal of Clinical Monitoring and Computing 1999; 15:85–91. 
29. Stetz CW, Miller RG, Kelly GE, Raffin TA. Reliability of the thermodilution 
method in the determination of cardiac output in clinical practice. American 
Review of Respiratory Disease 1982; 126:1001–4. 
30. Stevens JH, Raffin TA, Mihm FG, Rosenthal MH, Stetz CW. Thermodilution 
cardiac output measurement. Effects of the respiratory cycle on its 





Review of the PiCCO device; our experience in the ICU
R.B.P. de Wilde, P.C.M van den Berg and J.R.C. Jansen
Department of Intensive Care, Leiden University Medical Center, Albinusdreef 2,
P.O.B. 9600, 2300 RC, Leiden, the Netherlands
Published in:
Neth J Crit Care 2008 april; 12(2):60-4
Letter to the editor and reply
Published in: Neth J Crit Care 2008 august; 12(4):175-9
50
Introduction
Many intensivists consider it very useful to know the cardiac output of 
hemodynamically unstable patients. For more than 30 years the pulmonary artery 
catheter (PAC) has been delivering this information. Modern PACs also permit 
continuous monitoring of right atrial pressure (RAP), right ventricular pressure (RV), 
pulmonary artery pressure, pulmonary artery wedge pressure, continuous cardiac 
output (CCO), mixed venous oxygen saturation,
RV ventricular ejection fraction and RV end diastolic volume. These parameters 
allow diagnosis of right ventricular failure (low mean arterial pressure, low CCO, and 
low mixed venous oxygen saturation, combined with a high RAP) as well as 
pulmonary hypertension. Besides the pulmonary artery catheter, echocardiography is 
the most commonly-used technique to diagnose right heart failure and pulmonary 
hypertension.
Nowadays, some authors consider the pulmonary artery catheter to be out of date, [1]. 
However, we should realize that the long history of monitoring with the PAC has 
resulted in a great deal of experience with its technology and its clinical implications 
and inadequacies, whereas the new techniques are still standing on the threshold of 
being tested in clinical practice and their shortcomings are still to be discovered. 
Besides giving information on cardiac output, these modern devices provide specific 
information about intra-vascular volume status. In mechanically ventilated subjects, 
physiological experiments on heart lung interaction showed that stroke volume 
decreases during inspiration and recovers during expiration. In the early nineteen-
eighties, a strong relationship between the magnitude of these tidal changes in stroke 
volume variations and hemodynamic filling status was shown in animals [2]. Several 
modern cardiac output devices are using this physiological principle to offer 
information about fluid responsiveness, i.e. they provide information to answer the 
question: Will fluid administration increase cardiac output in this patient? This 
clinical application has generated many papers and reviews over the past few years [3-
7].
In this review we focus on the PiCCO device (Pulsion Medical Systems, Munich, 
Germany), the first widely available commercial system for measuring and 
monitoring of cardiac output by arterial pulse contour analysis. We will describe the 
basic principle of the device and the monitoring approach. Furthermore, we will 
review the main parameters and we will discuss the use as well as the limitations of 
this device in the light of our own experience.
The PiCCO system
This system combines a transpulmonary thermodilution technique and an arterial 
pulse contour method into one instrument (Fig. 4a.1).
PiCCO’s pulse contour method
The estimation of cardiac output via pulse contour analysis is an indirect method, 
computed from arterial pressure pulsation based on a model of the circulation. The 
original concept of the pulse contour method for estimation of beat-to-beat stroke 
volume was first described by Otto Frank in 1899 as the classic Windkessel model. 
Most pulse contour methods used today are derived from this model.
51








Global End-Diastolic Volume 
Intrathoracic Blood Volume 
Extravascular Lung Water
Pulmonary Vascular Permeability Index 
Cardiac Function Index 
Global Ejection Fraction




Stroke Volume Variation 
Pulse Pressure Variation
Systemic Vascular Resistance 







Figure 4a.1 The PiCCO system with the transpulmonary thermodilution technique and the pulse 
contour technique. In the upper panel a schematic diagram of the transpulmonary thermodilution 
method, with injection of cold fluid central venously and detection of the dilution curve in the femoral 
artery. CVP, central venous pressure; RA, right atria; RV, right ventricle; LA, left atria pressure; LV, 
left ventricular; Pfem, femoral artery pressure. In the lower panels the parameters derived from these 
two techniques are given.
The PiCCO - system utilizes pulse contour analysis according to a modified version of 
Wesseling’s cZ algorithm [8, 9]. This pulsecontour algorithm analyzes the actual 
shape of the pressure waveform in addition to the area under the systolic portion of 
the pressure wave (Fig. 4a.2).
Figure 4a.2 The pulse contour algorithm. After calibration by the transpulmonary thermodilution 
technique the system is able to follow cardiac output beat by beat. For further explanation see text.
The software takes into account the individual aortic compliance and systemic 
vascular resistance based on the following considerations. During systole, more blood 
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is ejected from the left ventricle into the aorta than blood that actually leaves the 
aorta. During the subsequent diastole, the volume stored in the aorta flows into the 
arterial network at a rate determined by the aortic compliance (C), systemic vascular 
resistance (R), and the blood pressure (Windkessel effect). The shape of the arterial 
pressure curve (exponential decay time = R x C) after the dicrotic notch is 
representative for this passive emptying of the aorta. The systemic vascular resistance, 
R, is determined by the quotient of mean arterial pressure (MAP) and cardiac output
measured by the reference method (R=MAP/CO). As the decay time and R are 
known, compliance, C, can be computed. The PiCCO algorithm is summarized in the 
equation in figure 4a.2.
  dP/dt)dt x C(P(t)/SVR x HR x calPCCO (P)
Where: PCCO, cardiac output; cal, calibration factor; HR, heart rate; P, arterial blood 
pressure; ∫P(t)dt, area under the systolic part of the pressure curve; SVR, systemic 
vascular resistance; C(P), pressure dependent arterial compliance; dP/dt, describes the 
shape of the pressure wave. This version of the PiCCO device was published by 
Godje et al. [10] in 2002.
Input pressure for pulse contour analysis
In clinical practice, aortic pressure cannot be measured and the radial artery or 
femoral artery pressure are used instead. Although radial and femoral pressure waves 
are distorted by reflections, pulse contour methods should accept these pressures. As 
was shown by Wesseling KH et al. [9], cardiac output derived from aortic pressure is
not different from that derived from radial artery pressure. Recently, we [11] showed 
the interchangeability of femoral and radial pressure signals as input for the PiCCO 
device. These findings are in agreement with the results reported by Mignini et al. 
[12] who demonstrated that mean arterial blood pressure from radial or femoral 
arteries are clinically interchangeable. In addition, Soderstrom et al. [13] showed that 
left ventricular afterload can be derived from the radial artery pressure, after backward 
filtering to the aortic pressure. It is not clear which type of backward filtering has 
been integrated into the PiCCO device.
PiCCO’s transpulmonary thermodilution method
To derive the calibration factor “cal” and the individual compliance function C(p) a 
reference cardiac output is needed. PiCCO utilizes a transpulmonary thermodilution 
technique, where cardiac output is determined after central venous injection of a 
volume (Vi) of at least 10mL indicator with a temperature (Ti) of at least 10 °C below
blood temperature (Tb). After passage through the right heart, lungs and left heart 
(Fig. 4a.1), the resulting temperature change (ΔTb) is measured with a thermistor 
tipped catheter, usually sited in the femoral artery. Cardiac output is calculated by the 
classical Steward - Hamilton equation: COao=k*(Tb-Ti)*Vi/(∫∆Tb.dt), where: ∫ΔTb.dt 
is the area under the thermodilution dilution curve (Fig.4a.1), k is a computation 
constant depending on type of injection catheter and on specific heat and specific 
mass of blood and injection fluid respectively.
 To measure the transpulmonary thermodilution curve, L’E Orme et al. [14] tested an 
alternative site. They compared the results obtained with a standard femoral artery 
catheter with a thermistor tipped, 50cm long, radial artery catheter. With a bias, for 
the difference between the two approaches, of 0.38 (SD 0.77), they concluded that 
53
both approaches are interchangeable. Many authors compared conventional 
pulmonary thermodilution (COpa) with transpulmonary thermodilution (COao) and 
found an acceptable agreement between the two methods, see [15] for references. 
However, in most papers a small overestimation of COao compared to COpa was 
found, explained by incomplete recovery of cold indicator after its passage through 
the pulmonary circulation.
Validation studies on accuracy and precision
Several comparisons have been made between PiCCO’s new pulse contour cardiac 
output and conventional bolus thermodilution cardiac output (COpa) [10, 16-20] 
(Table 4a.1). An individual example of such a comparison is shown in figure 4a.3.
Table 4a.1 Comparison between conventional thermodilution cardiac output and PiCCO’s pulse contour cardiac 
output.
Authors and references Number of   Bias ±SD Limits of 
agreement
Patients / Measurements L/min L/min
Gödje O et al. [10] 24 / 517 -0.2 ± 1.15 -2.32 to 2.28
Felbinger et al.* [16] 20 / 360 -0.28 ± 0.66 -1.46 to 1.18
Della Rocca et al. [17] 62 / 186 -0.02 ± 0.74 -1.50 to 1.46
Dell Rocca et al. [18] 58 / 318 -0.04 ± 0.85 -1.65 to 1.73
Mielck et al. [19] 22 / 96 -0.40 ± 1.3 -3.00 to 2.20
De Wilde et al.** [20] 27 / 199  0.14 ± 0.87 -1.60 to 1.88
Cardiac output estimated from cardiac index, ** radial artery pressure used instead of femoral artery pressure.
Although these evaluations of the PiCCO pulse contour device reveal acceptable 
results with respect to the bias (range from -0.40 to 0.31 L/min), the limits of 
agreement show considerable differences between studies. Possible explanations of 
these phenomena are probably related to alterations in vascular compliance and to 
peripheral vascular resistance during the studies. Therefore, in our opinion, due to re-
warming during the first few hours on the ICU, a regular recalibration of cardiac 
output at 4-6 hr intervals seems necessary in postoperative cardiac surgical patients. 
During our studies [11, 15, 20] two more problems came to light, namely the 
phenomenon of misclassification of a heartbeat, and false detection of the dicrotic 
notch in the pressure recording. Under these circumstances we found false high 
cardiac output values in combination with a false high value of stroke volume 
variation. In using the radial artery pulse wave with the PiCCO [11], we incidentally 
also encountered temporarily false low cardiac output values, due to damping of the 
arterial waveform by clotting and due to local vasospasm after flushing the arterial 
line.
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Figure 4a.3 Trend recording of an individual patient. Observation moments are indicated by A to E. 
Solid line cardiac output (CO) by the continuous thermodilution method (CCO). At point A PiCCO’s 
pulse contour method is calibrated. At the observation moments, the bolus thermodilution CO is 
indicated by symbol ○ and PiCCO’s pulse contour CO is indicated by symbol □.
Why not comparing PCCO with COao?
In a recent study, Della Rocca et al. [17] compared the results of cardiac output of two 
intermittent methods; -pulmonary thermodilution (COpa) and transpulmonary 
thermodilution (COao) - with the results of two continuous cardiac output methods -
PCCO (PiCCO) and CCO (Edwards)- (Table 4a.1). Measurement of COpa by the 
PiCCO device results in an automatic calibration of PiCCO’s pulse contour cardiac 
output, PCCO. Therefore, during each comparison of COao and PCCO the system 
automatically recalibrates PCCO. Tzenkov and Perez Peña [21] questioned, correctly, 
the method of automatic recalibration of the PiCCO system as used by Della Rocca 
and colleagues [17] as well as of other authors. Because of this automatic 
recalibration of the PiCCO system, the value of PCCO after recalibration is in 
principle equal to thermodilution COao. This automatic recalibration was considered 
to be misleading [21], figure 4a.4. 
When performing a comparative study it is normal that the necessary practical 
operations are first carried out before recording the results of COao and PCCO. But, 
with the PiCCO it is necessary to record PCCO results first and then perform three or 
more thermodilution measurements and to make a note of the average results of these 
three measurements afterwards. In their answer to Tzenkov and Perez Peña, Della 
Rocca and colleagues stated: “As previously reported by Rödig et al. [22], Gödje et al. 
[23, 24] and Bottiger et al. [25]: we measured PCCO immediately before and after the 
series of intermittent COao measurements, and the averages of these data pairs were 
recorded”. If we understand this statement correctly, the difference found between 
PCCO and COao must be multiplied by two, because PCCO after performing the 
measurement of COao (recalibration) is equal to COao. Difference= COao-
(PCCObefore+PCCOafter)/2, as PCCOafter=COao it follows that the computed 
Difference=(COao-CCObefore)/2. To prevent such uncertainty about the presented 
data, authors should explicitly mention the way in which they performed their study. 
In addition, the manufacturer should adapt the software in such a way that the user 
gets the simultaneously collected values of PCCO and COao as well as the choice of 
deciding whether to calibrate or not.
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Figure 4a.4 Trend recording of an individual patient. Observation moments are indicated by A to F. 
Solid line PiCCO’s pulse contour cardiac output. At the observation moments, bolus thermodilution 
CO is indicated by symbol ○ and PiCCO’s pulse contour CO is indicated by symbol □. Observe the 
recalibration after performing a bolus thermodilution measurement at all moments A to F.
A remarkable difference in study setup compared to Della Rocca et al has become 
apparent from the study of Rödig et al. [22]. Rödig et al. as well as Rauch et al. [26] 
explicitly mentioned that they used the transpulmonary thermodilution technique 
(COao) only to calibrate PCCO at two or three points (at the start and after transfer to 
the ICU). Further comparisons were made with the conventional thermodilution 
(COpa) instead of the COao method to prevent a sequential automatic recalibration of 
PCCO.
Comparison with other pulse contour methods
In a recent publication [20] we compared the bias precision and the tracking ability of 
five pulse contour methods. The bias between the methods was low; however the 
limits of agreement differed between the methods for the PiCCO pulse contour; these 
values were 0.14 and -1.60 to 1.89 L/min. For the LiDCO-PulseCO device (LiDCO, 
Cambridge, UK) they were -0.17 and -1.55 to 1.20 L/min. The Modelflow method 
(BMEYE, Academic Medical Center, Amsterdam, the Netherlands) and the Hemac 
program (author JRC Jansen) performed the best with 0.00 and -0.74 to 0.74 L/min. 
and 0.06 and -0.81 to 0.93 L/min. respectively. Also tracking changes in cardiac 
output were performed significantly better by the Modelflow and Hemac methods.
SVV and PPV as spin-offs of pulse contour analysis
Measurement of left ventricular stroke volume variation due to mechanical ventilation 
has become clinically available since the introduction of pulse contour analysis. 
Stroke volume variation (SVV) is the difference between maximal and minimal stroke 
volume during a mechanical breath divided by the average of the two values, figure 
4a.5. SVV has been shown to be a functional indicator to predict the effects of volume 
loading on cardiac output [3].
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Figure 4a.5 Stroke Volume Variation (SVV) over the ventilatory cycle. SVV is measured over last 30s 
time window.
In general, a patient with a SVV larger than 9.5 to 15% will respond with a positive 
increase in CO after volume loading with 500 mL [27]. A similar approach has been 
introduced for pulse pressure variation (PPV). Here, a PPV value larger than 13% 
predicts an increase in CO larger than 15% after volume loading of the patient with 
500 mL fluid [3]. These precise percentage value of SVV and PPV were postulated 
despite Reuter et al. [28] having shown SVV and PPV to be dependent on tidal 
volume. De Backer et al. [29] recommended tidal volumes larger than 8 mL/kg body 
weight. However, the use of larger tidal volumes is in contradiction with the 
recommendations in the literature which advises that patients be ventilated with low 
tidal volumes and PEEP to prevent barotrauma [30, 31]. Nevertheless, because of 
their high sensitivity and specificity, SVV and PPV are the most popular 
hemodynamic monitoring parameters in recent literature [32-36].
Quality control of conditions The use of SVV and PPV as predictors of fluid 
responsiveness is only possible in fully ventilator dependent patients with a regular 
heart rate. However, in many postoperative cardiac surgical patients weaning from a 
ventilator has already started on arrival in the ICU, or is started shortly after. 
Furthermore, irregular heart rates are quite common in cardiac surgical patients. The 
software in the PiCCO device does not perform a quality check for these conditions 
which impels the physician to do so, especially in the event of a high SVV or PPV 
value. In our opinion, this all makes the use of SVV or PPV as predictors for volume 
loading on cardiac output of limited value in daily clinical use.
GEDV and ITBV as spin-off of transpulmonary thermodilution
Transpulmonary thermodilution-derived global end-diastolic volume index (GEDVI) 
and intrathoracic blood volume index (ITBVI) may reflect left ventricular end-
diastolic volume and are supposed to reflect preload and predict fluid responses after 
cardiac surgery much better than cardiac filling pressures [37-42]. The superior value 
of these volume indices over pressures is questionable, since fluid loading guided by 
CVP changes has been shown to increase volumes and cardiac output in patients after 
cardiac surgery for instance [43]. In addition, the predictive value may be confounded 
by mathematical rather than physiological coupling, as in the PiCCO system both 
cardiac output and volumes are derived from the same transpulmonary thermodilution 
curve. The coupling may contribute to falsely high correlations between volumes and 
cardiac output (changes) as a consequence of shared measurement error [44]. 
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Mundigler et al. [45] demonstrated the insensitivity of GEDV or ITBV in monitoring 
the effects of volume loading in patients with reduced left ventricular function. They 
concluded that cardiac filling pressures rather than intra-thoracic volumes should be 
used to monitor fluid loading. Remark: consider a patient with a normal heart having 
an end diastolic volume of 100 mL, the same volume in a patient with a large heart 
due to cardiomyopathy will not generate an end diastolic wall tension at all! 
Furthermore, based on theory and observation, we have the impression that the 
precision of these variables is dependent on SVV.
In a recent prospective multicentre study, Uchino et al. [46] compared hemodynamic 
monitoring by PAC with that by PiCCO derived variables. The major outcome of this 
study was that on direct comparison, the use of the PiCCO was associated with a 
greater positive fluid balance and fewer ventilator-free days. After adjustments for 
confounding variables, the choice of monitoring technique was shown not to predict 
outcome, but a large positive fluid balance was a significant predictor of greater 
mortality. As many of our patients have congestive heart failure we found GEDV and 
ITBV of limited use, despite the publications that demonstrate the superiority of these 
parameters [37-42].
Limitations and remarks based on own experience
Quality control of the arterial pressure waveform Radial artery pressure is usually 
measured with fluid-filled catheter-transducer systems. The catheter lines are 
routinely kept open with continuous flush devices. Malfunction of flush devices or 
catheter-related problems are of direct influence on the measured pulse contour 
cardiac output and derived variables. Therefore, frequent visual control of the pressure 
wave form is advisable, or better still, a detection of damped waveforms is greatly 
needed and should be built into pulse contour systems.
Patient related concerns The performance of all pulse contour methods is 
compromised in those patients who have aortic valve regurgitation, an aortic 
aneurysm or an intra-aortic balloon pump, as well as during cardiopulmonary bypass 
and aortic clamping. Also, the physiological properties of the aorta may change with 
the patient’s position. No data is available on changes when going from supine to 
upright - nor on changes from supine to prone position. In two adult patients, we [15] 
showed clinical significant differences in PiCCO cardiac output values for PCCO and 
COao compared with the continuous thermodilution cardiac output from the 
pulmonary artery catheter (Vigilance, Edwards). These differences appeared to be 
dependent upon the site of measurement and the underlying pathology. In one patient 
with a severe haemorrhage the difference in CO was related to excessive loss of cold 
indicator during the passage through the pulmonary circulation. In the other patient, 
the difference could be explained by the presence of a partial anomalous pulmonary 
vein entering the right atrial cavity. From these observations we learned that improved 
analysis of the transpulmonary dilution curve may help to alert the operator in the 
event of intrathoracic abnormalities. Detection of the false high cardiac output by the
PiCCO system in the patient with severe haemorrhage and the real difference between 
the output of the right and left heart in the patient with intrathoracic abnormalities was 
possible because these patients were participating in a study protocol. Ong et al. [47] 
reported a third patient with induced hypothermia for anoxic brain injury, in which the 
PiCCO system failed to calibrate, even after several attempts with increased injection 
volumes of cold injectate (temperature lower than 8oC) and exchange of the PiCCO 
device and of the femoral arterial line.
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Summary and conclusions
From the literature and our own comparative studies using different pulse contour 
cardiac output systems, we concluded that the accuracy (bias), precision (SD) as well 
as the tracking of changes in cardiac output by the PiCCO system is inferior to most 
of its competitors. During our use of the PiCCO system, several technical and patient
related limitations were uncovered by coincidence. The technical limitations were 
related to i) incorrect detection of heart beats, ii) incorrect detection of ejection phase, 
iii) no detection of damped arterial pressure tracings, all leading to incorrect 
computations of cardiac output. Patient-related problems were found during severe 
episodes of bleeding and cardio-pulmonary anatomical abnormalities. In most 
cardiothoracic patients, SVV or PPV to monitor preload dependency was only useful 
for a short time as most patients were weaned from the ventilator shortly after arrival 
in the ICU. In patients who are candidates for a heart assist device (intra-aortic
balloon pump) a femoral arterial puncture for application of the PiCCO device is 
contra-indicated. We experienced, consistent with the literature, that measurement of 
GEDVI and ITBVI in cardiomyoplasty patients is irrelevant.
Furthermore we have, based on theory and observation, the impression that the 
precision of these variables is dependent on SVV. From the foregoing we consider 
that the PiCCO system is of limited value in monitoring cardiothoracic patients.
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Letter to the Editor
The PiCCO device in cardiothoracic patients – more useful than 
suggested
Joris Lemson, MD, Johannes G. van der Hoeven, MD PhD 
Department of Intensive Care Medicine Radboud University Nijmegen Medical 
Centre Nijmegen, the Netherlands
To the editors:
With interest we read the review of de Wilde and colleagues about the use of the 
PiCCO device in cardiothoracic patients in relation to their own extensive experience 
[1]. We are pleased they took effort to explain how this interesting technique works 
and what the possible advantages and disadvantages are. However, we do not agree 
with the authors that the PiCCO system is of limited value in monitoring 
cardiothoracic patients. We feel that the authors have omitted several potentially 
beneficial possibilities of the PiCCO device that might be of interest to the readers of 
the Netherlands Journal of Critical Care.
Determination of cardiac output 
As de Wilde et al. correctly mention, despite a small overestimation, the 
transpulmonary thermodilution technology (TPTD) is a reliable method to measure 
cardiac output (CO) but also tracks changes in CO over time. We, like many others, 
have proven this in an animal model [2]. It is therefore even considered the gold 
standard for measuring cardiac output in critically ill pediatric patients [3].
Using the TPTD technique the PiCCO device calibrates it’s arterial pressure driven 
pulse contour cardiac output method and subsequently provides the clinician with a 
fast beat-to-beat CO measurement. Although some types of pulmonary artery 
catheters automatically measure CO, these measurements are not continuous and do 
not provide insight when fast changes in CO (might) occur.
The accuracy and precision of the pulse contour method are not as good as the TPTD 
method, therefore frequent recalibration is needed. However the accuracy of the pulse 
contour method of the PiCCO device is comparable to the only other commercially 
available calibrated pulse contour method (LiDCO system, Cambridge, UK). The 
uncalibrated techniques mentioned by the authors namely Modelflow (BMEYE, 
Amsterdam) and Hemac (from one of the authors) may perform better but do not have 
the essential ability to be calibrated against an established and incorporated method. 
Besides that, they are not commercially available for use in the critical care 
environment. 
The conclusion that accuracy, precision and ability to track changes in CO of the 
PiCCO device are inferior to its competitors is therefore not substantiated by the 
authors. 
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Determination of fluid responsiveness 
The authors correctly mention the ability of the PiCCO device to record stroke 
volume variation (SVV) and pulse pressure variation (PPV), which are potentially 
useful predictors of fluid responsiveness. The authors state that these measurements 
are of limited use because “irregular heart rates are quit common in cardiac surgery 
patients”. We think this has little clinical consequences since the use of preload 
parameters is most important on the first or second postoperative day while most 
rhythm disturbances (e.g. atrial fibrillation) occur after this time period. In a recent 
series from our own hospital (CORRAD database registration, UMC St Radboud) an 
episode of atrial fibrillation developed in only 7.7% of postoperative cardiac surgery 
patients during their ICU treatment. 
We do not agree with the authors that SVV and PV are of limited value in 
spontaneously breathing patients. SVV and PPV appear to have a high specificity in 
patients breathing spontaneously without mechanical supportand only the sensitivity 
appears to be low. In that case the possibility of a passive leg raising test should be 
considered. As the PiCCO device provides a fast beat-to-beat CO measurement it 
enables the determination of fluid responsiveness using the passive leg raising (PLR) 
test [4]. 
Although we agree with the authors that measurement of global end diastolic volume 
(GEDV) is of limited value in predicting fluid responsiveness in patients with reduced 
myocardial function, we believe this measurement can be of value for many other 
patients. The opinion that SVV influences the precision of the GEDV measurement is 
interesting but has never been substantiated. We have never observed this 
phenomenon; neither can we explain this on basis of theory. Since stroke volume 
variation occurs almost beat to beat while the TPTD measurement technique measures 
GEDV during a time interval of at least 10 seconds, and comprises many heartbeats, 
we find this difficult to accept. We certainly encourage the authors to publish this 
observation because it can be of importance to clinicians using this device. 
Determination of extra vascular lung volume 
Using the PiCCO device extra vascular lung water (EVLW) can reliably be measured 
by means of the TPTD technique. It offers the clinician the opportunity to quantify the 
amount of pulmonary edema [5]. A therapeutic strategy aimed at reducing EVLW has 
been shown to decrease ventilator- and ICU days [6]. Measurement of EVLW in 
adults can therefore be regarded as a relevant parameter for the management of 
critically ill patients [7]. 
Unfortunately the authors have left the capability of the PiCCO device to measure 
EVLW completely unmentioned. We are aware of at least one other ongoing trial 
comparing a strategy of increasing cardiac output versus a strategy limiting 
extravascular lung water. 
Conclusion 
We consider the PiCCO device as reliable as the PAC in measuring CO using the 
transpulmonary thermodilution technique. Furthermore using pulse contour analysis 
this technology enables the determination of fluid responsiveness using either arterial 
pressure variations or the passive leg raising test. Also it offers the possibility to 
measure extra vascular lung water en thereby quantify the amount of pulmonary
edema. Potentially the PiCCO system could thus be superior to other devices and 
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useful to all ICU patients, including children. However like the pulmonary artery 
catheter, it’s clinical value still needs to be quantified. 
As with every other medical device it is not the technology that cures ICU patients, 
but the doctors and nurses who must interpret the obtained data and translate them 
into appropriate therapeutic protocols. 
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Review of the PiCCO device; our experience in the ICU 
R.B.P. de Wilde, P.C.M. van den Berg and J.R.C. Jansen
Department of Intensive Care, Leiden University Medical Centre, NL-2300 RC, 
Leiden, the Netherlands
Reply
The authors, Lemson and van der Hoeven (L&H), do not agree with us that the 
PiCCO system is of limited value in monitoring cardiothoracic patients. They feel that 
we omitted several potentially beneficial possibilities of the PiCCO device that might 
be of interest to the readers of the Netherlands Journal of Critical Care.
Before responding in this discussion about the limitations of the PiCCO system, we 
need to draw attention for the main assumptions made in the calculation of 
(transpulmonary) thermodilution cardiac output. Furthermore, definitions about
accuracy and precision of cardiac output methods and about interpretation of 
differences between methods must be made.
Introduction
In the analysis of accuracy (also called bias) and precision (standard deviation of 
measurements), the thermodilution method is generally considered accurate but not 
precise whereas pulse contour methods are considered precise but inaccurate, figure 
4b.1. However, after calibration by thermodilution pulse contour methods are 
supposed to be accurate and precise.
Figure 4b.1 Schematic representation of accuracy and precision.
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What makes the thermodilution methods less precise? Or what causes sequential 
measurements to differ so much?
The thermodilution method is based on the law of conservation of thermal energy. If 
and only if blood flow is constant, if no loss of indicator between injection site and 
detection site occurs, if mixing of blood and indicator is complete and if a bolus 
injection of a limited amount of cold indicator is applied then the classical Stewart 
Hamilton equation can be used. Neglecting these assumptions may lead to 
considerable spread in cardiac output (CO) values as has been reported by several 
authors. So, the results of many CO measurements must be averaged to acquire one 
accurate estimate of mean cardiac output. More then 25 years ago we [1] showed this 
spread in CO estimates was mainly caused by violation of the assumption of constant 
blood flow. As known from physiology, during mechanical ventilation, blood flow 
decreases during inspiration and recovers during expiration. This violation of the 
assumption of constant blood flow resulted into a cyclic pattern of thermodilution 
cardiac values related to ventilation. The amplitude of this cyclic modulation appeared 
to be larger during hypovolemia and smaller during hypervolemia. As a practical 
solution we proposed to estimate mean cardiac output by taking the mean value of 
three or four measurements performed equally spread over the ventilatory cycle [2]. In 
patients, this approach has shown to improve the precision from 10-15% to 3-5% [2]. 
These findings were confirmed in many of our studies as well as of others, among 
them Groeneveld et al. [3]. We still support our conclusion that in the ICU and OR the 
estimation of cardiac output by thermodilution can be accurate and precise if the 
limitations of the method are taken into account. 
More then 25 years ago we developed an equation that did not require the assumption 
of constant blood flow [patent NL 189547, Patent USA 4595015, 4]. However, for 
this solution a relative measure of blood flow is needed. For this purpose we used 
pulse contour analysis. A simplified schematic graphical representation of the
underlying mathematics is shown in figure 4b.2. 
In this figure we illustrate the effects of non constant blood flow, panel a, on the 
thermodilution curve, panel b. During periods of no flow the temperature change 
measured with a thermistor is constant, panel b. In panel c, the temperature change 
after weighing with a measure of relative flow is given (∆Tf). It is obvious that there 
is no transport of cold indicator during periods of no flow and the area under the 
temperature curve is zero during these periods as it should be. In panel d, a normal 
dilution curve is found after transformation of the time axis according to our 
invention. This is the curve that might be found in case of a measurement with a 
constant flow and averaged value as indicated by the dashed line in panel a.
In animal experiments [4] as well as in patients [5] we showed that during mechanical 
ventilation cardiac output can be estimated with high accuracy and precision by single 
measurements (precision improved from 20 to 5%).
By changing ventilatory frequency and tidal volume we found the spread of CO 
estimates to increase with tidal volume and to decrease with ventilatory rate. 
Furthermore, we showed that model fits of the dilution curves with a mixing chamber 
model (model used in the PiCCO system) improved significantly after application of 
our patented equation.
The PiCCO device with its incorporated transpulmonary thermodilution technique 
calculates CO with use of the Steward-Hamilton equation based on the assumption of 
constant blood flow. However, the same device may show, by pulse contour analysis,
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that stroke volume is varying with the phase of mechanical ventilation (SVV), 
implying a violation of the Steward-Hamilton equation. This limits the application of 
the PiCCO device.
What is the meaning of the conclusion of several authors that a clinical acceptable 
agreement between transpulmonary thermodilution and pulmonary thermodilution 
exists? Comparing the results of two methods that have a large spread (low precision) 
(Fig. 4b.1, c and d) may easily lead to the invalid conclusion that no significant 
difference between methods exists. So that one method can replace the other. 
Whereas, comparing two methods with high precision (Fig. 4b.1, a and b) would show 
a significant difference. Therefore, it is highly relevant to improve the precision of the 
methods. This is especially of importance for the reference method or gold standard.
Fig. 4b.2 Schematic diagram of flow averaging of concentration and of time. In panel a, Q  actual 
blood flow and mean blood 

Q mean flow (dashed line). In panel b, T temperature change of the 
blood after injection of a bolus cold fluid. In panel c, Tf the temperature change after flow 
averaging. In panel d, blood temperature as a function of transformed time tf .
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Determination of cardiac output 
Based on the forgoing one may conclude that we should consider a precision of 10 to 
15% for the thermodilution unacceptable. We therefore consider it premature to 
accept the transpulmonary thermodilution as gold standard in critically ill pediatric 
patients.
The remark of L&H that the continuous pulmonary thermodilution technique is not 
continuous is wrong, it is most certainly a continuous measurement but its value will
not necessarily change in synchrony with fast changes in cardiac output. 
According to the definition given for accuracy and precision, the accuracy (not the 
precision) of PiCCO’s pulse contour method is less than the thermodilution method 
and, indeed, frequent recalibration may be needed. However, this frequent need for 
recalibration turns the method from continuous to intermittent. The uncertainty to 
measure cardiac output correctly, shortly after a recalibration, limits the applicability 
of the method. It is our experience that during the first hour after admission of a 
patient to the ICU a regularly a recalibration is needed. After this first hour intervals 
of 8 hours between calibrations will normally be sufficient under standard clinical 
conditions. 
L&H miss the ball by stating that the Modelflow and Hemac methods do not have the 
essential ability to be calibrated against an established method. We have extensively 
given attention to this item in several publications [6-9].
In several comparative studies [10-13] the PiCCO device was ranked low with respect 
to accuracy and precision. Therefore, we have arguments to repeat our conclusion that 
the PiCCO device has been outperformed by its competitors. With this conclusion, we 
intent to push forward the development of pulse contour methods with a better 
performance, so that changes in cardiac output during passive leg raising or during 
small amounts of fluid loading can be used to predict fluid responsiveness of a patient 
reliably and safely.
Determination of fluid response
One of our statements mentioned by L&H is that because of commonly observed 
irregular heart rates in the ICU the use of SVV and PPV to predict fluid 
responsiveness is limited. In their letter L&H mentioned that in a recent series from 
their own hospital (CORRAD database registration, UMC St Radboud, the 
Netherlands) an episode of atrial fibrillation developed in only 7.7% of postoperative 
cardiac surgery patients during their ICU treatment. Their results differ from ours and 
from results given in literature [14, 15]. According to Parrikka et al [15] postoperative 
arrhythmias in the first two to three days after cardiothoracic surgery appear to happen 
in up to 43% of the patients. We are very interested in explanations of this difference 
and look forward to a publication on this subject. Based on the relatively high 
incidence of arrhythmias, we still come to the conclusion that the PiCCO device is 
limited in its use.
Of course the use of SVV and PPV is of no value in patients with spontaneously 
breathing activity. This is indeed illustrated, for instance, by the fact that even in 
patients with a regular breathing pattern (constant tidal volume and rate of ventilation) 
the sensitivity to predict fluid responsiveness is low.  
L&H state that the opinion that SVV influences the precision of the GEDV 
measurement has never been substantiated. From the introduction given in the current 
reply it must be clear that this is not an opinion but a conclusion based on scientific 
work performed more then 25 years ago [4, 5]. Indeed, neglecting the modulation on 
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stroke volume by mechanical ventilation (duration approximately 5 sec) may clearly 
influence the determination of the down slope time of the transpulmonary dilution 
curve. We encourage the readers of the Netherlands Journal of Critical Care to discuss 
this item with the developers of the PiCCO system in order to gain more accurate and 
precise apparatus (with fewer limitations) in the near future.
Conclusion
The letter of L&H did not change our opinion about the use of the PiCCO device. 
This letter illustrates that definitions about accuracy and precision are needed. 
Furthermore, that a comparison between methods is only valid when the reference 
method is precise and accurate. Thermodilution methods as reference methods with a 
precision of 10-15% are unacceptable. To archive unambiguous results knowledge of 
basic physiology and physics is imperatively needed. Only then, with data that can be 
relied on, the development of an appropriate scientifically based protocol is possible 
which can help the doctors and nurses to cure the patient.




1. Jansen JR, Schreuder JJ, Bogaard JM, van Rooyen W, Versprille A. 
Thermodilution technique for measurement of cardiac output during artificial 
ventilation. J Appl Physiol. 1981 Sep; 51(3):584-91.
2. Jansen JR, Schreuder JJ, Settels JJ, Kloek JJ, Versprille A. An adequate 
strategy for the thermodilution technique in patients during mechanical 
ventilation. Intensive Care Med 1990, 16:422-425.
3. Groeneveld AB, Berendsen RR, Schneider AJ, Pneumatikos IA, Stokkel LA, 
Thijs LG. Effect of the mechanical ventilatory cycle on thermodilution right 
ventricular volumes and cardiac output. J Appl Physiol. 2000 Jul; 89(1):89-96.
4. Jansen JR, Bogaard JM, Versprille A. Discrepancies between models as a 
basis for cardiac output estimation and medical practice. In modeling and data 
analysis in Biotechnology and Medical Engineering G.C. Vansteenkiste and 
P.C. Young (eds), North-Holland Publishing Company, IFIP, 1983. 
5. Jansen JR, Schreuder JJ, Settels JJ, Kornet L, Penn OC, Mulder PG, Versprille 
A, Wesseling KH. Single injection thermodilution. A flow-corrected method. 
Anesthesiology. 1996 Sep; 85(3):481-90.
6. Jansen JR, Wesseling KH, Settels JJ, Schreuder JJ. Continuous cardiac output 
monitoring by pulse contour during cardiac surgery. Eur Heart J. 1990 Dec; 11
Suppl I:26-32.
7. Wesseling KH, Jansen JR, Settels JJ, Schreuder JJ. Computation of aortic flow 
from pressure in humans using a nonlinear, three-element model. J Appl 
Physiol. 1993 May; 74(5):2566-73.
8. Jansen JRC, Schreuder JJ, Mulier JP, Smith NT, Settels JJ, Wesseling KH. A 
comparison of cardiac output derived from the arterial pressure wave against 
thermodilution in cardiac surgery patients. Br J Anaesth. 2001 Aug;
87(2):212-22.
9. de Vaal JB, de Wilde RB, van den Berg PC, Schreuder JJ, Jansen JR. Less 
invasive determination of cardiac output from the arterial pressure by aortic 
diameter-calibrated pulse contour. Br J Anaesth. 2005 Sep; 95(3):326-31. 
10. J.R.C. Jansen and P.C.M. van den Berg. Cardiac output by both 
thermodilution and arterial pulse contour techniques Update in intensive care 
and emergency medicine, section “Functional hemodynamic monitoring” 
2004; Editors: Michael R. Pinsky and Didier Payen. 
11. de Wilde RB, Schreuder JJ, van den Berg PC, Jansen JR. An evaluation of 
cardiac output by five arterial pulse contour techniques during cardiac surgery.
Anaesthesia. 2007 Aug; 62(8):760-8. 
72
12. Waal EE, Kalkman CJ, Rex S, Buhre WF. Validation of a new arterial pulse 
contour-based cardiac output device. Crit Care Med. 2007 Aug; 35(8):1904-9.
13. Button D, Weibel L, Reuthebuch O, Genoni M, Zollinger A, Hofer CK. 
Clinical evaluation of the FloTrac/Vigileo system and two established 
continuous cardiac output monitoring devices in patients undergoing cardiac 
surgery. Br J Anaesth. 2007 Sep; 99(3):329-36.
14. Parikka H, Toivonen L, Pellinen T, Verkkala K, Järvinen A, Nieminen MS. 
The influence of intravenous magnesium sulphate on the occurrence of atrial 
fibrillation after coronary artery by-pass operation. Eur Heart J. 1993 Feb; 
14(2):251-8.
15. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic 
surgery. N Engl J Med. 1997 May 15; 336(20):1429-34.
73
Chapter 5
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Background Evaluating the performance of the FloTrac-Vigileo system (FCO) in 
relation to simultaneously obtained cardiac output (CO) values with the PiCCOplus 
(PCO), PulseCO/LiDCOplus (LCO), Vigilance continuous pulmonary artery 
thermodilution (CCO) and intermittent bolus pulmonary artery thermodilution (ICO).
Methods Cardiac output data were collected during standard clinical care in 28 cardiac 
surgery patients, after ICU admission. The number observation periods per patient 
varied between 4 and 8. Data was analyzed with Bland Altman statistics, cross tables 
and linear regression.
Results We obtained 179 data sets. Mean CO’s were 5.1 ± 1.0, 5.2 ± 1.3, 5.0 ± 1.4, 5.7 
±1.0, and 5.4 ± 1.1 litre∙min-1 for ICO, LCO, PCO, FCO and CCO respectively. ICO 
ranged from 2.90 to 8.70 litre∙min-1. Ranking the results of Bland-Altman analysis in 
order from best to least yields precisions of: CCO (12%), FCO (18%), LCO (19%), 
and PCO (24%). When cardiac output changes of less than 10% were defined as 
clinically insignificant, directional changes with ICO were equally followed by 
LiDCO in 81%, by PiCCO in 82%, by FloTrac-Vigileo in 92%, and by CCO in 98% 
of the cases. FloTrac-Vigileo and PiCCO showed a slight but statistical significant, 
drift with time. 
Conclusions The performance of pulse contour methods has significantly increased 
the last few years, which makes comparisons with older publications invalid. The 
auto-calibrated FloTrac-Vigileo system can replace the initially PAC-calibrated 
LiDCO and PiCCO system. The Vigilance continuous thermodilution method 
demonstrated the best agreement with bolus thermodilution and had the highest score 
in following slow changes in cardiac output. 
Introduction
Cardiac output is considered as in important parameter to monitor adequate tissue 
perfusion. A pulmonary artery catheter (PAC) is frequently used in patients
undergoing complex cardiac surgery. In other patient groups the use of the PAC to 
monitor cardiac output has been questioned frequently; and several, recently 
developed, less invasive methods have been proposed. The arterial waveform analysis 
performed by the PiCCO and LiDCO system are considered to be reliable 
alternatives.1-3 However these devices require calibration to compensate for individual 
vascular compliance, either by transpulmonary thermodilution or lithium dilution.
This vascular compliance may change soon after each calibration leading to 
uncertainties in cardiac output results.
The FloTrac-Vigileo system is the most recently introduced technology to determine 
cardiac output less invasively from arterial waveform analysis. The FloTrac-Vigileo 
system’s continuous auto-calibration algorithm compensates for changes in vascular 
tone and thus does not require periodic external calibration. However, first studies 
ended with controversial conclusions ranging anywhere from in good agreement with 
intermittent pulmonary artery thermodilution to not recommended.4
The purpose of the current study is to evaluate the performance of the second 
generation FloTrac-Vigileo method in relation to other continuous cardiac output 
methods in a heterogeneous group of severely ill cardiac surgery patients. Hereto, 
simultaneously obtained cardiac output (CO) values with the PiCCOplus (PCO), 
LiDCOplus (LCO), FloTrac-Vigileo (FCO) and Vigilance continuous pulmonary 
artery thermodilution (CCO) were compared with CO values by intermittent bolus 
pulmonary artery thermodilution (ICO).
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Methods 
Patients In a prospective study the bias, precision, limits of agreement and tracking 
ability of three different pulse contour cardiac output devices and one continuous 
pulmonary artery thermodilution method were compared with standard thermodilution 
cardiac output under conditions of routine use in our ICU.
Twenty eight adult ICU patients scheduled for elective cardiac surgery were studied 
after IRB approval and written informed consent obtained one day prior to surgery. 
All patients with a pre-operative indication for placement of a pulmonary arterial 
catheter (PAC) were eligible candidates. Patients with severe peripheral vascular 
disease, aortic aneurysm, intra-cardiac shunts, as well as postoperative patients with 
arrhythmia, need for mechanical cardiac support or persistent valvular dysfunction 
were excluded. Before surgery, a peripheral venous cannula, a radial artery cannula 
(RA 04220, Arrow International, Reading, PA, USA) and a pulmonary artery catheter 
(139HF75P, Edwards Lifesciences, Irvine, CA, USA) were introduced. After surgery 
the patients were moved to the ICU where sedation was maintained with target 
infusion of propofol and sufentanil, the first 3 to 4 hours. Patient’s lungs were 
ventilated with 40% oxygen in air, PEEP of 5 cmH2O, and a respiratory frequency of 
12-14 breaths min-1. Minute ventilation was adjusted to maintain arterial pCO2
between 4.2-5.6 kPa. When the clinical condition of the patients was considered 
hemodynamically stable, patients were weaned from the ventilator. Patients were 
treated with vasodilators, inotropes and/or fluids according to institutional guidelines.
Cardiac output methods
Cardiac output was measured with the use of three pulse contour devices and two 
thermodilution methods, i.e. FloTrac-Vigileo™ system with upgraded software 
version V1.07 (Edwards Lifesciences, Irvine, CA, USA), the PulseCO/LiDCOplus™
system (LiDCO Ltd, Cambridge, UK), PiCCO™ system (Pulsion Medical Systems, 
Munich, Germany), continuous (CCO) and intermittent bolus thermodilution cardiac 
output (ICO), with a Vigilance™ cardiac output monitor (Edwards Lifesciences, 
Irvine, CA, USA).
Figure 5.1 Schematic diagram of the setup of different pulse contour methods using a FloTrac pressure 
transducer. Prad, radial artery blood pressure; FCO, cardiac output (CO) by Vigileo system; LCO, CO 
by PulseCO/LiDCOplus system; PCO, CO by PiCCO system; ICO, CO by intermittent pulmonary 
thermodilution (TD); PAC, pulmonary artery catheter.
76
Intermittent pulmonary artery thermodilution (ICO) (reference method) was 
performed with a bolus injection of 10-ml iced-dextrose 5% at a temperature of 4-7
°Celsius, and calculated as an average of 3 randomly applied measurements. Pulse 
contour cardiac output values were averaged over 5 minutes at predefined time points. 
LCO and PCO were not calibrated per their manufacturer’s recommended techniques 
due to the difficulty of performing these measurements concurrently. Instead the LCO 
and PCO systems were initially calibrated using the averaged value of ICO measured 
from the PAC. In clinical practice, the use of lithium dilution for LCO and 
transpulmonary thermodilution for PCO in lieu of PAC calibration will add additional 
error to the results measured in this study. All pulse contour devices used the same 
radial artery pressure signal derived from a FloTrac transducer, figure 5.1. The 
FloTrac transducer was referenced to the intersection of the anterior axillary line and 
the 5th intercostal space. The LiDCO system was calibrated by directly entering the 
PAC ICO measurement into the monitor. The PiCCO system is calibrated by a 
thermodilution simulator that generates thermal curves, which result in a CO 
computed by the the PiCCO system equal to the values measured by the conventional 
pulmonary artery thermodilution method. 
Study protocol
Besides medical history and demographic information of the patients, we measured 
cardiac output values at predefined time points. These time points were at: arrival on 
the intensive care unit (t0, baseline); one hour (t1); two hours (t2); four hours (t3); 
eight hours (t4); twelve hours (t5); 24 hours (t6); 36 hours (t7), after baseline. In 
addition to cardiac output body core temperature, mean arterial blood pressure 
(MAP), central venous pressure (CVP), and heart rate (HR), fluid intake and 
concomitant medication were recorded. Data was stored on a computer disk for 
documentation and further analysis.
Data analysis
Paired data was analyzed using three different statistical methods. First method, the 
limits of agreement (LOA) method of Bland and Altman for assessment of agreement 
between methods was used.5 The differences between ICO and LCO, PCO, FCO, and 
CCO were plotted against their average together with the LOA, given by bias ± 2SD. 
Second method, we investigated the ability of the different continuous cardiac output 
methods (LCO, PCO, FCO and CCO) to track changes in cardiac output. Percentage 
changes cardiac output (∆CO%) within individual patients were calculated as: ∆CO% 
= 100*(CO(t)/COmean). When simultaneously measured ICO and LCO, PCO, FCO 
or CCO both indicate a positive or negative trend, a positive score was counted. 
Changes in opposite direction resulted in a negative score. Ideally, only positive 
scores would be present. Similar scores were made when consecutive changes in 
cardiac output values differ by at least 10%, which is considered clinically relevant. 
Positive and negative counts are evaluated using cross tabulations and presented as 
percentages of identical changes in cardiac output.  Third method, drift against time of 
each CO method was evaluated. To compute drift against time, at each time point, the 
ICO value was subtracted from the simultaneously obtained LCO, FCO, PCO and 
CCO value. Drift was quantified by the slope, with 95% confidence interval (CI95%), 
of the linear regression between time and the difference between ICO and method 
under study. This slope of the regression was tested against a horizontal line 
(reflecting no change over time). P values < 0.05 were considered as significant. 
Normality of distribution was tested with Kolmogorov–Smirnov analysis. All data are 
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presented as averages and SD. Statistical analysis was performed using SPSS for 
Windows Release 15.0 (SPSS Inc., Chicago, IL, USA).
Results
Characteristics, surgical interventions and medication at admission to the ICU of 28 
patents are presented in table 5.1. A large diversity in surgical interventions as well as 
use of cardiovascular drugs can be observed. In our study group no adverse events 
were experienced and all patients left the hospital alive.
Table 5.1 Patient characteristics (n=28).
Patient characteristics Mean (SD) Range
Age (year) 67 (9) 42 - 78
Weight (kg) 81.6 (14.5) 52 – 144
Height (cm) 175 (7) 162 - 188
BSA (m2) 2.00 (0.20) 1.58 – 2.44
BMI (kg-1 m-2) 26.5 (3.9) 17.0 -32.3
Gender (male/female) 23/5
Type of surgery No of Patients
CABG 2
CABG & DOR 2
CABG & valve repair 7
Single valve repair 5
Two valve repair (in part with AF ablation) 7
DOR & LV-lead  2
DOR & MVP 1
DOR & AF ablation 1
CorCap & two valve repair & LV-lead 1





* Single use 8, double use 8, and triple use 11
BSA, body surface area; BMI, body mass index; CABG, coronary artery bypass grafting; DOR,
endoventricular circular patch plasty; LV-lead, left ventricular pacemaker lead; MVP, mitral valve 
plastic; AF, atrial fibrillation.
We compared the results of four different continuous CO methods (LCO, PCO, FCO, 
and Vigilance-CCO) with CO by the standard pulmonary thermodilution method 
(ICO). The precision of ICO was 9.7% for single measurements and 5.7% for the 
averaged value of series of 3 measurements. A total of 183 series of measurements 
were collected at 8 time points. Four series with excessive measurement errors were 
deleted. Table 5.2 shows hemodynamic data at these time points. Due to calibration at 
baseline (t0), LCO and PCO are equal to reference ICO, whereas FCO and CCO 
differ from ICO. With time the number of patients enclosed in the study decline as 
patients were discharged from the ICU. Also the number of patients on the 
mechanical ventilator decreased with time. After 36 hours (t7) only 4 patients were 
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still treated in the ICU. All data showed normal distributions. Reference cardiac 
output (ICO) ranged from 2.90 to 8.70 litre∙min-1, with a mean value of 5.12 
(SD=1.02) litre∙min-1. The distribution of CO values was not different for the different 
methods.
Agreement of methods with ICO
Bland-Altman error diagrams for the difference between ICO and the four continuous 
cardiac output methods are given in figure 5.2.  For FCO and CCO 179 data points are 
available and for LCO and PCO 151 data points because the reference device (PAC 
ICO) was also used for calibration, thus the data points obtained during calibrations 
are invalid. Bland-Altman statistics for pooled data are in table 5.3. The difference 
between methods under study and the reference method showed an instrumental error 
as almost all data points fell within the limits of agreement if expressed in percentage 
(LOA%) , i.e. at low CO a small error and at high CO a higher error is observed. 
From figure 5.2 it is observable that the distribution of errors is different among the 
methods. This is confirmed by Levine’s statistics, which showed significant (F-value 
= 20.5, p < 0.001) unequal homogeneity of the variances of the four methods. CCO 
has the smallest range of the limits of agreement -0.99 to 1.61.
The limits of agreement of FCO, LCO and PCO are larger, -1.37 to 2.54, -2.00 to 1.90
and -2.61 to 2.29 litre∙min-1, respectively.
Figure 5.2 Graphical representation of Bland-Altman analysis. The bias for the difference is indicated 
by a solid line, limits of agreement by dotted lines and percentage limits of agreement (LOA%) by 
dashed lines. In panel A, the difference between intermitted thermodilution cardiac output (ICO) and 
cardiac output (CO) by the LiDCO system (LCO) against the mean value of ICO and LCO. In panel B, 
CO by the PiCCO system (PCO). In panel C, CO by the FloTrac-Vigileo system (FCO). In panel D, 
Vigilance continuous thermodilution cardiac output (CCO).
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Tracking cardiac output changes
Changes in cardiac output of each of the four continuous cardiac output methods 
versus change in thermodilution cardiac output are shown in figure 5.3. Changes in 
cardiac output in all four methods correlate significantly (p<0.001) with the changes 
in cardiac output by ICO (slope for CCO 0.87, CI95% 0.76 to 0.98; for FCO 0.43, 
CI95% 0.33 to 0.53; for LCO 0.75, CI95% 0.55 to 0.95; and for PCO 0.79, CI95% 
0.51 to 1.07). The agreement of positive and negative changes of ICO and CO in each 
of the four methods was calculated using cross tabulation. The agreement in change 
was 76 (CI95% 70 to 83)% for CCO; 62 (CI95% 55 to 70)% for FCO; 68 (CI95% 61 
to 75)% for LCO and 68 (CI95% 61 to 75)% for PCO. These scores improve if 
clinically irrelevant changes smaller then 0.5 litre∙min-1 (i.e. < 10% change) are 
excluded from counting. Now, agreement is found in 98 (CI95% 93 to 100)%, 92 
(CI95% 79 to 100)%, 81 (CI95% 68 to 94)%, and 82 (CI95% 70 to 94)% for changes 
in CO with CCO, FCO, LCO and PCO respectively.
Effects of time
In figure 5.4 we show changes in difference between the four continuous CO systems 
and ICO with time. We indicated a wanted stability range of ± 10% by dashed lines. 
As can be observed for the LCO system the data range indicated by the CI95% 
crosses the threshold value of 10% at 2, 12 and 24 hour, implying more than 2.5% of 
the data points are outside the chosen 10% limits at these time points. This occurs 
with PCO from 1 hour to 24 hour, with FCO at 4, 8, 12 and 24 hour, and with CCO at 
4, 12 and 24 hour. 
No change with time was found for the difference between CCO and ICO (slope 0.02 
litre∙min-1∙hr-1, CI95% -0.12 to 0.17, p = 0.763) nor for the difference between LCO 
and ICO (slope = 0.011 litre∙min-1∙hr-1, CI95% -0.11 to 0.03, p = 0.322). However, a 
small but statistically significant drift with time was calculated for the difference 
between PCO and ICO (slope -0.017 litre∙min-1∙hr-1, CI95% -0.032 to -0.001, p = 
0.036) as well as for FCO and ICO (slope 0.029 litre∙min-1∙hr-1, CI95% 0.003 to 
0.055, p = 0.027).
Discussion 
In ranking the methods, we found the results of the auto-calibrated FCO equivalent or 
better than those obtained by the initially PAC calibrated LCO and PCO methods. We 
anticipate that in clinical practice, when lithium and transpulmonary thermal dilution 
methods are used, the accuracy of these systems will be degraded by calibration 
errors. However, the best precision and limits of agreement were found for CCO. All 
continuous methods significantly followed changes in CO as measured by ICO. But, 
the tracking capabilities could be ranked from highest to lowest as CCO, FCO, LCO 
and PCO. The difference between ICO and PCO as well as ICO and FCO drifted 
slightly but statistically significantly with time. None of the continuous cardiac output 
methods can replace mean cardiac output obtained with three randomly applied 
intermittent bolus thermodilution measurements.
Acquiring precise data to allow a reliable comparison between methods requires 
several precautions. Firstly, in comparative studies, the quality of reference method is 
of utmost importance. Indeed, in evaluation of differences between the investigated 
method and a reference method the results are highly dependent on the precision of 
the reference method. 
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Figure 5.3 Changes in cardiac output by the four methods against changes in intermittent 
thermodilution cardiac output. The data in between the dotted lines indicated a clinical insignificant 
change of 10%. For abbreviations see figure 5.2.
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Figure 5.4 Effects of time on the difference between method under study and intermittent 
thermodilution cardiac output. To study time effects, FCO and CCO were calibrated at start (t0) against 
ICO. Dotted lines indicated values at start ± 10% of start value. For abbreviations see figure 5.2.
In our study individual thermodilution cardiac outputs differ by 10%. Averaging the 
results of three measurements randomly performed resulted in a precision of 6%. A 
better precision may be obtained by averaging the results of three measurements 
performed at equally spaced times over the ventilatory cycle.6;7 In the present study, 
we accepted the clinically most used method of averaging three measurements 
randomly applied as precise enough. Secondly, we selected sequentially all cardiac 
surgery patients that were equipped with a pulmonary artery catheter. The resulting 
patient selection was quite diverse in surgical intervention and use of vasoactive 
agents (Table 5.1).
However, none of the patients had aortic aneurism and none had, after cardiac 
surgery, signs of aortic regurgitation. An aortic aneurysm affects a patient’s aortic 
compliance resulting in a mismatch between expected model and actual compliance. 
A patent aortic valve is needed because the three pulse contour methods compute 
forward blood flow into the aorta and in regurgitation ignores backward flow. We can 
not exclude the existence of small undetectable valve leakage. If so, this will increase 
the inaccuracy of our comparison with the ICO method. Thirdly, during each 
observation period, before performing measurements, the level of the arterial pressure 
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transducer was checked and, if needed corrected for. In addition a visual inspection of 
the arterial pressure waveform was done and the arterial pressure line was flushed in 
case of doubt on the quality of the pressure signal. Fourthly, during the observation 
period hemodynamic stability was promoted by constant (no changes in) management 
of the patients.
Agreement of methods with ICO 
This is the first study which compared simultaneously, within the same patient 
population, intermittent pulmonary thermodilution cardiac output with four 
commercial available methods to monitor cardiac output continuously, with three of 
them based on arterial pulse contour (i.e. LCO, PCO, FCO) and one based on 
continuous thermodilution (i.e. CCO). Button et al.8 compared FCO, PCO (with 
femoral artery catheter) and CCO with ICO and concluded that the three methods are 
comparable. The overall accuracy (bias) and precision calculated from their results 
agree with ours for FCO 0.21 and 1.13 vs. 0.59 and 0.98, PCO 0.29 and 1.30 vs. -0.16 
and 1.22 (with radial artery catheter) and CCO 0.33 and 1.19 vs. 0.31 and 0.65 
litre∙min-1. The simultaneous comparison of methods against the same reference 
method allows us to rank the performance of the methods. Ranking our results with 
respect to precision results in; first CCO, second LCO, third FCO and last PCO (Table 
5.3). Button et al.8 reported FCO as best, followed by CCO and PCO, where LCO was 
not evaluated. In the discussion focused on agreement between methods references 
based on animal studies are not included, because, especially, the LCO and FCO 
methods relies on the pressure dependent arterial compliance (pressure volume 
relationship) found in humans.9
Table 5.3 Comparison of four continuous cardiac output systems with cardiac output (CO) by 
intermittent thermodilution (ICO).
Cardiac Output difference LOA calculated precision
Mean SD Bias precision lower   upper ICO=6% ICO=10%
L∙min-1     L∙min-1 L∙min-1 L∙min-1 %      L∙min-1 %        %
Pooled data n=179 / 151(*)
LCO*   5.15     1.26   -0.05   0.94 18.82   -2.00 to 1.90    17.84    15.95
PCO*   5.03     1.37   -0.16   1.22 23.93   -2.61 to 2.29    23.17    21.74
FCO   5.70     0.96    0.59   0.98 18.09   -1.37 to 2.54    17.07    15.07
CCO   5.41     1.11    0.31   0.65 12.37   -0.99 to 1.61    10.82     7.28
LOA, limits of agreement; LCO; PCO; FCO; CCO: cardiac output by, LiDCO, PiCCO, FloTrac and 
continuous thermodilution respectively.
FloTrac-Vigileo system Recent studies 4;8;10-20 investigating the FloTrac-Vigileo 
system showed inconsistent results, Table 5.4. Best accuracy and precision were 
found by Prasser et al.15 Organizing the results with respect to software versions 
revealed that precision improved significantly (p = 0.004) after the introduction of 
software version 1.07. Furthermore, the transpulmonary thermodilution method 
compared to the pulmonary thermodilution method demonstrated a significant higher 
value for bias and precision (p = 0.015 and 0.045 respectively). Most comparisons 
were performed in the ICU with patients after cardiac surgery. With software version 
>1.07, less good or unacceptable results were found in studies with include septic 
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patients 16;19, or consisted solely out of patients with sepsis.10 In our study good results 
for bias and precision were found for all observation periods (Table 5.2) as well as for 
the pooled data (Table 5.4), similar to the results presented by Breukers et al.17 and 
Prasser et al.15 This finding may be explained by the fact that we all used a software 
version >1.07, used the conventional pulmonary thermodilution method as reference 
method and studied patients in the ICU after cardiac surgery.
LiDCOplus system In recent patient evaluation studies with the LiDCO system3;21;22
controversial conclusions were drawn. Pittman et al.3 compared LCO with the lithium 
dilution method and considered a bias and precision of 0.01 and 0.82 litre∙min-1 (14%) 
as accurate. Costa et al.22 compared LCO with ICO and found an overall bias and 
precision of 0.29 and 1.09 litre∙min-1 (13%) and concluded for a good agreement. 
Whereas Yamashita et al.21 found bias and precision to be dependent of the level of 
prostaglandin E1, ranging from 0.02 and 0.14 litre∙min-1 (4%) to -0.18 and 0.48 
litre∙min-1 (13%), overall results -0.15 and 0.36 litre∙min-1 (10%), and concluded that 
the LCO system might be unsuitable in patients after cardiac surgery. Thus the study 
with the best results had a less positive conclusion than the two others. This illustrated 
the need for a more uniform judgment of the performance of monitoring systems. Our 
results for PAC calibrated LCO (Table 5.3) fit well with the cited studies.3;21;22
PiCCOplus system Our results of bias and precision (Table 5.3) are comparable to the 
results of recently published comparative studies with the PiCCO system (software 
version 6 and 7).8;18;23  Bias and precision reported by Button et al.8 with ICO as 
reference were 0.29 and 1.30 litre∙min-1 (25%), by DeWaal et al.18 with 
transpulmonary thermodilution as reference and repeated recalibrations were 0.02 and 
0.93 litre∙min-1 (17.5%) and from Hamzaoui et al.23 with transpulmonary 
thermodilution as reference we recalculated 0.24 and 1.22 litre∙min-1 (17.5%). They 
all concluded a clinical acceptable accuracy. 
Concerns
Myles 24 criticized in a recent editorial the use of the original Bland-Altman
technique, in repeated measurements. Indeed, the results of the studies summarized in 
table 5.4 as well as of our study in table 5.2 were obtained with multiple observations 
per patients, thus as repeated measures. However, to our opinion, performing multiple 
observations per patient does not automatically mean that we have to consider them as
such. We realize that the measurements within a patient are not completely 
independent of each other. In our data the variation between patients is approximately 
equal to the variation within the patients. This is caused by the fact that the patient 
that enters the ICU (hemodynamically instable and highly in need of care) differs 
from the patient that leaves the ICU. Because of this we have chosen our time scale of 
performing observations with increasing time intervals (Table 5.2). Although based 
on the nature of our data the use of a random effects model 24 is most appropriate. 
Using this method we calculated the bias and precision for LCO 0.05 and 0.48; for 
PCO -0.04 and 0.54; for FCO 0.59 and 0.80 and for CCO 0.31 and 0.36 litre∙min-1. In 
this line of thought we have decided to use the data analyses as proposed in the 
original Bland-Altman analysis.5 By doing so, we are able to compare our results with 
the results recently published, table 5.4. Furthermore, in this we have followed Bland-
Altman’s advice 25 that it is better not to run the risk of producing limits of agreement, 
which are too narrow. Incorrectly calculated limits would lead us to think that 





In answering the question which method can replace an older method we follow 
Critchley and Critchley 26 who stated “if a new method has to replace an older, 
established method, the new method itself should have errors not greater than the 
older method”.
In our present study a single pulmonary thermodilution estimate of cardiac output, 
ICO, has a coefficient of variation, further called ‘error’, of 10%. The averaged result 
of a triplicate randomly injected pulmonary thermodilution has an error of 6%. 
Furthermore, we have found errors for the difference of 24, 19, 18 and 12% for PCO, 
LCO, FCO and CCO respectively, Table 5.3. By assuming the errors in ICO to be 
independent of the errors in PCO, LCO, FCO and CCO we can calculate their errors 
by applying Pythagoras law (Fig. 5.5). The results are given in the figure and table 
5.3, column calculated precision, ICO 6%. So, if a triplicate random thermodilution 
determination is to be replaced by LCO, PCO, FCO or CCO, these methods should 
have an error < 6% too. Therefore, none of these methods (PCO 23%, LCO 18%, 
FCO 17%, CCO 11%) can replace this triplicate intermittent pulmonary 
thermodilution method. However single intermittent thermodilution measurements 
may be replace by the CCO method. Thanks to the simultaneous comparison of PCO, 
LCO and FCO against the same reference method we could raise the following 
questions. Can FCO replace the other methods? Yes, the FCO method may replace the 
LCO and PCO method. No, the FCO method cannot replace the CCO method.
Figure 5.5 Graphical analysis of the precision of the four methods. Horizontally the precision of the 
reference method (ICO) is given. The hypotenuse is the precision of the difference between method 
under study and reference method. The precision of the method under study, on horizontal axis, is 
calculated with Pythagoras law. For abbreviations see figure 5.2.
A remark with respect to the PCO system must be made. We used the radial artery 
signal as input for the PiCCO system (Fig. 5.1) and disregarded the advice of the 
manufacture to use the femoral artery signal, because there was no clinical need for an 
additional arterial catheter. In addition, in previous studies 27;28 we showed the 















































































































































































































Furthermore, the PCO and LCO systems were calibrated using the reference device: 
intermittent thermodilution measurements from the pulmonary artery catheter, and not 
the transpulmonary dilution method provided by the manufacturer of each device. If 
the calibration methods provided by the manufacturers (transpulmonary thermal and 
lithium dilution respectively) had been used, the errors in calibration relative to the 
PAC-ICO reference would have increased the errors reported here as described by the 
law of Pythagoras. In our comparison the continuous thermodilution with a PAC, 
CCO, remained the superior performing system despite the much effort made to 
improve the pulse contour methods. 
Tracking changes in cardiac output
Monitoring of changes in cardiac output in relation to changes in the clinical condition 
of a patient as well as the response to interventions is important for clinical decision 
making. We used a threshold for changes ≥ 10%. This threshold was chosen to 
evaluate the possibility of the four methods to detect fluid responsiveness of patients. 
Different authors 29-31 have demonstrated that stroke volume variations (SVV) larger 
than 10% are predictive for increase in cardiac output after fluid loading (i.e. 
responders). Also a fluid challenge of the circulation with 500 mL and observing an 
increase in cardiac output larger than 10% identifies a responder. In our study 
unidirectional changes (using a threshold of ± 10% CO change) were similar for LCO 
(81%), PCO (82%), FCO (92%) and CCO (98%), figure 5.3. It has to be emphasized 
that pulse contour methods follows changes in cardiac output on a beat-to-beat basis 
whereas CCO follows rapid changes with a considerable delay. 32  The good result for 
CCO may be explained by the presence of a hemodynamic stable circulation in our 
patients in the minutes before the observation periods and large time intervals 
between the observations (1 hour or longer), table 5.2. The pulse contour methods, 
with their beat-to-beat cardiac output, enables to monitor changes in CO during the 
ventilatory cycle or during a fluid loading and shortly thereafter (within 2 minutes), 
which is impossibility with the CCO method. 
A special note must be made to the alarming results of Lorsomradee et al.20 These 
authors showed an opposite change in cardiac output by the first generation FCO and 
CCO due to phenylephrine infusion. Phenylephrine is a rapid acting alpha antagonist 
that will increase vascular resistance and venous return. The earlier generation FCO 
showed a significant dynamic increase whereas the time averaged CCO showed a 
small decrease in cardiac output. This probably related to the fact that phenylephrine 
creates a complex and dynamic physiologic response which makes it difficult to 
compare measurements obtained over different time bases. The phenylephrine 
increased arterial pulse pressure by increasing systemic vascular resistance and 
venous return into the heart; and the earlier version of the FCO algorithm did not 
respond quickly to changes in vascular tone and likely overestimated the change in 
flow. The phenylephrine also increased pulmonary vascular resistance. Therefore, the 
slow averaged CCO was likely more reflective of the initial response of the right heart 
to the increased afterload and underestimated the real time change in flow. To what 
extent this accounts for PCO and LCO is still unclear.
Stability of calibration and drift 
To our knowledge our study is the first that evaluate the FCO, LCO, PCO and CCO 
over time within the same study population. An uncertainty about the correctness of 
calibration during changing hemodynamic conditions has lead to a frequent 
recalibration for the PCO and LCO method.18;23;33 However, a too frequent need for 
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recalibration turns the method from continuous to intermittent. Thus uncertainty to 
measure cardiac output correctly, shortly after a recalibration, limits the applicability 
of the PCO and LCO method. The auto-calibration of the FCO accounts for dynamic 
changes in vascular tone and is calculated from the pressure waveform and large 
vessel compliance obtained from arterial pressure, gender, age, weight and height 
according to Langewouters.34 This auto-calibration is updated continuously based on a 
60s average (software versions ≥ 1.07). The CCO method, by principle, is calibration 
free. 
In our evaluation the difference between ICO and PCO or FCO showed a small but 
significant drift with time (Fig. 5.4). At first sight our results seems to differ from the 
results reported several authors 35-37 who reported an acceptable agreement between 
PCO and ICO over calibration-free periods ranging from 8 to 44 hrs, despite changes 
in SVR. However, the manufacturers of the PiCCO device advise their users to 
recalibrate on a regular basis every eight hours, or after changes in SVR of 20%. 
Boyle et al.33, however, demonstrated that the difference between PCO and reference 
method increased with time and conclude that a recalibration is needed after a 2-h 
calibration-free period. Also, Hamzaoui et al.23 concluded, from the results in a recent 
retrospectively ICU study, that after 1-hr calibration-free period recalibration may be 
encouraged. In this way cumulative effects of drift can be eliminated, resulting in a 
better accuracy and precision for the difference between methods. Following this 
reasoning it seems prudent to confirm PCO values by measuring pulmonary or 
transpulmonary thermodilution cardiac output before considering changes in therapy 
even in patients who appear to be hemodynamically stable.33
Conclusions
The performance of pulse contour methods has significantly increased the last few 
years, which makes comparisons with older publications invalid. The auto-calibrated 
FlowTrac-Vigileo system can replace the initially PAC-calibrated LiDCO and PiCCO 
systems. The Vigilance continuous thermodilution method demonstrated the best 
agreement with bolus thermodilution and had the highest score in following slow 
changes in cardiac output. The auto calibrated FloTrac-Vigileo and the initially PAC-
calibrated LiDCO system showed best performance in detecting beat-to-beat cardiac 
output changes.
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We evaluated cardiac output (CO) using three new methods - the auto-calibrated 
FloTrac-Vigileo (COed), the non-calibrated Modelflow (COmf) pulse contour method 
and the HemoSonic 100 ultra-sound system (COhs) - with bolus thermodilution 
(COtd) as the reference. In 13 postoperative cardiac surgical patients 104 paired CO 
values were assessed before, during and after four interventions: (a) an increase of 
tidal volume by 50%, (b) a 10 cmH2O increase in positive end-expiratory pressure, (c) 
passive leg raising and (d) head up position. With the pooled data the difference 
between COed and COtd, COmf and COtd and COhs and COtd was 0.33 ± 0.90, 0.30 
± 0.69 and -0.41 ± 1.11 l.min-1, respectively. Thus, Modelflow had the lowest mean 
squared error, suggesting that it had the best performance. COed significantly 
overestimates changes in cardiac output while COmf and COhs values are not 
significantly different from those of COtd. Directional changes in cardiac output by 
thermodilution were detected with a high score by all three methods.
Introduction
Ideally cardiac output monitoring is accurate, precise, operator independent, fast 
responding, non-invasive, continuous, easy of use, cost effectiveness and does not 
increase mortality and morbidity. Especially of interest are those methods that follow 
changes in cardiac output accurately. These methods may provide an early warning on 
changes in circulatory function and allow testing the circulation with applied 
interventions. 
In the last three decades cardiac output was commonly monitored by using a 
thermodilution pulmonary artery catheter (PAC). The intermittent bolus 
thermodilution cardiac output (COtd), is still considered the best reference method. 
While continuous thermodilution cardiac output (CCO) may not be feasible to follow 
changes on interventions or applied challenges, due to time delay [1, 2]. Devices 
better equipped to monitor fast changes in cardiac output adequately are those based 
on beat-to-beat assessment of stroke volume. Two technologies currently available at 
bedside to monitor beat-to-beat changes in cardiac output reliably are based on arterial 
pulse contour and trans-esophageal ultrasound.
The recently introduced auto-calibrated FloTrac-Vigileo™ (Edwards Lifesciences, 
Irvine, CA, USA) is a pulse contour method for cardiac output monitoring that in 
contrast to devices, like the the PiCCO™ (Pulsion Medical Systems, Munich, 
Germany) and LiDCO™ (LiDCO Ltd., Cambridge, UK), does not require an 
independent calibration [3] and thus do not  add invasiveness to the method. The 
system obtains like the Modelflow method the pressure signal from any standard 
peripheral arterial line and add by this no extra invasiveness to OR and ICU patients. 
The standard deviation of the pulse pressure is correlated to stroke volume based on 
patients age, gender, body height and weight) after an automatic adjustment to actual 
vascular compliance. Early validation showed conflicting results, however, after the 
introduction of software version 1.07, the results became more uniform [4-8].
The Modelflow method derives an aortic flow waveform from arterial pressure by 
using a three element input impedance model. Stroke volume is integrated from the 
flow waveform. The parameters of the model are based on aortic pressure, gender, 
age, height and weight of the patient under study. In different studies [9-12] the 
Modelflow (pulse contour) method have shown the ability to follow beat-to-beat 
cardiac output changes, both after calibration by thermodilution as well as non-
calibrated [11, 12].
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The HemoSonic™ 100 monitor system (Arrow International, Reading, PA, USA) 
comprises an ultrasound probe with both M-mode and pulsed Doppler transducers 
[13, 14]. The M-mode is used to measure (in real time) the diameter of the descending 
aorta and the Doppler transducer to measure the blood velocities across the aorta. 
From diameter and blood velocity aortic blood flow (ABF) is computed. Cardiac 
output is determined via a known relationship between ABF and cardiac output. 
Based on the continuous nature of the technique the system is used to measure 
ventilator induced changes in blood flow in patients as well as to quantify changes in 
ABF on passive leg raising in intensive care patients [15].
The aim of our study is to compare the accuracy, precision and monitoring ability of 
cardiac output measurements by FloTrac-Vigileo, Modelflow and HemoSonic with 
intermittent pulmonary artery thermodilution as reference method. To change cardiac 
output four types of interventions are applied to ICU patients after cardiac surgery.
Methods
Patients and anaesthesia 
After approval of the study protocol by the University Medical Ethics committee,
thirteen patients were studied after coronary arterial bypass grafting or mitral valve 
reconstruction. The study was conducted according to the principles of the Helsinki 
declaration and written informed consent was obtained from all patients prior to 
operation. All patients had symptomatic coronary artery disease without previous 
myocardial infarction. Patients with a history of abnormal ventricular function, aortic 
aneurysm, extensive peripheral arterial occlusive disease, aortic valve pathology, and 
pharyngeal or esophageal pathology were excluded. Patients with persistent 
postoperative arrhythmia or the necessity for artificial pacing or heart assist devices 
were also excluded. All patients were included in the study during their initial post-
operative period in the Intensive Care Unit (ICU).
Anesthesia during surgery and stay in the ICU was with propofol, sufentanil and 
vasoactive medication according to institutional standards. The lungs were 
mechanically ventilated (Dräger EVITA 4, Dräger AG, Lübeck, Germany) in a 
volume-control mode with settings aimed to achieve normocapnia with a tidal volume 
of 8-12 ml.kg-1 and a respiratory frequency of 12-14 breaths.min-1. Fraction of 
inspired oxygen was 0.4 and PEEP 5 cmH2O. During the observation period ventilator 
settings, sedation and vasoactive medication, when used, were unchanged.
Monitoring techniques 
Prior to ICU admission, all patients were catheterized with a 20G radial artery 
catheter (RA 04220, Arrow Int., Reading, PA, USA) to monitor arterial pressure (Pa) 
and a pulmonary artery catheter (139HF75P, Edwards Lifesciences, Irvine, CA, USA) 
introduced into the right jugular vein to monitor central venous pressure (CVP), 
pulmonary artery pressure (PAP) and to estimate cardiac output (CO) by the 
intermittent thermodilution method (COtd). 
COtd measurements were performed with an automated system under computer 
control. COtd was measured in triplicate (with 10 ml saline solution at room 
temperature) in two minutes, with the measurements equally spread over the 
ventilatory cycle. The three individual COtd measurements were averaged [16].Blood 
pressure transducers were referenced to the level of the tricuspid valve and zeroed to 
atmospheric pressure. 
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The radial artery pressure (Pa), derived via the radial artery catheter, was measured 
with a FloTrac™ pressure transducer (Edwards Lifesciences, Irvine, CA, USA)). Of 
the bifurcated cable, one limb was connected to the Vigileo system (Edwards 
Lifesciences) to measure pulse contour cardiac output (COed) and the other limb was 
connected to a bedside monitor pressure module (Hewlett Packard model M1006A, 
Hewlett Packard Company, Palo Alto, Ca, USA) which output was used as input 
signal to the modified Modelflow system (BMEYE, Academic Medical Center, 
Amsterdam, the Netherlands) to estimate pulse contour cardiac output (COmf). 
Detailed information about the FloTrac-Vigileo system [3] and Modelflow system 
[17, 18] can be found elsewhere.
The HemoSonic 100 ultra-sound probe (Arrow International, Reading, PA, USA) to 
monitor aortic blood flow (ABF) was inserted through the mouth and advanced in the 
esophagus to the level of the fourth intercostal space. Next, its position was adjusted 
to obtain the highest Doppler velocity signal along with simultaneous optimal 
visualization of aortic wall images [12, 14]. The final position of the probe was 
checked by chest X-ray, and readjusted after changes in position of the patient, if 
necessary. All measurements were made by the same clinician under supervision of 
team members experienced with HemoSonic100 cardiac output monitoring. Cardiac 
output (COhs) was calculated from ABF [14].
COtd, COed, COmf, COhs, Pa, PAP, CVP, blood temperature, heart rate (HR), were 
continuously recorded and stored on a personal computer for documentation and 
offline analysis.
Study protocol
Measurements were carried out within two hours after arrival in the ICU following Pa 
hemodynamical stabilization. Characteristics and treatment data of each patient were 
collected. During baseline 1 (Fig. 6.1) a series of measurements: HR, MAP, CVP, 
PAP, COtd, COed, COmf, and COhs were obtained. To change cardiac output four 
interventions were applied to the patients. Tidal volume of the ventilator was 
increased with 50% for five minutes, two 2 minutes after this change, the series of 
measurements were repeated (VT-series). Five minutes after return to baseline 2 
series of measurements were performed. Next, positive airway pressure (PEEP) was 
increased with 10 cm H2O for 5 minutes, and after 2 minutes the next series of 
measurements was started (PEEP-series). Five minutes after return from increased 
PEEP, baseline 3 series of measurements were carried out. Next, passive leg raising 
was performed from the supine position by lifting both legs at a 30° angle and holding 
them there for 5 minutes, 2 minutes after initial elevation of the legs with legs still 
elevated the series of measurements were repeated (PLR-series). Five minutes after 
return from passive leg raising, baseline 4 measurements were performed. Last, a head 
up tilting (HUT) procedure was done by rotating the bed to a 30o head-up (anti-
Trendelenburg) position, 2 minutes after rotation of the bed series of measurements 
were started (HUT-series). Five minutes after return from HUT, during baseline 5, the 
last series of measurements was performed. 
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Figure 6.1 Different positions of the patient during the interventions.  A: During supine position VT 
was increased with 50% and PEEP was increased with 10 cmH2O. B: PLR, Passive leg raising is 
performed by maintaining the patient in a supine position and raising the legs by repositioning of the 
bed. C: HUT, head up tilting. During all interventions except for HUT, the heart (symbol ♥) and 
baroreceptors (symbol ○) are in-level and blood pressure transducers do not have to be re-referenced. 
The Doppler probe may move during PLR and HUT and a repositioning of the probe is needed.
Calculations and Statistics
After confirming a normal distribution of data with the Kolmogorov–Smirnov test, 
agreement between COed, COmf, COhs and COtd as well as agreement in changes in 
cardiac output was evaluated with Bland-Altman statistics. The agreement between 
COmf or COed or COhs and COtd was computed as the bias (i.e. accuracy) and 
standard deviation (SD) (i.e. precision), with the limits of agreement (LOA) computed 
as the bias ± 2 SD [19]. The coefficient of variation was computed as 
[CV=100*(SD/mean)]. Following Myles and Cui [20], we also used the random 
effects model to calculate precision and limits of agreement. When the mean of the 
repeated measurements is used, the variation of the differences of the original 
measurement between two methods will be underestimated because the measurement 
error has been removed. A random effects model was chosen to reflect the different 
intercept and slope for each individual on their repeated measurements. We included 
the effects of intervention (VT, PEEP, PLR and HUT) as a covariate in order to get a 
more precise estimate of the residual within-subject variation.
Differences in cardiac output were analysed further with factorial ANOVA, and there 
were three factors; monitoring method (fixed factor, four levels); intervention (fixed 
factor, eight levels, repeated) and subjects (random factor, 13 levels). If ANOVA 
indicated a statistically significant result in cardiac output between baseline and 
intervention, a post-hoc test (Tukey-HSD in multiple comparisons, LSD in pairwise 
comparison) was used to identify the significant effect.
Monitoring capability in cardiac output change (ΔCO) due to an intervention with VT, 
PEEP, PLR and HUT was calculated by subtraction the averaged cardiac output 
values (COavg) of the baseline values before and after the intervention from the 
cardiac output during the intervention (COi). Percentage change is calculated by 
expressing the change in percentage of averaged baseline value: ΔCO% = 100*(COi –
COavg)/COavg. A positive trend is observed if the changes in cardiac output were in 
the same direction as those found for COtd, whereas, a negative trend was scored with 
changes in opposite direction. Ideally, only positive scores should be present. These 
scores were analysed using 2x2 tables and presented in percentages. Separate scores 
were counted for changes when thermodilution cardiac output values differed at least 
a clinically relevant 5 or 10%. A statistical test is considered to be significant if the 
associated p-value is less than 0.05.
PLR HUTBaseline, VT, and PEEP
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Results
We included 13 cardiac surgical patients, 11 after coronary arterial bypass grafting 
and 2 after mitral valve reconstruction. A total of hunderd seventeen paired CO data 
sets with COtd, COed, COmf and COhs were obtained during 5 baselines periods and, 
VT, PEEP, PLR and HUT interventions. Averaging the baseline value before and the 
baseline value after the intervention resulted in 104 paired values for statistical 
evaluation. The data were normally distributed. Mean COtd was 5.28 l.min-1 (range 
2.57 to 8.61 l.min-1). The coefficient of variation for averages of three thermodilution 
measurements equally distributed over the ventilatory cycle was 5%.
Agreement of methods with intermittent thermodilution cardiac output
The error diagrams for the difference between COtd and COed, COmf or COhs are 
given in the three panels of basic Bland-Altman plots (Figure 6.2). For the three 
methods, i.e. COed, COmf and COhs 104 data points are available. Bland-Altman 
statistics for pooled data are indicated in the figure by bias and limits of agreement 
(LOA).
Figure 6.2 Bland-Altman plots of the difference of cardiac output (CO) values between conventional 
thermodilution (COtd) and three minimal invasive methods (n = 104). In panel A, COed, CO by auto-
calibrated FloTrac-Vigileo system. In panel B, COmf, CO by non-calibrated Modelflow method. In 
panel C, COhs, CO by HemoSonic 100 ultrasound system. Solid line represents the bias, dotted lines 
absolute limits of agreement and dashed-dotted lines the limits of agreement in percentage.
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COed – COtd 0.33 0.90 34
COmf – COtd 0.30 0.69 26
COhs – COtd -0.41 1.11 44
Modified Bland-Altman statistics (Random effects model)
COed – COtd 0.33 0.69 25
COmf – COtd 0.30 0.64 24
COhs – COtd -0.41 1.07 42
COtd, intermitted thermodilution cardiac output (reference method); COed, CO measured with 
FloTrac-Vigileo; COmf, CO measured with non-calibrated Modelflow; COhs, CO measured with 
HemoSonic 100.
Bias between COtd and COed or COmf was 0.33 and 0.30 l.min-1 respectively which 
was significantly different from the bias between COtd and COhs (-0.41 l.min-1, for 
both p < 0.001). COmf has best precision (0.69 l.min-1) and smallest range of the 
limits of agreement (-1.08 to 1.68 l.min-1, 26%) whereas values of precision and limits 
of agreement for COed and COhs are larger (-1.47 to 2.13, 34% and -2.62 to 1.80 
l.min-1, 44%, respectively), table 6.1. Also, from figure 6.2 it is observable that the 
distribution of errors is different among the methods. 
Based on the study design (in which multiple measurements per patient were 
obtained) we followed Myles and Cui [20] and used the random effects model (Table 
6.1 and Figure 6.3).
The residual within-subject standard deviation was substantially smaller after adjusted 
for baseline. For example, the original within-subject standard deviation was 0.41 and 
0.79 for COtd and COed, respectively. After adjusting for the relevant covariates, the 
within-subject standard deviation reduced to 0.21 and 0.20, respectively. This reduced 
the width of the 95% limits of agreements accordingly (Figs. 6.2 and 6.3). Bias and 
precision of both, the original and modified Bland-Altman methods are in table 6.1.
Table 6.2 shows the pair wise comparison of mean CO in relation to measurement 
methods, post-hoc analysis. Except for COmf and COed pairs (z = -0.023, p = 0.996), 
the mean cardiac output between all other pairs are significantly different.
Effects of intervention on CO 
The effects on cardiac output by the four applied interventions and four measurement 
techniques are in table 6.2. A 50% increase in tidal volume, did not resulted in a 
change in cardiac output according to all four cardiac output methods. Changes in CO 
were found for all three other interventions, during PEEP a decrease, during passive 
leg raising an increase and during head up tilt position a decrease. An increase of 
PEEP with 10 cm H2O has the largest impact on cardiac output. With Factorial 
ANOVA the main effects on cardiac output values related to the measurement 
techniques was (F = 23.73, p < 0.001), and related to the interventions was (F = 13.85, 
p < 0.001). Differences between methods were consistent across all interventions (F = 
0.19, p = 1.000).
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Figure 6.3 Modified Bland-Altman plots of the difference of cardiac output (CO) values between 
conventional thermodilution (COtd) and three minimal invasive methods, based on a random effects 
model (N =13). In panel A, COed, CO by auto-calibrated FloTrac-Vigileo system. In panel B, COmf, 
CO by non-calibrated Modelflow method. In panel C, COhs, CO by HemoSonic 100 ultrasound 
system. Solid line represents the bias, dotted lines absolute limits of agreement and dashed-dotted lines 
the limits of agreement in percentage
Monitoring cardiac output changes
Fifty-two data points are available to describe changes in cardiac output by COtd, 
COed, COmf or COhs due to interventions. Cardiac output changes by all three 
methods correlate significantly (p ≤ 0.001) with cardiac output changes by COtd 
(COed v COtd, slope 1.46, CI95% 1.07 to 1.81; COmf v COtd, slope 0.82, CI95% 
0.61 to 1.01; COhs v COtd, slope 0.88, CI95% 0.62 to 1.15). The change in COed is 
significantly overestimated compared to the change in COtd. The changes in COmf 
and COhs are not significantly different from identity. The agreement of positive and 
negative trend of COtd and CO in each of the three methods was calculated using 
cross tabulation. The score for agreement in change was 86% for COmf and 81% for 
COed and COhs. These scores improve if clinically irrelevant changes of <5% or 
<10% are excluded from counting. For a 5% threshold, agreement is found in 96%, 
85% and 93% with COmf, COed and COhs respectively. For a 10% threshold, these
values are 100%, 89% and 100% respectively.
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The Bland-Altman plots for changes in cardiac output with LOA are shown in figure 
6.4. Bias between change COtd and change COed, change COmf or change COhs is 
not significantly different (-3.03, -3.28, and -2.01 % respectively). COed (-29.59 to 
23.52 %) has the largest range of the limits of agreement in contrast to COmf (-17.23 
to 10.67 %) and COhs (-20.28 to 16.27%), respectively changes between COed and 
COtd clearly depends on the level of averaged change of COed and COtd (Fig. 6.4A).
Figure 6.4 Bland-Altman plots with percentage changes in cardiac output by three minimal invasive 
methods and percentage changes by conventional thermodilution. For abbreviations see figure 6.2. 
Solid line presents bias and dotted lines limits of agreement. 
Discussion
The present study was designed to evaluate the monitoring capabilities of minimal 
invasive cardiac output systems. The non-calibrated Modelflow method showed a 
good performance in estimation of cardiac output with bias 0.30 l.min-1, precision 
0.68 l.min-1 and limits of agreement of 26% in cardiac surgery patients. Only the % 
limits of agreement obtained with Modelflow (26%) are below the 30% criteria for 
limits of agreement for a theoretically acceptable alternative to thermodilution cardiac 
output [21]. Monitoring changes in cardiac output can be done accurately with non-
calibrated Modelflow and HemoSonic, directional changes in cardiac output larger 
than 5% were correctly followed in 96% and 93% of the cases. For changes larger 
than 10% this was 100% for both methods. For the auto-calibrated FloTrac-Vigileo 
these percentages were calculated 85% and 89%.
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Table 6.2 Changes in cardiac output (CO) related to increase of tidal volume, increase of PEEP, 
passive leg raising and head up tilt intervention.
COtd, intermitted thermodilution cardiac output; COed, CO measured with FloTrac-Vigileo; COmf, 
CO measured with non-calibrated Modelflow; COhs, CO measured with HemoSonic 100; CO 
difference is difference between CO intervention and CO baseline. Results of post-hoc analysis, 
pairwise comparison (LSD) of cardiac output differences related to interventions, factorial ANOVA (F 
= 13.85, p < 0.001).
CO Baseline CO Intervention CO difference
Mean (SD) l.min-1 Mean (SD) l/min-1 in % p - value 
Increased  tidal volume
COtd 5.28 (1.28) 5.28 (1.44) 0.0 0.954
COed 5.72 (0.88) 5.89 (1.47) 3.0 0.507
COmf 5.75 (1.38) 5.43 (1.48) -5.6 0.052
COhs 4.83 (0.93) 4.75 (0.98) -1.7 0.669
Increased  PEEP
COtd 5.37 (1.35) 4.66 (1.47) -13.3 < 0.001
COed 5.99 (0.93) 4.61 (1.51) -23.0 < 0.001
COmf 5.73 (1.45) 4.88 (1.47) -14.8 < 0.001
COhs 4.86 (0.89) 4.17 (1.04) -14.2 0.001
Passive leg raising
COtd 5.39 (1.33) 5.79 (1.37) 7.4 < 0.001
COed 5.61 (0.93) 6.07 (0.97) 9.6 0.078
COmf 5.72 (1.44) 5.97 (1.46) 4.4 0.133
COhs 5.11 (0.74) 5.56 (0.76) 8.8  0.025
Head up tilt
COtd 5.33 (1.20) 5.16 (1.21) -3.8 0.089
COed 5.78 (1.06) 5.23 (1.35) -9.5 0.041
COmf 5.81 (1.31) 5.38 (1.30) -7.4 0.009
COhs 5.14 (1.13) 4.55 (1.01) -11.5 0.004
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Reference method of CO measurement
An important factor in our study was the availability of a reliable reference method. 
Indeed, the error in the reference method has a direct impact on the comparison 
between cardiac output by thermodilution and FloTrac-Vigileo, Modelflow or 
HemoSonic. Individual thermodilution cardiac output estimates show substantial 
scatter (10-15%) in their values even under stable hemodynamic and ventilatory 
conditions [22]. In such circumstances, in general, an average of at least three 
measurements, with randomly in time applied bolus injections, is advised to obtain 
cardiac output estimate with acceptable precision [11]. In ventilated patients, 
however, a better precision is obtained by doing these measurements equally spread
over the ventilatory cycle. In this way ventilator effects on cardiac output are 
maximally averaged out [16]. However, this requires the injections to be performed 
by a motor driven syringe under computer control. In doing so, precision is enhanced 
further by limiting the deviation of injection time and of volume [23]. We used for 
thermodilution cardiac output measurement such a simple but not generally available 
system.
Agreement of cardiac output methods with literature
Auto-calibrated FloTrac-Vigileo In 5 recently published studies with software version 
1.07 and 1.10 [4-8] averaged cardiac output ranged from 5.2 to 5.9 l.min-1, bias from -
0.14 to 0.58 l.min-1 and precision from 0.83 to 1.28 l.min-1. Thus, our present results 
characterized by a mean thermodilution cardiac output of 5.28 l.min-1, a bias of 0.33 
l.min-1 and a precision of 0.90 l.min-1 are consistent with those reported.
Non-calibrated Modelflow From Jansen’s et al. [11] three centre study in 54 cardiac 
surgery patients, using the same methodology as in our present study, we deduced the 
following results for the non-calibrate Modelflow; compared to thermodilution (mean 
4.9 l.min-1) the bias was 0.32 l.min-1 and the precision 0.90 l.min-1 (LOA of -1.58 to 
2.12 l.min-1). From another study in ICU patients after complex cardiac surgery [12], 
again using the same methodology as in our present study, we recalculated for non-
calibrated Modelflow method, after removing two out-layers, a bias of  0.34 l.min-1, a 
precision of 1.16 l.min-1 (LOA of -1.98 to 2.66 l.min-1) and a mean thermodilution 
cardiac output of 5.45 l.min-1. Thus, our present results for non-calibrated Modelflow 
(mean COtd 5.28 l.min-1, bias 0.30 l.min-1, precision 0.69 l.min-1 and LOA -1.08 to 
1.68 l.min-1) are in range with these previous results. 
HemoSonic 100 In 13 cardiac surgery patients Moxon et al. [24] compared 47 
HemoSonic and thermodilution cardiac output pairs and found a bias of 0.23 l.min-1
and a precision 1.06 l.min-1 (LOA -1.89 to 2.35 l.min-1). Su et al. [25] found in a 
similar setup a bias of 0.11 l.min-1 and precision of 1.12 l.min-1 (LOA -2.13 to 2.35
l.min-1). Our results are in agreement with these two studies (bias = -0.41 l.min-1, 
precision = 1.11 l.min-1, LOA -2.62 to 1.80 l.min-1). 
In summary, the present study did not show conflicting results for cardiac output with 
respect to results of previous reports, obtained with either one of the three minimal 
invasive cardiac output methods. 
Effects of interventions on cardiac output
During clinically stable conditions cardiac output was changed by increasing tidal 
volume of the ventilator, increasing PEEP, performing passive leg raising and 
positioning the patient in head up tilt position (Table 6.2). We found a decrease in 
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cardiac output due to PEEP with all four methods, as described in literature [26-29]. 
Passive legs raising recruits blood from the venous reservoirs in the legs 
(approximately 300ml) thereby converting unstressed volume to stressed volume 
resulting in an increase of cardiac output [15, 30]. This increase in cardiac output with 
passive leg raising is confirmed in our study by all four methods. Head up tilt mimics 
the cardiovascular response to haemorrhage in which the central blood volume is 
transmitted to the legs [31]. Thus head up tilt leads to a reduction of stressed volume 
resulting in a decrease in cardiac output. This is established by our results as well, 
where all four methods showed a decrease in cardiac output. 
Monitoring changes in cardiac output
Reliability in monitoring changes of cardiac output on interventions or therapy is a 
cornerstone of medical practice. Therefore, we extensively evaluated the tracking 
ability of the three methods upon four interventions. Especially the passive legs 
raising intervention in combination with esophageal ultra-sound blood flow 
measurement has been used to separate those patients that respond to a fluid loading 
by an increase in cardiac output from those that do not benefit [32-34]. In a nice study 
Monnet at al. [33] investigated in 71 mechanically ventilated patients and 31 patients 
with spontaneous breathing activity and/or arrhythmias the feasibility of the 
HemoSonic device. They showed that based on an increase in aortic blood flow >10% 
by passive leg raising, responder, a volume expansion induced increase in cardiac 
output could be reliably predicted. Using the 10% threshold FloTrac-Vigileo scores 
cardiac output changes equally 89% whereas the non-calibrated Modelflow and 
HemoSonic scored 100%. Based on these results we may expect FloTrac-Vigileo and 
Modelflow to be valuable substitutes for the HemoSonic. With the advantage that 
these methods would provide the clinician with a simple, readily available robust 
measure of cardiac output change that is user independent.
Concerns
Myles and Cui [20] criticized in a recent editorial the use of standard Bland-Altman 
analysis to compare methodologies (such as ours in this study) where repeated 
measurements are used. We feel, however, that multiple observations in a patient 
really only apply when taken under the same experimental conditions. Where 
conditions are changing with time, it seems valid to take several observations and then 
assess response over time. Nonetheless, we took the precaution of applying both the 
‘classical’ Bland-Altman statistics [19] and the random effects model proposed by 
Myles and Cui [20]. The differences in results of analysis are presented in the figures 
6.2 and 6.3. For all three methods the limits of agreement of the classical Bland-
Altman analysis are larger than with the random effects model. This can be explained 
by the removal of within patient variation in cardiac output. Especially the difference 
between COed and COtd (Fig. 6.2A) decreased considerably with the random effects 
model (Fig. 6.3A). This is account for the overestimation of changes in cardiac output 
by the FloTrac-Vigileo system (Fig. 6.4A).
In our study, patients remain in a supine position during the increased tidal volume, 
PEEP and passive leg raising intervention (Fig. 6.1). During passive leg raising only 
the legs are raised by repositioning of the bed. The heart and baroreceptors are in-
level and blood pressure transducers do not have to be re-referenced. However, upon 
passive legs raising the esophageal probe can change position due to fixation of the 
probe to the bed and possible movement of the patient. We regular repositioned the 
probe to obtain an optimal signal again. Also during the head up tilt intervention the 
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position of the probe may be compromised and repositioning may be needed. During 
(re)positioning we focused on maximum for after wall distance, maximal acceleration 
of aortic blood flow and optimal aortic wall visualization [14]. In addition, the 
position of the pressure transducers needs to be corrected too, as we did. However, the 
position of baroreceptors in relation to the heart is changed which may influence 
arterial blood pressure by auto-regulation (Fig. 6.1). These differences may have 
influenced the results (Table 6.2) differently for the three methods of cardiac output 
measurement.
Conclusions
Non-calibrated Modelflow method showed best performance in estimation of cardiac 
output. Changes in cardiac output by thermodilution were tracked significantly by 
HemoSonic and non-calibrated Modelflow whereas auto-calibrated FloTrac-Vigileo 
overestimated the changes in cardiac output. Directional changes in cardiac output by 
thermodilution were detected with a high score by all three methods. Encouraged by 
the simplicity of setup procedure and advantage for the patient, we stress to further 
exploration of FloTrac-Vigileo and Modelflow system.
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Summary
Background Cardiac output by Modelflow pulse contour method can be monitored 
quantitatively and continuously only after an initial calibration, to adapt the model to 
an individual patient. The Modelflow method computes beat-to-beat cardiac output 
(COmf) from the radial artery pressure, by simulating a three-element model of aortic 
impedance with post-mortem data from human aortas.
Methods In our improved version of Modelflow (COmfc) we adapted this model to a 
real time measure of the aortic cross-sectional area (CSA) of the descending aorta just
above the diaphragm, measured by a new transoesophageal echo device (HemoSonic 
100). COmf and COmfc were compared with thermodilution cardiac output (COtd) in 
24 patients in the intensive care unit. Each thermodilution value was the mean of four 
measurements equally spread over the ventilatory cycle.
Results Least squares regression of COtd vs COmf gave y = 1.09 x [95% confidence 
interval (CI) 0.96 to 1.22], R2 = 0.15, and of COtd vs COmfc resulted in y = 1.02 x
(95% CI 0.96 to 1.08), R2 = 0.69. The limits of agreement of the un-calibrated COmf 
were -3.53 to 2.79, bias = 0.37 litre min–1 and of the diameter-calibrated method 
COmfc, -1.48 to 1.32, bias = -0.08 litre min–1. The coefficient of variation for the 
difference between methods decreased from 28 (un-calibrated) to 12% after diameter-
calibration.
Conclusions After diameter-calibration, the improved Modelflow pulse contour 
method reliably estimates cardiac output without the need of a calibration with 
thermodilution, leading to a less invasive cardiac output monitoring method.
Introduction
Different authors have shown in patients, by comparing the Modelflow estimates with 
thermodilution estimates, the ability of the Modelflow (pulse contour) method to 
replace the thermodilution method to follow cardiac output changes. 1-3 A patient
calibration of the Modelflow method is, however, needed to obtain quantitative 
cardiac output with high accuracy. This calibration is usually carried out by 
thermodilution cardiac output.1-3 
The parameters of Modelflow are based on aortic pressure, and post-mortem data of 
cross-sectional area (CSA) vs pressure of the aorta just above the diaphragm.4 A 
recently developed M-mode ultrasound method, (HemoSonic 100, ARROW, Reading, 
PA, USA) has the ability to measure the diameter of the descending aortic just above 
the diaphragm. In addition, the system also measures aortic blood flow velocity.5 The
oesophageal ultrasound method is considered to be less invasive than thermodilution 
cardiac output measurement by a pulmonary artery catheter (PAC).
In this paper we would like to test the hypothesis that calibration of the Modelflow 
method by the measure of the aortic diameter results in an improvement of the 
accuracy of the method such that a calibration by thermodilution is no longer needed.
Methods
Patients and materials The study was approved by the hospital ethical committee and
was conducted according to the principles stated in the Helsinki convention. Written 
informed consent from each patient was obtained the evening before surgery. The 
improved Modelflow method was evaluated in the intensive care unit (ICU) in 24 
patients following coronary artery bypass graft and/or valve replacement. Exclusion
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criteria were severe tricuspid heart valve insufficiency, aortic aneurysm, aortic valve 
pathologies, and known pharyngeal or oesophageal pathologies.
Anaesthesia during surgery was performed according to institutional standards, with 
invasive monitoring of arterial pressure, central venous pressure, pulmonary artery 
pressure, pulmonary capillary wedge pressure, and thermodilution cardiac output with 
a PAC (Edwards IntelliCath, Irvine, CA, USA).
After transfer of the patient to the ICU, the hemodynamic status was stabilized giving 
fluids and catecholamines as required. The lungs were ventilated with oxygen 40%, 12 
bpm, and a positive airway pressure of 5 cm H2O. Tidal volume was adapted to bring
the arterial  in the range of 40 – 45 mm Hg. The HemoSonic 100 probe was 
inserted into the oesophagus after hemodynamic and respiratory stability had been 
achieved. During this stage diameter-calibration of Modelflow was performed. To 
prevent instability during this period, nursing activities and treatment of the patients 
were minimized. Measurement series with changes in arterial pressure or heart rate 
larger than 5% were rejected and repeated.
Modelflow method Increase in aortic pressure as a result of left ventricular contraction
causes inflow of blood into the arterial system. This inflow is, however, opposed and 
thus moderated by aortic and peripheral systemic properties such as arterial counter
pressure and impedance.
The Modelflow method simulates this behaviour according to a three-element 
Windkessel model of arterial input impedance.6 7 The three-element model, 
representing the three major properties of the aorta and arterial system, has three 
principal components: aortic characteristic impedance, which represents the 
opposition of the aorta to pulsatile inflow; Windkessel compliance, which represents 
the ability of the aorta and arterial system to elastically store the cardiac stroke output 
of the left ventricle; and peripheral resistance, which represents the opposition of the 
vascular beds to the drainage of blood.
The impedance and compliance of the model depend on pressure itself,4 and total 
systemic peripheral resistance depends on many factors including circulatory filling, 
metabolism, sympathetic tone, and vasoactive drugs.
The aortic Windkessel compliance decreases substantially when aortic pressure 
increases. This non-linear behaviour of the aortic wall would be a major source of 
error if not taken into account. The aortic characteristic impedance, in contrast to
compliance, increases moderately when aortic pressure increases. These non-linear 
relationships were studied post-mortem by Langewouters and colleagues4 and 
described as mathematical functions of the patient's age, gender, height, and weight. 
Individual inaccuracy in aortic diameter determination translate into an inaccuracy in 
the absolute level of cardiac output computed for an individual patient, but the ability 
to reliably track the changes in cardiac output remains intact.3 To overcome the 
individual inaccuracy in aortic diameter determination, a real time measurement of
aortic diameter was introduced using an ultrasound echo system (M-mode, 
HemoSonic 100). According to Langewouters and colleagues,4 the thoracic aortic 
CSA can be predicted as a function of aortic pressure (Pa) by the following formula: 




















CSAmax is the maximal cross sectional area at a very high pressure; P0 defines the 
position of the inflection point. P1 defines the width between the point at one-half and 
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three-quarter amplitude. The measured CSA of the descending aorta is computed from 
the measured aortic diameter. The patient-dependent arctangent relation between 
pressure and CSA is next linearly scaled through the measured CSA (Fig. 7.1).
Figure 7.1 Pressure–area relationship. Pa, arterial pressure; P0, P1, and CSAmax (for details see 
Methods). Thin line, predicted curve of a 59-yr-old female with a height of 160 cm and a weight of 48 
kg. Solid line, corrected relation, scaled from the predicted diameter (20.7 mm) to the measured 
diameter (16.7 mm) at an arterial pressure of 82 mmHg.
Total systemic peripheral resistance is known only approximately from physiology. 
The uncertainty in this model parameter is removed as follows. For the first beat 
detected in the arterial pressure waveform a population average value for peripheral
resistance is assumed in the model and mean arterial pressure and cardiac output is 
computed. The ratio of pressure to cardiac output for this first beat defines a new 
resistance value used in the model for the next beat, and so forth. Within 5 beats after 
start, usually, model resistance stabilizes to the systemic peripheral resistance value. 
The model follows changes in systemic peripheral resistance that further occurs. This 
self-adaptation scheme is possible because systemic peripheral resistance changes are 
slow, with time constant typically near 10 s.
Radial arterial pressure was taken from the monitor in use in the ICU, and HemoSonic 
100 diameter was sampled by a computer system at 100 Hz and used as input to the 
model, to compute an aortic flow waveform. The flow waveform was integrated 
during arterial systole to deliver stroke volume. Cardiac output was computed for each 
beat as the product of stroke volume and heart rate. A detailed description of the 
computation can be found in previous papers.1 3 
Measurement of aortic diameter Aortic diameter was obtained from the M-mode 
transducer of the oesophageal HemoSonic probe.5 During probe positioning, first, best 
ultrasound signal quality was adjusted by rotation of the probe using the acoustic and 
visual Doppler signal. Secondly, the M-mode transducer was rotated giving the largest 
distance between anterior and posterior wall, is diameter, of the descending aorta. 
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After operator validation and adjustment of the edge detection of the anterior and 
posterior wall of the aorta, the measurement of the diameter is then automatically and 
continuously followed by the instrument, and displayed on the screen. A chest X-ray 
was taken to check the position of the probe.
Thermodilution method To improve the accuracy of the thermodilution method, 
measurements were performed with an automated system under computer control,3 8-10
and included an injectate system (CO-SET, Edwards, Irvine, CA, USA), a proprietary, 
motor driven injectate syringe, a PAC (Edwards) and a cardiac output computer 
(COM2, Edwards).
Cardiac output was estimated four times, each measurement initiated in a different 
phase of the ventilatory cycle. Hence, each injection of 10 ml of glucose at room 
temperature was delayed from the start of the ventilatory period over either: 0, 25, 50, 
or 75% of the duration of the ventilatory cycle. The start of the ventilatory cycle and 
the cycle time were detected from the tracheal pressure waveform. The four cardiac 
output measurements were averaged to obtain one single value for averaged cardiac 
output. For this technique to work optimally, the hemodynamic and ventilatory
frequency must be stable during the series.11
Data acquisition and analysis The best position of the ultrasound probe was checked 
shortly before the determination of mean cardiac output by performing one series of 
four thermodilution measurements. During this series of four measurements the 
position of the probe was not changed. As cardiac output in a patient can be quite 
variable it is important to acquire the data of each method simultaneously. Therefore, 
the data of arterial pressure, thermodilution cardiac output and aortic diameter was 
stored on computer disk, simultaneously. To obtain one single data pair per series, 
Modelflow cardiac output (COmf and COmfc) and thermodilution cardiac output 
(COtd) are averaged over the same period of time. Hemodynamic stability was 
verified by analysis of mean arterial pressure and heart rate (not cardiac output) during 
a series. Stability was considered absent if mean arterial pressure and heart rate 
averaged per injection deviate more than 5% from their overall average during a 
series.3 Severe, persistent arrhythmias during passage of thermal indicator was 
additionally considered as absence of stability. If stability was not present, the series 
were repeated as one prerequisite for a precision comparison had not been fulfilled.
Statistical analyses The main statistical tool is the Bland–Altman analysis with 
differences in data pairs plotted against their average.12 Agreement between 
Modelflow and thermodilution cardiac output was computed as the bias [mean (SD)], 
with limits of agreement computed as bias ± 2SD when the distribution of differences
was normal as tested with the Kolmogorov - Smirnov test. The coefficient of variation 
was computed as [CV = (SD/mean) x 100%]. Data are given as mean (SD). Statistical 
significance was considered present if P < 0.05.
Results
Twenty-four paired sets of data were obtained in 24 patients. Individual 
thermodilution cardiac output measurements indicated a certain scatter within some 
series of four measurements, but no measurement was rejected. In all patients we were 
able to obtain a measure of the diameter of the aorta with the HemoSonic 100. In one 
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patient, with acromegaly, the measured diameter of 42.0 mm was used although it was 
not within the HemoSonic specified measurement range.
Table 7.1 summarizes the patient data and selected hemodynamic variables. These 
include thermodilution cardiac output and the differences between Modelflow and 
thermodilution cardiac output before and after diameter-calibration. The mean 
calibration factor of all patients was 0.99 and not significantly different from 1.00, P >
0.05. 
Table 7.1 Patient characteristics and haemodynamic data. 
Variable Units Mean  SD   Range
  Age Yr   61  12  35 - 79
  Height Cm 173    8 160 - 186
  Weight Kg   81  14   48 - 118
  MAP mmHg   91  16   70 -126
  PAP mmHg   22    5   15 - 30
  CVP mmHg   10    4     4 - 17
  HR min-1   81  14    50 - 108
  COtd litre min-1  5.43  1.23 3.11 to 8.82
  COmf-COtd litre mn-1 -0.37  1.58 -4.45 to 4.48
  COmfc-COtd litre min-1 -0.08  0.70 -1.41 to 1.08
MAP, mean arterial pressure; PAP, mean pulmonary artery pressure; CVP, central venous pressure; 
HR, heart rate; COtd, thermodilution cardiac output; COmf–COtd, difference between un-calibrated 
model and thermodilution cardiac output; COmfc–COtd, difference between calibrated model and 
thermodilution cardiac output.
The cardiac output bias of -0.37 litre min–1 before calibration decreased to -0.08, and 
are both not significantly different from 0.00, P > 0.05. The SD of the difference of 
1.58 litre min–1 is halved after calibration to 0.70 litre min–1.
Figure 7.2 shows un-calibrated and diameter-calibrated Modelflow vs thermodilution 
cardiac output. In the scatter diagram, upper panel, the line of identity is given. Least 
square regression of COtd vs COmf gave y = 1.09 x [95% confidence interval (CI) 
0.96 to1.22], R2 = 0.15 and of COtd vs COmfc gave y = 1.02 x (95% CI 0.96 to 1.08),
R2 = 0.69. The Bland–Altman analyses showed the limits of agreement of the un-
calibrated COmf (-3.53 to 2.79, bias = 0.37 litre min–1) and of the diameter-calibrated 
method (-1.48 to 1.32, bias = -0.08 litre min–1). Two extreme values can be observed 
in Figure 7.2 (3.15 and -4.45 litre min–1), one in the male patient with acromegaly and 
an aorta diameter of 42.0 mm and the other in a small lady with an aortic diameter of
16.7 mm. After calibration of Modelflow with the diameters measured by the 
HemoSonic system the differences became much smaller, 0.05 and -1.41 litre min–1, 
respectively.
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Figure 7.2 Diagrams showing the data pairs of all 24 patients before (left) and after (right) diameter 
(diam) calibration. In the scatter diagrams (A and B), the line of identity is given. The dashed lines in 
the Bland–Altman plots (C and D), indicate bias (–7 and 1%) and limits of agreement (–62 to +50% 
and –27 to 24%).
Discussion
In a previous study we found the Modelflow method can reliably track directional 
changes in thermodilution cardiac output larger than 0.5 litre·min–1.3 Cardiac output 
can be monitored quantitatively and continuously with little error by the Modelflow
method only after an initial calibration to adapt the model to the individual patient. 
This study explored the feasibility to perform this initial calibration with a 
measurement of the aortic diameter in each patient. We found that the cardiac output
values obtained with this adapted Modelflow method agreed with the mean of four 
bolus-thermodilution measurements equally spread over the ventilatory cycle.
HemoSonic A proper positioning of the M-mode echo probe is crucial. Therefore, to 
gain experience in using the HemoSonic 100, we underwent training, by the 
developers of this ultrasound device, followed by a learning population of six patients. 
Data of these patients were not included in this study. Despite such training, the aortic 
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walls could not always be automatically identified unambiguously by the edge 
detecting of the HemoSonic 100. To overcome the problem we regularly needed to 
change the edge detection window manually. This was especially so in patients with 
aortic valve replacement. In these patients, the anterior wall was often seen at a larger 
distance from the probe due to oedema between the oesophagus and the aorta. In 
addition, the acoustical energy absorbed by the oedema results in a less pronounced 
edge of the posterior wall.
Model calibration How the properties of the aorta depend on age, gender, pressure,
and arteriosclerosis are well understood. We are, however, still left with the individual 
aortic diameter at maximal pressure, which may vary up to ± 30% from the population 
average.4 Therefore, the absolute value of cardiac output cannot be computed with 
certainty. In contrast, changes in cardiac output can be detected with precision.3 If we 
calibrate (scale) the parameter of the maximal CSA of the aorta with the quotient 
between predicted CSA and measured CSA at the mean arterial pressure during the
comparison, the agreement between model calculated cardiac output and measured 
thermodilution cardiac output improved significantly. This was most explicitly 
demonstrated in the patient with acromegaly, where we found a model predicted 
diameter of 29.2 mm, and when measured with the echo probe, a diameter of 42.0 
mm. After diameter-calibrating the Modelflow (calibrated = CSA-measured/CSA-
predicted = 2.06), the computed cardiac output value increased from 2.90 to 6.01 litre 
min–1 and the difference between thermodilution and the model calculated cardiac 
output decreased from 3.15 to 0.05 litre min–1. This patient-case illustrates the
advantage of a direct measure of the aortic diameter with the HemoSonic 100, above a 
predicted diameter.
Error analysis Critchley and Critchley13 stated that if a new method is to replace an 
older, established method, the new method should have not greater errors than the 
older method. Thermodilution is the reference cardiac output in almost all studies, as 
in the present one. A standard single thermodilution estimate of cardiac output has a 
coefficient of variation, further called error, of 15–20%.11 A triplicate, randomly 
injected thermodilution has an error of 10% as the result of averaging.11 The model
mean error after diameter-calibration for the difference between methods is near zero 
(Table 7.1). Thus, only the scatter errors of thermodilution and Modelflow remain. 
They are statistically independent because the methods are based on different physical
principles. The error that we found between the calibrated model and thermodilution 
is approximately 12% (Table 7.1). Our reference cardiac output only has a 5% error.9 
10 Therefore, we may conclude that our calibrated model cardiac output has an error of 
122 - 52 = 11%. This is not as good as a triplicate phase spread thermodilution (11 vs
5%),11 but it is close to the most commonly performed mean of a triplicate random 
thermodilution method (10 vs 11%), and thus might replace it.1
Position of the model method In recent years, several studies based on different pulse 
contour models have attempted to provide reliable continuous cardiac output from the 
systemic arterial pressure. The method, proposed by Romano and Pistolesi,14 based on 
real time extraction of the model parameters was tested in 22 patients. The error for
the difference between cardiac output by their pulse contour method and 
thermodilution is approximately 13%. Linton and Linton15 found an error of 
approximately 12% for the difference between their pulse contour method and
thermodilution cardiac output, this after calibration with one series of thermodilution
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cardiac output. Another pulse contour method based on the Windkessel model, 
however, with no dependency of model parameters on gender and age, has been build 
into the PiCCO device (Pulsion Medical Systems, Munich, Germany). Conflicting 
results were reported by various authors16-18 using this simplified Windkessel model.
Rauch and colleagues 17 demonstrated, after one initial calibration of the PiCCO 
system with a series of transpulmonary thermodilution measurements, that pulse 
contour cardiac output differs from thermodilution cardiac output by approximately 
20% whereas others reported found values of 16 18 and 10%.16 In a former study 3 we 
used the averaged result of one series of four thermodilution measurements equally 
spread over the ventilatory cycle to calibrate Modelflow and found a probability error 
of 7% for Modelflow. Furthermore, it has been shown that one calibration of the 
Modelflow method was adequate for more than 48 hrs of monitoring in ICU patients.2 
In this study we calibrated Modelflow cardiac output by a measure of aortic diameter 
once per patient. Similar to calibration of Modelflow by thermodilution,2 we expect 
that one calibration is adequate for more than 48 hrs of cardiac output monitoring. If 
we compare the results of our study to that of other pulse contour methods such as 
mentioned above, we found a similar error of comparison (12%). However, 
Modelflow calibrated by thermodilution measurements equally spread over the 
ventilatory cycle outperforms the other pulse contour methods. Therefore, if a patient 
is already equipped with a thermodilution catheter, we consider calibration by 
thermodilution preferable above diameter-calibration. In addition, diameter-calibration 
of Modelflow requires a trained operator to position the ultrasound probe whereas our 
thermodilution method runs under computer control and no extra training is needed.
Invasiveness The pressure that determines cardiac output is proximal aortic pressure, 
which is not routinely available. Although the model simulated blood flow shape from 
the radial artery pressure differs considerably from the one simulated from the 
pressure measured in the proximal aorta, the computed stroke volume was found to be 
not different.1 In our ICU, almost all patients have a radial artery pressure monitoring 
system. Notwithstanding the calibration of our new method by measuring the aortic 
diameter with the transoesophageal M-mode ultrasound system, our new method can 
be considered as less invasive than other methods using indicator dilution methods to 
calibrate.
Conclusion
Previously, we showed the ability of Modelflow to continuously monitor changes in 
cardiac output.3 After diameter-calibration, the improved Modelflow pulse contour 
method reliably estimates cardiac output without the need of a calibration with 
thermodilution, leading to a less invasive cardiac output monitoring method.
Declaration of interest ARROW International provided the equipment for this study. 
One of the authors (J.S.) is a consultant to this company.
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Background The aim of the study was to compare the accuracy of stroke volume 
variation (SVV) measured by the LiDCOplus system (SVVli) (LiDCO Ltd.,
Cambridge, UK) (SVVli) and by the FloTrac-Vigileo system (SVVed) (Edwards 
Lifesciences, Irvine, CA, USA).
Methods In fifteen postoperative cardiac surgical patients SVVli and SVVed  was 
measured after; a 50% increase in tidal volume (VT), an increase of PEEP with 10 cm 
H2O, passive legs raising (PLR), a head-up tilt procedure (HUT), and after fluid 
loading (FL). Between these applied study interventions baseline measurements were 
performed.
Results 136 data pairs were obtained. SVVli ranged from 1.4 to 26.8%, average 8.7 ± 
4.6%, SVVed from 2.0 to 26.0%, average 10.2 ± 4.7%. The bias is significantly 
different from zero, 1.5 ± 2.5%, p < 0.001, (95% confidence interval 1.1 to 1.9). The 
upper and lower limits of agreement are 6.4 and -3.5%. The coefficient of variation 
for the differences between SVVli and SVVed is 26%. This result in a relative large 
range for the limits of agreement, expressed in percentages, is 52%. Analysis of 
repeated measurements shows a coefficient of variation of 21 and 22% for SVVli and 
SVVed, respectively.
Conclusion The LiDCOplus and FloTrac-Vigileo system are not interchangeable. 
Furthermore, the determination of SVVli and SVVed are too ambiguous, as can be 
concluded from the high values of the coefficient of variation for repeated 
measurements. These findings underlines Pinsky’s warning to be careful in the 
clinical use of SVV by pulse contour techniques.
Introduction
With the introduction of continuous cardiac output measurement by arterial pulse 
contour analysis, real time measurement of stroke volume (SV) stroke volume 
variation (SVV) and pulse pressure variation (PPV) during mechanical ventilation 
was introduced in clinical practice. Most studies showed, SVV and PPV to be a good 
indicators of fluid responsiveness [1-3]. However, in two separate publications [4, 5]
Pinsky advised caution in the clinical use of SVV based on the fact that beat-to-beat 
SV by the pulse contour technique has not been validated to monitor rapid changes in 
SV, as occur within a single breath. This is further complicated by the use of different 
algorithms to calculate SV and SVV by different monitoring systems. In this light, a 
clinical validation study on SVV seems important. 
Aim of our study was to compare SVV estimates by the LiDCOplus system (SVVli) 
(LiDCO Ltd. Cambridge, UK) with SVV estimates by the FloTrac-Vigileo system 
(SVVed) (Edwards Lifesciences, Irvine, CA, USA) in post operative cardiac surgery 
patients. To induce changes in SVV we applied 6 different conditions to these study 
subjects; measurements in supine or baseline position, after an increase of tidal 
volume (VT), an increase in level of PEEP, after head up tilt procedure (HUT), during 
passive leg raising (PLR) and ater fluid loading (FL). Effects of these interventions on 
SVVli and SVVed, were compared with simultaneously measured PPV and bolus 
thermodilution cardiac output (COtd).
Methods
After approval of the study protocol by the University Medical Ethics committee,
fifteen patients were studied after coronary arterial bypass grafting with or without 
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mitral valve repair. The study was conducted according to the principles of the 
Helsinki declaration and written informed consent was obtained from all patients the 
day before surgery. All patients had symptomatic coronary artery disease without 
previous myocardial infarction and were on β-adrenergic blocking medication. 
Patients with a history of abnormal ventricular function, aortic aneurysm, extensive 
peripheral arterial occlusive disease, or postoperative valvular insufficiencies were not 
considered for this study. Patients with postoperative severe arrhythmia or the 
necessity for artificial pacing or heart assist devices were also excluded. 
All patients were included in the study during their initial post-operative period in the 
ICU. Anesthesia during surgery and ICU-stay was maintained with propofol (2.5 
mg·kg-1·h-1), sufentanil (0.06-0.20 mg·kg-1·h-1) and vasoactive medication according to 
institutional standards. The lungs were mechanically ventilated (EVITA 4, Dräger 
AG, Lübeck, Germany) in a volume-control mode with settings aimed to achieve 
normocapnia with a tidal volume of 8-12 ml·kg-1 and a respiratory frequency of 12-14 
breaths·min-1. Fraction of inspired oxygen was 0.4 and PEEP 5 cmH2O. During the 
observation period sedation and vasoactive medication, when used, were unchanged.
Measurements
Measurements started in the postoperative period. Prior to ICU admission, all patients 
were catheterized with a 20G radial artery catheter (RA 04220, Arrow Int., Reading, 
PA, USA) to monitor arterial pressure (Pa) and a pulmonary artery catheter 
(139HF75P, Edwards Lifesciences, Irvine, CA, USA) introduced via the right jugular 
vein to monitor central venous pressure (CVP), pulmonary artery pressure (PAP) and 
to estimate cardiac output (CO) by the intermittent thermodilution method (COtd). 
The radial artery pressure (Pa), derived via the radial artery catheter was measured 
with a FloTrac pressure transducer (Edwards Lifesciences). Of the bifurcated cable, 
one limb was connected to the Vigileo system (Edwards Lifesciences, software 
version v1.07) to measure pulse contour cardiac output and SVVed and the other limb 
was connected to a bedside monitor pressure module Hewlett Packard model 
M1006A, (Hewlett Packard Company, Palo Alto, CO, USA) of which the output 
signal was used as input signal for the LiDCOplus pulse contour system to deliver 
cardiac output, pulse pressure variation (PPVli) and SVVli. Detailed information 
about both pulse contour techniques can be found in recent literature [6-9]. Pa, PAP 
and CVP, were recorded online on computer disk for documentation and offline 
calculations. Pa, PAP and CVP transducers were referenced to the intersection of the 
anterior axillar line and 5th intercostal space. After changes in position of the patient 
the transducers were re-referenced. Airway pressure (Paw) was measured at the 
proximal end of the endotracheal tube with an air-filled catheter connected to a 
pressure transducer. Paw was balanced at zero level against ambient air. 
We calibrated the LiDCOplus system with 3 thermodilution cardiac output 
measurements at start of the observation period. The FloTrac-Vigileo system used its 
internal auto-calibration. From the beat-to-beat cardiac output values with the 
LiDCOplus and FloTrac-Vigileo system, stroke volume (SVli and SVed), stroke 
volume variation (SVVli and SVVed) and pulse pressure variation (PPVli) were 
determined. SVV and PPV were calculated over 20 second periods of Pa data. 
Study protocol
To induce changes in CO, SVV and PPV, and evaluating clinical relevance,
measurements were performed during baseline in supine position, after increased tidal 
volume (+50%) (VT), during increased PEEP (+10 cm H2O), during passive leg 
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raising (PLR) of both legs with 30 degrees , during 30 degrees head up tilting (HUT) 
and in supine position after fluid loading (FL) with 500 ml Hydroxyethyl Starch (HES 
130/0.4) in 15 minutes. Between study interventions, baseline conditions were re-
established. Measurements of MAP, HR, COtd, SVVli, SVVed and PPV, from the Pa 
signal, were collected during each study period, 2 minutes after the change in study 
intervention, and between study interventions at baseline. The study protocol lasted 
about 90 minutes where after sedation was stopped and weaning procedures were 
started. During the protocol we encountered no adverse events. All patients were 
discharged from the intensive care unit on the first postoperative day.
Statistical analysis
After confirming a normal distribution of data with the Kolmogorov – Smirnov test, 
differences between SVVed and SVVli during study interventions and baseline were 
analyzed using a paired t-test. Values of SVV and changes in SVV based on 
interventions and devices are analysed with factorial ANOVA. Calculations of bias 
and precision and limits of agreement between SVVed and SVVli are performed 
using Bland-Altman analysis [10]. In which bias is the difference between SVVli and 
SVVed and precision the standard deviation (SD) of this difference. The upper and 
lower limits of agreement are calculated as the bias ± 2∙SD. The coefficient of 
variation (CV) is calculated as 100%∙SD/mean (SVVli and SVVed). The percentage 
limits of agreement are calculated as 2·CV. A p-value < 0.05 was considered 
statistically significant. Unless otherwise stated, data are presented as mean (SD).
Results
In fifteen post operative cardiac surgical patients, gender; male/female 12/3, mean age 
66 (range 55 to 82) years, mean BSA 1.98 ± 0.20 m2, were included. Only 8 patients 
received fluid loading. A total of 136 paired data sets were obtained. The data was 
normally distributed. COtd ranged from 2.6 to 7.7 with an average of 5.0 ± 1.1 L.min-
1. HR ranged from 54 to 92, average was 75 ± 8 min-1. SVVli ranged from 1.4 and 
26.8%, average 8.7 ± 4.6%, SVVed from 2.0 to 26.0%, average 10.2 ± 4.7% and 
PPVli from 1.9 to 25.3, average 8.8 ± 4.7%.
Agreement of SVVli and SVVed
Bland-Altman statistics are indicated in the figure by bias and limits of agreement 
(LOA). The bias is significantly different from zero, 1.5 ± 2.5%, p < 0.001, (95% 
confidence interval 1.1 to 1.9). The upper and lower limits of agreement are 6.4 and -
3.5%.Coefficient of vanriance for the differences between SVVli and SVVed is 26%. 
This result in a large range for (error-percentage) limits of agreement of 52% (2·CV).
The error diagram for difference between SVVli and SVVed is shown in figure 8.1.
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Figure 8.1 Bland-Altman plot (pooled data), representing agreement between stroke volume variation 
(SVV) by the LiDCO system (SVVli) and by Edwards FloTrac-Vigileo system (SVVed). The solid line 
represents the bias and the dotted lines the limits of agreement, dashed lines the limits of agreement in 
percentage.
Interventions
COtd, HR, PPVli, SVVli and SVVed as well as the differences between SVVli and 
SVVed for the different experimental conditions are presented in table 8.1. With 
Factorial ANOVA the main effects on SVV values related to the measurement 
techniques was (F = 14.49, p = 0.02), and related to the interventions was (F = 8.29, p
< 0.001). Differences between SVV measurement methods were consistent across all 
interventions (F = 1.54, p = 0.142). One-way ANOVA statistics showed no significant 
difference between the five baseline measurements for COtd (F = 0.203, p = 0.936), 
HR (F = 0.094, p = 0.984), PPVli (F = 0.184, p = 0.946), SVVli (F = 0.254, p = 0.906) 
and SVVed (F = 0.390, p = 0.815) expressing that there were no significant effects 
over time. On average VT showed no change in COtd and an increase in PPVli, 
SVVli and SVVed; PEEP and HUT decreased COtd and increased PPVli, SVVli and 
SVVed whereas PLR and FL increase COtd and decreased PPVli, SVVli and SVVed. 
Heart rate did not change during study interventions. When analyzing our 
observations as repeated measures, analysis showed the following coefficient of 
variation, for PPVli = 23%, SVVli = 21% and SVVed = 22%.
Discussion
We found SVVli and SVVed to differ significantly. With percentage limits of 
agreement of 52% we conclude that the LiDCOplus and FloTrac-Vigileo devices are 
not interchangeable. Furthermore, the determination of SVVli and SVVed appeared to 
be ambiguously as can be concluded from the high value of coefficient of variation
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(21 and 22%) for repeated measurements. These findings underlines Pinsky’s warning 
to be careful in the clinical use of SVV by pulse contour techniques [5].
The significant mean difference between SVV measured by the LiDCO and FloTrac-
Vigileo device is most probably not caused by the calculation of SVV because both 
systems use a similar computation i.e. SVV = 100∙(SVmax – SVmin)/SVmean. 
Therefore, most likely, it must be explained by the difference in the calculation of 
SVmin, SV max and SVmean by the two systems. The main difference in 
computation of SV is based on the correction for individual arterial compliance. The 
LiDCO system uses a pressure dependent correction for compliance based on 
Remington’s equations [11] whereas the FloTrac-Vigileo uses Langewouter’s 
equations [12]. There is a large similarity between the computations of SV, figure 8.2. 
With both systems these equations lead to a diminished SV at higher pressure levels 
compared to lower pressure levels with the same arterial pressure curve. However, 
this correction for compliance may differ between the two systems. A difference in 
calibration between the two systems has no influence on SVV, indeed, assuming a 
calibration constant k leads to SVV = 100 (k∙SVmax – k∙SVmin)/ k∙SVmean. With k 
in the nominator and denominator the calibration factor is ruled out in the 
determination of SVV.
In a recent paper Hofer et al. [13] compared the FloTrac-Vigileo and the PiCCOplus 
system for assessment of SVV to predict fluid responsiveness. The authors concluded 
for similar performance of the two systems. Although, the SVV threshold level of
predicting fluid responsiveness, by the PiCCO system (12.1%) and FloTrac-Vigileo 
system (9.6%), differ. 
Not confirmed by the small number of patients in our study, but based on similarity of 
their study with ours, and our results, we predict different threshold levels for the 
LiDCO and FloTrac-Vigileo system, as well. 
Besides the difference in mean SVV we observed a wide range of the percentage
limits of agreement (52%) between the two systems. This wide range for the 
percentage limits of agreement can be observed also in two recent papers [13, 14].
Figure 8.2 Similarity of calculation of cardiac output by the LiDCO system and by Edwards FloTrac-
Vigileo system. Arterial volume (V) changes derived after transformation of the radial artery pressure 




From the results of Hofer et al. [13] we calculated percentage limits of agreement of 
40% during 30o head up-position and 42% during 30o head-down position. Also in the 
paper of de Castro et al. [14], comparing SVV measured by the PiCCOplus system 
with SVV measured by aortic Doppler echocardiography, a wide ranged for the 
percentage limits of agreement of approximately 40% can be observed. Given these 
margins of error, we concluded that none of these systems is interchangeable with one 
of the others. Furthermore, it seems that the calculation of SVV is prone to 
propagation of errors in the calculation of SVV [14]. This is supported by the high 
coefficient of variation for repeated measurements of SVVli of 21% and SVVed of 
22% in our study. This fluctuation can also be seen on the display of both monitor 
systems by the frequent changes in SVV value. The reason for these fluctuations is 
still unclear. As the errors in the measurements of SVVli and SVVed are not 
completely independent we cannot estimate the coefficient of variation for the 
difference from the coefficient of variations of both systems. The coefficient of 
variation for the difference may vary between 1 and 43%. The coefficient of variation
found for the difference of 26%, is in range with these numbers.
Nevertheless the above, the changes in SVV induced by our interventions are in 
concordance with what was expected (Table 8.1). During the increase in tidal volume 
we observe, in comparison to baseline, no change in cardiac output but an increase in 
SVV. A similar increase in SVV to the increase of VT was observed by Kim and 
Pinsky [15] in a well controlled animal study. During PEEP and head up position CO 
decreased and SVV increased and during passive leg raising and after fluid loading 
we observed an increase in CO and decrease in SVV with both systems. However, the 
difference between SVVli and SVVed fluctuates considerably.
Despite these shortcomings, SVV seems a variable of considerable interest. Several 
authors have shown that SVV can predict the effects of fluid loading on cardiac 
output, however with different thresholds ranging from 9.5 to 12.5%  to separate 
responder and non responders [13, 16-18]. Although there is no reason to doubt about 
the general principle of SVV as predictor of fluid responsiveness, we conclude from 
our results that some precaution in the use of SVV in an individual patient is justified.  
Indeed, based on Bland-Altman analysis for repeated measurements for SVV with 
percentage limits of agreement, the value of SVV may differ up to approximately 
40% between measurements. Taking in mind a stable condition with  at a certain 
moment in time we measure a SVV of 10%, a moment later in time this value may be 
14% and an at another moment 6%. With SVV = 14% one may conclude for fluid 
loading to improve cardiac output, whereas with 6% one may conclude for 
catecholamines.
Conclusions
SVVli and SVVed differ significantly. With a percentage limits of agreement of 52% 
the two methods do not agree and cannot be used interchangeably. Furthermore, the 
determination of SVVli and SVVed appeared to be ambiguously as can be concluded 
from the high value of coefficient of variation (21 and 22%) for repeated 
measurements. These findings limit clinical use in individual patients and limit the 
comparability of fluid loading responsiveness results between different studies. 
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Accurate clinical assessment of the circulatory status is particular desirable in 
critically ill patients in the intensive care unit (ICU) and patients undergoing cardiac, 
thoracic, or vascular interventions. As the patient’s haemodynamic status may change 
rapidly, continuous monitoring of cardiac output will provide information allowing 
rapid adjustment of therapy. 
Aim of this thesis is an overview and evaluation with respect to less invasive cardiac 
output measurement and monitoring systems, especially the pulse contour technique.
The introduction highlights historical and physiological aspects of cardiac output 
measurement and effect of respiratory changes on blood flow and pressure. Secondly 
it introduces methodological aspects of measurement, with attention to the reference 
method and analysis of agreement.
Chapter 2
Because pulse contour cardiac output is derived from on the input signal from the 
arterial blood pressure, it can be deduced that the place of measurement could be of 
major interest to the results found. The shape of the arterial blood pressure signal 
depends on the location of measurement. In this context, it is useful to investigate 
whether and how cardiac output differs when radial or femoral blood pressure signals 
are used.
The first commercially available cardiac output monitoring systems based on the 
pulse contour method is the PiCCO-system. This system is prior to measurement to be 
calibrated (by transpulmonary thermodilution), requiring a central venous for bolus 
infusion and a thermistor tipped femoral catheter. Our study was performed to 
determine the interchangeability of femoral artery pressure and radial artery pressure 
as input of the PiCCO-system (Pulsion Medical Systems, Munich, Germany).
We studied fifteen intensive care patients after cardiac surgery. A five second 
averages of the cardiac output derive from the femoral artery pressure (COfem) were 
compared to 5 second averages derived from the radial artery pressure (COrad). The 
equality of the two PiCCO devices (A and B), used in this study, was confirmed in
dataset of 1243 comparative cardiac output values (COfem), Figure 9.1a.
One patient was excluded from our study because of problems in the pattern 
recognition of the arterial pressure signal. In the remaining fourteen patients, 14734 
comparative cardiac output values were analysed. The mean sample time was 88 min, 
range [30 - 119 min]. Mean (SD) COfem was 6.24 (1.1) l.min-1 and mean COrad was 
6.23 (1.1) l.min-1. 
We concluded that femoral artery pressure and radial artery pressure are 
interchangeable as input of the PiCCO device, allowing change to the radial artery 
pressure line if the preferred femoral artery pressure line is no longer available for 
use.
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Fig. 9.1a. Analysis of two used PiCCO devices with linear regression. In analysis one data set used
 (N 1243) Values on X and Y axis are CO in L/min. Equation of linear regression is y = 0.99x,
 r2 = 0.99
Chapter 3
Bias, precision and tracking ability of five different pulse contour methods were 
evaluated by simultaneous comparison of cardiac output values with that of the 
conventional intermittent thermodilution technique (COtd). The five different pulse 
contour methods enclosed in this study were: Wesseling’s method (cZ); the 
Modelflow method; the PulseCO system (LiDCO Ltd., UK); the PiCCO system 
(Pulsion Medical Systems, Germany) and a recently developed Hemac method. 
We studied twenty-four cardiac surgery patients undergoing uncomplicated coronary 
arterial bypass grafting. In each patient, the first series of COtd values was used to 
calibrate the five pulse contour methods. All pulse contour techniques need a reliable 
invasive calibration. After calibration, most methods may replace the thermodilution 
method with a precision of ≈ 10% (i.e. the averaged result of three randomly 
performed measurements). The Modelflow and Hemac technique even, might replace 
the thermodilution estimates based on the averaged result of four measurements done 
equally spread over the ventilatory cycle i.e. a precision of ≈ 5%. The slightly lower 
precision of the continuous pulse contour cardiac output techniques may compared to 
COtd, in clinical settings, be outweighed by the advantages of being automatic and 
continuous. However, under research conditions the use of conventional 
thermodilution method with four measurements equally spread over the ventilatory 
cycle remains the method of choice.
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Due to the character of the examined study population, we need to emphasize that the 
findings of this study are restricted to patients without congestive heart failure, with 
normal heart rhythm and reasonable peripheral circulation. 
Chapter 4
In a review we focus on the PiCCO device: the first widely available commercial 
system for measuring and monitoring of cardiac output by arterial pulse contour 
analysis. We described the basic principle of the device and the monitoring approach. 
Furthermore, we reviewed the main parameters and discussed the use as well as the 
limitations of this device in the light of our own experience.
From the literature and our own comparative studies using different pulse contour 
cardiac output systems, we concluded that the accuracy (bias), precision (SD) as well 
as the tracking of changes in cardiac output by the PiCCO system is inferior to most 
of its competitors. During our use of the PiCCO system, several technical and patient
related limitations were uncovered by coincidence. The technical limitations were 
related to i) incorrect detection of heart beats, ii) incorrect detection of ejection phase, 
iii) no detection of damped arterial pressure tracings, all leading to incorrect 
computations of cardiac output. Patient-related problems were found during severe 
episodes of bleeding and cardio-pulmonary anatomical abnormalities.
In most cardiothoracic patients, stroke volume variation (SVV) or pulse pressure 
variation (PPV) to monitor preload dependency was only useful for a short time as 
most patients were weaned from the ventilator shortly after arrival in the ICU. In 
patients who are candidates for a heart assist device (intra-aortic balloon pump) a 
femoral arterial puncture for application of the PiCCO device is contra-indicated. We 
experienced, consistent with literature, that measurement of global end diastolic 
volume index (GEDVI) and intrathoracic blood volume index (ITBVI) in 
cardiomyoplasty patients is irrelevant. Furthermore we have, based on theory and 
observation, the impression that the precision of these variables is dependent on SVV. 
From the foregoing we consider that the PiCCO system is of limited value in 
monitoring cardiothoracic patients.
Chapter 5
In 2006 a new pulse contour monitoring system was introduced by Edwards 
Lifesciences, (Irvine, CA USA), the FloTrac-Vigileo-system. Unlike the PiCCO and 
the PulseCO system this new monitoring system don’t need to be calibrated, with an 
external calibration method. Because the challenging prospects in clinical practice, 
this un-calibrated pulse contour method, gained our interest and was entered in a 
study. In a first evaluation, we studied twenty-eight cardiothoracic surgical patients, 
after ICU admission. The performance of the new un-calibrated FloTrac-Vigileo
system was compared with simultaneously obtained cardiac output values with 
Vigilance continuous pulmonary artery thermodilution, the calibrated PiCCOplus, and 
LiDCOplus. All systems were evaluated with the intermittent pulmonary artery 
thermodilution as reference method.
The number observation periods varied between 4 and 8 per patient. Data was 
collected during standard care. Data was analyzed with respect to bias and precision 
(classical Bland - Altman statistics), cardiac output changes and stability of 
calibration (drift). We concluded that the performance of pulse contour methods is 
significantly increased the last few years, which makes comparisons with older 
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publications invalid. The auto-calibrated FloTrac-Vigileo system can replace the ones 
calibrated LiDCO and PiCCO system. The Vigilance continuous thermodilution 
method agreed the best with bolus thermodilution and had the highest score in 
following slow changes in cardiac output. The auto calibrated FloTrac-Vigileo and the 
ones calibrated LiDCO system showed best performance in detecting beat-to-beat 
cardiac output changes. 
Chapter 6
New developed cardiac output (CO) methods are preferred to be minimal invasive, or 
at least do not add supplementary invasive procedures for external calibration. 
The only two candidate methologies available, compliance concordant with this 
demand are the ultrasound and pulse contour methods. In this chapter we evaluated 
the transesophageal ultrasound, HemoSonic 100 monitorsystem (ARROW 
International, USA), the un-calibrated Modelflow and the auto-calibrated FloTrac-
Vigileo, from which the last two are both pulse contour systems.
In thirteen postoperative cardiac surgical patients paired CO values of these un-
calibrated cardiac output monitoring methods were compared with intermittent 
pulmonary thermodilution cardiac output before, during and after four study 
interventions. These interventions were: tidal volume increase of 50%, increase of 
positive end expiratory pressure (PEEP) by 10 cmH2O, passive leg raising (PLR) and 
head-up position (HUT) of the patient.
The un-calibrated Modelflow method showed best performance in estimation of 
cardiac output. Changes in cardiac output by thermodilution were tracked 
significantly by HemoSonic and un-calibrated Modelflow whereas auto-calibrated 
FloTrac-Vigileo overestimated the changes in cardiac output. Directional changes in 
cardiac output by thermodilution were detected with a high score by all three 
methods. 
Chapter 7
Cardiac output by Modelflow pulse contour method can be monitored quantitatively 
and continuously only after an initial calibration, to adapt the model to an individual 
patient. The Modelflow method (COmf) computes beat-to-beat cardiac output from 
the radial artery pressure, by simulating a three-element model of aortic impedance 
with post-mortem data from human aortas. In an improved version of Modelflow 
(COmfc) we adapted this model to a real time measure of the aortic cross-sectional 
area (CSA) of the descending aorta just above the diaphragm, by a transoesophageal 
echo device (HemoSonic 100). The COmf and COmfc were compared with 
intermittent pulmonary thermodilution cardiac output in twenty-four patients in the 
intensive care unit. Each COtd value was the average cardiac output value of four 
intermittent pulmonary thermodilution cardiac output measurements equally spread 
over the ventilatory cycle.
After diameter-calibration, the improved Modelflow pulse contour method reliably 
estimates cardiac output without the need of a calibration with thermodilution, leading 
to a less invasive cardiac output monitoring method.
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Chapter 8
With the introduction of continuous cardiac output measurement by arterial pulse 
contour analysis, real time measurement of stroke volume, and stroke volume 
variation (SVV) during mechanical ventilation was introduced in clinical practice. 
Studies showed, SVV to be a good indicator of fluid responsiveness. Only one study 
reported a lack of correlation between SVV and the response of the cardiac output to 
fluid loading. Pinsky, in two separate publications advised caution in the clinical use 
of SVV, he stated; “although validation of mean SV is adequate by the pulse contour 
technique, it is not been validated to monitor rapid changes in SV, which will occur 
over a single breath”. This is further complicated by the fact that different algorithms 
are been used by different monitoring systems. In this light, clinical validation studies 
of SVV by various pulse contour monitoring systems seem important.
In this chapter we reported on a study aimed to compare left ventricular stroke volume 
variation measured by PulseCO (LiDCO) and FloTrac-Vigileo system (Edwards 
Lifesciences). After informed concent, all measurements were collected during 
standard clinical care in fifteen postoperative cardiac surgical patients. Clinical 
relevance of SVV was evaluated by enforced changes in left ventricular preload. 
Applied study interventions included an increase of tidal volume and the level of 
PEEP, passive leg raising (PLR), a tilt procedure of the patient (HUT), and volume 
loading (500 ml Voluven).
At baseline and study interventions SVV(LiDCO) and SVV(Edwards) differ 
significantly. With percentage limits of agreement of 52% (pooled data) the two 
methods do not agree and cannot be used interchangeably. Furthermore, the 
determination of SVV(LiDCO) and SVV(Edwards) appeared to be ambiguously as 
can be concluded from the high value of the coefficient of variance (21 and 22%) for 
repeated measurements. These findings limit clinical use in individual patients and 
limit the comparability of fluid loading responsiveness results between different 
studies.
Conclusions
 Intermittent pulmonary thermodilution cardiac output with pulmonary artery 
catheter was used as reference measurement in all studies without 
complications. 
 The average value of cardiac output using four equally spread measurements 
over the ventilatory cycle, the error of measurement (calculated as coefficient 
of variation), was < 5%.
 Of the cardiac output measurement and monitoring systems, the arterial 
derived pulse contour, Modelflow performed best. The Modelflow and Hemac 
technique, can replace the thermodilution estimates based on the averaged 
result of four intermittent pulmonary thermodilution cardiac output 
measurements, equally spread over the ventilatory cycle. 
 Considering stability of calibration or drift in time, the PulseCO system 
performed better than the than the PiCCO system and FloTrac-Vigileo system.
 In our studies, we included only cardiac surgical patients. Therefore study 
results may not be valid for other patient categories or an entire adult ICU-




Nauwkeurige klinische beoordeling van de hemodynamische conditie is bijzonder 
wenselijk bij de ernstig zieke patiënten op de Intensive Care (IC) en patiënten in de 
direct postoperatieve fase. Deze hemodynamische conditie kan snel veranderen en 
zich openbaren als daling in bloeddruk en/of afname van de hoeveelheid bloed die 
door het hart per minuut uitgepompt kan worden (cardiac output). Continue bewaking 
van de cardiac output kan informatie verschaffen die aanpassing van de therapie 
mogelijk maakt.
Doel van dit proefschrift is een overzicht en evaluatie te geven van de minder 
invasieve cardiac output meet- en monitorsystemen, in het bijzonder de verschillende 
puls-contourmethoden die momenteel op de IC-afdelingen worden gebruikt.
In de introductie zullen historische en fysiologische aspecten van het meten van de 
cardiac output en de hart-longinteractie voor het voetlicht gebracht worden. Tevens 
wordt ingegaan op methodologische aspecten van de meting, met extra aandacht voor 
de referentiemethode en de analyse van de mate van overeenkomst tussen cardiac-
outputmethoden.
Hoofdstuk 2
Puls contour cardiac output wordt afgeleid van het arteriële bloeddruksignaal
(inputsignaal). Hierdoor zal de plaats van meten in de bloedsomloop van groot belang 
kunnen zijn voor de waarden van gevonden resultaten. De vorm van het arteriële 
bloeddruksignaal is immers afhankelijk van de plaats van meten. In dit kader is het 
zinvol om te onderzoeken of en hoe groot de cardiac-outputverschillen zijn als 
bloeddruksignalen van verschillende meetplaatsen gebruikt worden.
In dit hoofdstuk wordt de uitwisselbaarheid van arteria-femoralis- en arteria-
radialisbloeddruk als inputsignaal van het PiCCO-systeem (Pulsion Medical Systems, 
München, Duitsland) getest.
We bestudeerden dit in vijftien IC-patiënten na een openhartoperatie. Gemiddelden 
van vijf opeenvolgende cardiac-outputwaarden van de arteria-femoralisdruk (COfem) 
werden vergeleken met waarden afgeleid van de arteria-radialisdruk (COrad). 
Voorafgaand aan het onderzoek werden de twee gebruikte monitoren met elkaar 
vergeleken door een identiek inputsignaal (COfem) te gebruiken. Met een testset van 
1243 cardiac-outputwaarden vonden we een goede correlatie (Figuur 9.1b). Hieruit 
bleek dat de twee PiCCO-monitoren (A en B) de cardiac-outputwaarden identiek 
meten. Gegevens van één patiënt werden niet meegenomen in de evaluatie.
Bij de overgebleven veertien patiënten werden in totaal 14734 gelijktijdig opgenomen
cardiac-outputwaarden (COfem en COrad) geanalyseerd. Hieruit bleek dat het 
bloeddruksignaal van de arteria femoralis en de arteria radialis als inputsignaal voor 
de PiCCO-monitor, uitwisselbaar zijn. Waarmee gesteld mag worden dat, indien de 
druklijn van de arteria femoralis niet (meer) beschikbaar is, cardiac output ook via de 
arteria radialis bepaald kan worden. 
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Fig. 9.1b. Analyse van de twee gebruikte PiCCO-apparaten met lineaire regressie. Analyse van een 
testset van 1243 cardiac-outputwaarden. De cardiac-outputwaarden (CO) van de X en Y-as worden 
weergegeven in L/min. Lineaire regressie y = 0.99x, r2 = 0.99.
Hoofdstuk 3 
Dit hoofdstuk beschrijft een studie waarbij de nauwkeurigheid en precisie van 
verschillende puls-contourmethoden van cardiac-outputmeting onderzocht werden. In 
deze studie werden gelijktijdig gemeten cardiac-outputwaarden vergeleken met de 
waarden van de conventionele thermodilutietechniek (COtd). De vijf verschillende 
puls-contourmethoden in deze studie waren: Wesseling-methode (cZ); de Modelflow-
methode; het LiDCO-systeem; het PiCCO-systeem en een recent ontwikkelde puls-
contourmethode, Hemac. We onderzochten cardiac-outputdata in vierentwintig
patiënten die een ongecompliceerde coronaire arteriële bypassoperatie (CABG) 
hadden doorstaan. Bij elke patiënt werd de eerste reeks van COtd-waarden gebruikt 
voor kalibratie van de vijf bestudeerde puls-contourmethoden. Na kalibratie hebben 
we 199 gelijktijdig opgenomen cardiac-outputwaarden kunnen analyseren. 
Uit onderzoek bleek dat na kalibratie de meeste onderzochte meetmethoden de 
referentiemethode (bolusthermodilutie, COtd) met een nauwkeurigheid van 10% 
konden vervangen. De Modelflow en Hemactechniek hadden een grotere precisie dan 
de andere puls-contourmethoden. Beiden konden de thermodilutiemethode, 
overeenkomend met het gemiddelde meetresultaat van vier metingen die gelijkmatig 
over de ademcyclus verdeeld zijn, vervangen. In het kader van onderzoek blijft de
conventionele thermodilutiemethode, met vier gelijkmatig over de ademcyclus 
verdeelde metingen, de meetmethode van keuze. Echter de iets lagere nauwkeurigheid 
van de continue puls-contourtechniek wordt in de klinische setting mogelijk
gecompenseerd door de voordelen van een automatische en continue waarneming. 
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Uitgaande van de eigenschappen van de onderzoekspopulatie, beklemtonen we dat de 
resultaten van deze studie beperkt kunnen zijn tot patiënten die leiden aan chronisch 
hartfalen met een normaal hartritme en zonder uitgebreide aandoeningen van het 
perifere vaatbed.
Hoofdstuk 4 
In dit overzichtsartikel beschrijven we onze ervaringen met het PiCCO-systeem. Het 
PiCCO-systeem is het eerste commerciële systeem, gebaseerd op puls-contouranalyse, 
dat klinisch gebruikt werd voor het meten en monitoren van de cardiac output. We 
beschrijven de fundamentele beginselen van de meetmethode en de follow-up 
benadering. Bovendien bespreken we, in het licht van onze eigen ervaring, de 
belangrijkste secundaire parameters die naast arteriële bloeddruk en de cardiac output 
worden weergegeven. Uit de literatuur en uit onze eigen vergelijkende studies naar de
verschillende puls-contourmeetmethoden van cardiac output zijn we tot de slotsom 
gekomen dat de nauwkeurigheid (bias), precisie (SD), als mede het volgen van 
veranderingen in de cardiac output van het PiCCO-systeem de mindere is in 
vergelijking met haar concurrenten. Tijdens het gebruik van het PiCCO-systeem 
werden een aantal technische en patiëntgerelateerde beperkingen blootgelegd. De 
technische beperkingen zijn in verband te brengen met i) een onjuiste indeling van de 
hartslag, ii) een verkeerde detectie van de ejectiefase van de hartcyclus, iii) dat geen 
oplossing geboden wordt ten aanzien van eventuele demping van het arteriële 
bloeddruksignaal, wat leidt tot onjuiste berekening van de cardiac output. Ook omdat 
slagvolumevariatie (SVV) en variatie van polsdruk (PPV) als dynamische parameters 
voor vulling alleen betrouwbaar gemeten kunnen worden bij beademende patiënten,
zijn deze van beperkte waarde bij de groep postoperatieve thoraxchirurgische 
patiënten die wij onderzochten. Deze groep patiënten wordt immers na operatie vrij 
snel ontwend van de beademing. Tevens beschrijven we enkele patiëntgerelateerde 
problemen. Bij patiënten met uitgebreide perifere vaatafwijkingen en patiënten 
waarbij de hartfunctie tijdelijk ondersteund moet worden met een intra-aorta-
ballonpomp, is bewaking met het PiCCO-systeem niet mogelijk en is de introductie 
van een arteriële katheter in de arteria femoralis zelfs gecontra-indiceerd. Naar onze 
ervaring en in overeenstemming met de literatuur, is het meten van volumetrische 
parameters als ‘Global Eind Diastolische Volume Index’ (GEDVI) en het ‘Intra 
Thoracaal Bloedvolume Index’ (ITBVI) bij patiënten met een vergroot hart, zoals het 
geval is bij ernstige cardiomyopathie, niet relevant. Bovendien hebben we, op basis 
van de achterliggende theorie, de indruk dat de nauwkeurigheid van deze parameters 
afhankelijk is van SVV. Uit het voorgaande zijn wij van mening dat het PiCCO-
systeem van beperkte waarde is tijdens de postoperatieve bewaking bij de groep van 
thoraxchirurgische patiënten op de IC. 
Hoofdstuk 5
In 2006 werd een nieuw puls-contourmethode geïntroduceerd welke niet geijkt hoeft 
te worden, met een externe kalibratiemethode. Ook deze ongekalibreerde puls-
contourmethode, FloTrac-Vigileo (Edwards Lifesciences, Irvine, CA, USA) werd in 
het onderzoek betrokken.
Wij vergeleken de gelijktijdig continu gemeten cardiac-outputwaarden van het
FloTrac-Vigileo-monitorsysteem, de LiDCOplus (LiDCO Ltd. UK), het PiCCOplus
monitorsysteem (Pulsion Medical Systems, Duitsland), en de continue cardiac output 
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(CCO) met intermitterende bolusthermodilutie cardiac-outputwaarden (COtd), 
gemeten met Swan-Ganzkatheter en de Vigilance-monitor (Edwards, Lifesciences, 
Irvine, CA, USA). Cardiac-outputgegevens werden tijdens standaard klinische zorg 
verzameld. Hiervoor werden achtentwintig patiënten geïncludeerd die na een open-
hartoperatie op de IC werden opgenomen. Het aantal observaties varieerde tussen de 4 
en 8 per patiënt.
We stelden vast dat de betrouwbaarheid van de puls-contourmethoden de laatste jaren 
dermate is toegenomen dat vergelijking met oudere publicaties niet langer 
gerechtvaardigd is. Uit de gevonden resultaten konden we ook concluderen dat de 
cardiac-outputwaarden gemeten met het FlowTrac-Vigileo-systeem uitwisselbaar zijn
met die van het LiDCO- en PiCCO-systeem. Voorts stelden we vast dat de cardiac-
outputwaarden met de continu gemeten cardiac output (CCO) het meest 
overeenkwamen met de waarden die we vonden met bolusthermodilutiemethode. Ook 
stelden we vast dat CCO de hoogste score had in het volgen van langzame 
veranderingen in de cardiac output. Alle puls-contoursystemen, met uitzondering van 
de LiDCO, toonden een significante drift in relatie met de tijd. Het FloTrac-Vigileo 
systeem en de eenmalig gekalibeerde LiDCO-systeem presteerden het best bij snelle 
veranderingen in de cardiac output (veranderingen in slagvolume).
Hoofdstuk 6 
De nieuw te ontwikkelen meetmethoden van de cardiac output moeten bij voorkeur 
minimaal invasief zijn of moeten in ieder geval toegepast kunnen worden zonder 
aanvullende invasieve procedures voor externe kalibratie. Tot op heden zijn slechts 
twee methoden beschikbaar. Deze meetmethoden zijn gebaseerd op de Doppler-
ultrageluidtechniek en de puls-contourmethode. In dit hoofdstuk beschrijven we een 
studie waarbij gelijktijdig verzamelde cardiac-outputwaarden met het HemoSonic
100-systeem (Doppler-ultrageluid), de ongekalibreerde Modelflow en het FloTrac-
Vigileo-systeem vergeleken werden met de cardiac-outputwaarden die met bolus-
thermodilutietechniek waren gemeten.
Bij dertien postoperatieve thoraxchirurgische patiënten werden veranderingen in 
cardiac output gegenereerd door vooraf afgesproken interventies uit te voeren. De 
cardiac-outputwaarden werden voor, tijdens en na de interventies geregistreerd. De 
interventies waren verandering van het opgelegde slagvolume van de beademing 
(toename van 50%), verhoging van de positieve eindexpiratoire druk (PEEP) met 10 
cm H2O, autotransfusie door de benen 45° op te tillen (passive leg raising, PLR) en 
houdingsverandering door de patiënt 30° in anti-Trendelenburg te leggen (head up tilt, 
HUT).
De ongekalibreerde Modelflowmethode bleek de beste in het schatten van de cardiac 
output. De mate van de cardiac-outputverandering (∆CO) was identiek tussen de 
pulmonale thermodilutietechniek en HemoSonic 100 en ongekalibreerde 
Modelflowmethode. Het automatisch gekalibreerd FloTrac-Vigileo-systeem bleek de 
veranderingen in de cardiac output te overschatten.
Hoofdstuk 7 
Met de Modelflow-puls-contourmethode kan men pas na aanpassing van het model 
voor een individuele patiënt (geslacht, lengte en gewicht) een kwalitatief goede 
cardiac output meten. De Modelflowmethode (COmf) berekent slag-op-slag cardiac
output uit het signaal van de arteria-radialisbloeddruk door het nabootsen van een 
141
(drie-elementen) model van de aorta-impedantie met postmortemgegevens van 
menselijke aorta’s.
In de verbeterde versie van Modelflow (COmfc) wordt de waarde van de 
aortadiameter (CSA) meegenomen in het model. In deze studie werd de CSA met een 
HemoSonic 100 bepaald om de cardiac output te berekenen. Na diameterkalibratie 
bleek de verbeterde Modelflow puls-contourmethode in staat om een betrouwbare 
schatting van de cardiac output te berekenen. Zonder de noodzaak van een op 
thermodilutietechniek gebaseerde kalibratie leidt dit tot een minder invasieve methode 
van cardiac-outputmeting.
Hoofdstuk 8 
Met de invoering van puls contour cardiac output werd het mogelijk in ‘real-time’ het 
linkerventrikelslagvolume en slagvolumevariatie (SVV) tijdens mechanische 
ventilatie te meten. Uit studies is gebleken dat SVV een goed voorspellende waarde 
heeft hoe een patiënt op vloeistof/volumetoediening zal reageren. Slechts een enkele 
studie maakte melding van een gebrek aan correlatie tussen de waarde van SVV en
veranderende cardiac output bij volumeexpansie. Pinsky stelde terecht vast dat SVV 
niet gevalideerd is om verandering in het linkerventrikelslagvolume (binnen één 
ademcyclus) te meten. Voorts zou de beoordeling verder gecompliceerd kunnen 
worden doordat in de monitorsystemen (PiCCO, LiDCO en FloTrac-Vigileo)
verschillende algoritmes gebruikt worden. In dit licht bezien, zijn klinische 
validatiestudies van SVV, waarbij verschillende puls-contourmonitorsystemen 
gebruikt worden, belangrijk. 
In dit hoofdstuk doen we verslag van een studie waarin we waarden van de 
slagvolumevariatie, gemeten met de PulseCO (LiDCO) en het FloTrac-Vigileo 
systeem (Edwards Lifesciences), met elkaar vergelijken. Alle SVV-waarden werden 
bij vijftien patiënten na openhartoperatie tijdens het verblijf op de Intensive Care 
verzameld. De klinische waarde van SVV werd geëvalueerd door bij de patiënten 
vooraf gedocumenteerde interventies uit te voeren.. Deze interventies waren: toename 
van het opgelegde beademingsvolume, toename van de eindexpiratoire 
beademingsdruk (PEEP), passief optillen van de benen (PLR), een kantelprocedure 
(HUT) en intraveneus toedienen van 500 ml Voluven (volume). Door de interventies 
uit te voeren konden we verschillende klinische condities bij de patiënten nabootsen. 
In onze studie bleken de waarden van SVV(LiDCO) en SVV (Edwards) te 
verschillen. Met een gemeten overeenstemming van 52% tussen de twee 
meetmethoden zijn de methoden niet uitwisselbaar, zoals kan worden opgemaakt uit 
de hoge waarde van de variatiecoëfficiënt (21 en 22%) voor herhaalde metingen. Uit 
deze bevindingen bleek dat gemeten SVV-waarden, als enkelvoudige parameter, 
geringe waarde heeft voor de individuele patiënt. Tevens beperken deze bevindingen 
de vergelijkbaarheid van studiesresultaten met betrekking tot de response van de 
hemodynamisch instabiele IC-patiënt op volumetherapie.
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Conclusies
 Als referentiemethode voor de onderzochte cardiac-outputmeetmethoden 
hebben we de bolus-thermodilutiemethode (COtd) met de Swan-Ganzkatheter 
gebruikt. Wij hebben tijdens de studies geen complicaties gevonden in relatie 
tot het gebruik van deze katheters. 
 De meetfout van de Cotd-methode (de variatiecoëfficiënt), berekend op basis 
van vier metingen die gelijkmatig over de ademhaling verdeeld zijn, was < 
5%.
 Van de geëvalueerde puls-contoursystemen bleek de Modelflow- en Hemac-
methode de beste meetresultaten te geven. Deze resultaten van de Modelflow-
en Hemac-methode kwamen overeen met de cardiac-outputwaarden die 
gevonden werden met de referentiemethode (COtd). De gemiddelde cardiac-
outputwaarde was berekend op basis van vier metingen met de intermitterende 
thermodilutiemethode, waarbij de metingen gelijkmatig over de ademcyclus 
verdeeld waren.
 De stabiliteit van de kalibratie en drift van het PiCCO- en LiDCO-systeem 
verschillen.
 In ons onderzoek hebben we alleen cardiochirurgische patiënten bestudeerd. 
Daardoor kunnen onze studieresultaten niet zonder voorbehoud worden 
gegeneraliseerd naar andere categorieën van patiënten. Validatiestudies waarin 
andere groepen patiënten worden onderzocht blijft belangrijk.
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